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ABSTRACT 
NEW FUNCTIONAL HYDROPHILIC POLYMERS FOR SOLUTION ASSEMBLY 
AND NON-VIRAL GENE THERAPY 
 
SEPTEMBER 2016 
 
RACHEL A. LETTERI, B.S., UNIVERSITY OF NOTRE DAME 
 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
PH.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professors Todd Emrick and Ryan Hayward 
 
 
This thesis examines functional hydrophilic polymers designed in linear and comb 
architectures and that carry functional moieties in the context of solution assembly and 
non-viral gene therapy. Specifically, polymers containing cations, zwitterions, and reactive 
groups are investigated as non-viral gene therapy reagents and at oil-water interfaces on 
droplets. Cations facilitate complexation of nucleic acids and interaction with cellular and 
nuclear membranes, while zwitterions impart stimuli-responsive solution properties and 
biocompatibility. Reactive groups, including alkenes, alkynes, and benzylic methylenes, 
permit post-polymerization modification leading to tunable polymer properties in solution 
and at interfaces. This work expands the knowledge base related to solution, interfacial, 
and DNA complexation properties imparted by the inclusion and arrangement of functional 
groups within hydrophilic polymers.  
Chapters 2-4 discuss polymers having a comb architecture designed for non-viral 
gene therapy. These polymers contain a polycyclooctene backbone and oligopeptide and 
zwitterionic pendent groups. Chapter 2 describes comb polymers with Simian Virus 40 
nuclear localization sequence (SV40 NLS) pendent groups that interact with receptors on 
x 
the nuclear membrane to provide enhanced nuclear uptake of complexed DNA. Cell culture 
experiments revealed a marked effect of oligopeptide orientation on the resulting gene 
expression levels provided by the NLS-containing comb polymers. Moreover, these 
polymers outperformed commercial transfection reagents, both in gene expression levels 
and cell viability. Chapter 3 describes the introduction of zwitterions into these comb 
polymers and investigates the impact of zwitterions on polymer-DNA complex (or 
‘polyplex’) properties. Dispersing small amounts of zwitterion into comb polymers with 
SV40 NLS and oligolysine pendent groups improved gene expression levels. Chapter 4 
describes the synthesis of comb polymers having oligoarginine sequences as pendent 
groups and properties of the corresponding polyplexes. Compared to oligolysine 
sequences, oligoarginine facilitated stronger polymer-DNA binding and allowed inclusion 
of higher loadings of biocompatible zwitterions without compromising the ability of the 
polymer to complex DNA. 
Chapters 5 and 6 investigate zwitterionic polymers at the oil-water interface of 
emulsion droplets. Experiments in Chapter 5 demonstrate the ability of zwitterionic 
sulfobetaine methacrylate polymers to stabilize oil-in-water droplets in pure water at room 
temperature, followed by coalescence upon increasing salt concentration or temperature. 
Integrating alkene and alkyne groups directly into the zwitterionic moiety allowed 
inclusion of high loadings of functional groups without interrupting the salt-triggered 
droplet coalescence exhibited by sulfobetaine homopolymers. Functional group placement 
was found to greatly impact interfacial properties. Chapter 6 describes the preparation of 
adhesive droplets from novel sulfur-based zwitterionic polymers. Droplet adhesion was 
modulated by the presence of salt and nucleophiles, and the resultant stability and 
xi 
adhesiveness of the droplets. The interdroplet interactions were found to dictate the 
mechanical properties of the emulsion and its stability upon application of centrifugal 
force. 
xii 
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CHAPTER 1 
SYNTHETIC HYDROPHILIC POLYMERS: FROM SOLUTION PROPERTIES 
TO BIOMEDICAL APPLICATONS 
1.1 Introduction 
Hydrophilic polymers, a broad class of neutral and charged polymer structures that 
are soluble or dispersible in water, have applications that range from medicine to 
engineering (Figure 1.1). In medicine, advances involving hydrophilic polymers have led 
to more than a dozen polymer-drug conjugates approved for clinical use and at least double 
that number currently undergoing clinical trials.1–3 The biocompatibility,4–7 anti-fouling,8–
11 and bactericidal11–13 properties of water-soluble polymers have enabled infection-
resistant biomaterials for use in catheters,14–17 contact lenses,18–20 medical devices, wound 
dressings,21 and scaffolds for tissue regeneration.22–25 The anti-fouling properties of 
hydrophilic polymers extend well beyond medicine, to coatings that prevent marine fouling 
on ship hulls26,27 and water purification membranes.28 In engineering applications, 
hydrophilic polymers provide viscosity control of fluids,29 high water absorption,30,31 
lubrication,32 and chelation of heavy metals.33 For example, derivatives of polyacrylamide 
(1) are often employed to increase the viscosity of aqueous solutions used to displace oil 
from wells to yield enhanced oil recovery from reservoirs, a technology known as ‘polymer 
flooding.’29,34,35 Furthermore, hydrophilic polymers confer water dispersibility to 
otherwise water-insoluble materials, such as metal nanoparticles,36–40 radiolabels,41 oil,42 
and hydrophobic drugs,43–48 enabling numerous technologies that range from encapsulation 
to high-test medical imaging. The substantial advances in biomaterials enabled by 
hydrophilic polymer structures, including single polymer chains, nanoscale polymer 
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assemblies, and macroscopic hydrogel networks, inspires the continual development of 
hydrophilic polymers tailored to meet many diverse needs in engineering and medicine. 
 
 
Figure 1.1 Hydrophilic polymers in (a) drug and gene delivery, (b) contact lenses, (c) 
scaffolds for tissue regeneration, (d) anti-fouling surfaces that repel bacteria and proteins, 
(e) dispersion of gold nanoparticles in water, and (f) enhanced oil recovery 
 
Neutral, anionic, and cationic polymers have distinct properties that avail them to 
use in different applications, particularly as biomaterials. Many neutral hydrophilic 
polymer-based materials are biocompatible, in that they do not provoke an immune 
response when introduced into the body,49 and anti-fouling in that they prevent the 
adsorption of proteins and bacteria.4,7,8,10,11,43,50,51 The attachment of small molecule 
therapeutics to neutral hydrophilic polymers yields larger water-soluble structures 
(polymer-drug conjugates) that exhibit prolonged bloodstream circulation times by size 
exclusion from the renal filtration system and prevention of opsonin absorption that 
triggers clearance by phagocytes.43,44,46,52 During World War II, poly(vinyl pyrrolidone) 
  3 
(2) was used as a plasma substitute to treat patients and in 1955 it was conjugated to the 
drug mescaline.44,53,54 Thereafter, copious reports appeared describing attachment of 
therapeutics to poly(ethylene glycol) (PEG, 3),43,46,55 poly(N-(2-
hydroxypropyl)methacrylamide) (4),56–58 poly(2-oxazoline)s (i.e. poly(2-methyloxazoline, 
5),6,59,60 and zwitterionic polymers.45,61–63 This work resulted in clinical implementation of 
several polymer-drug conjugates1–3 and remains an active area of research. Anionic 
polymers have documented anti-viral activity owing to electrostatic interaction with 
positively charged viral components.64 Zelikin and coworkers recently introduced a set of 
poly(methyacrylic acid)s and poly(2-hydroxypropylmethacrylamide)s with the 
azidothymidine antiviral drug incorporated as a comonomer for the treatment of human 
immunodeficiency virus (HIV).65 Poly(methacrylic acid) suppressed viral replication with 
and without azidothymidine comonomer in primary human T cells expressing receptors 
necessary for HIV infection, whereas neutral poly(2-hydroxypropyl methacrylamide) was 
ineffective without azidothymidine. Cationic polymers are useful both for anti-bacterial 
applications and for the delivery of nucleic acids in gene therapy (discussed in Section 
1.4).66 The electrostatic interaction of cationic polymers with the anionic membranes of 
prokaryotic bacterial cells causes disruption upon contact.12,13,67 In 2011 the Chan-Park lab 
in Singapore reported PEG- and quarternary ammonium-functionalized chitosan hydrogel 
coatings to inhibit > 99 % of the growth of four clinically prevalent bacterial strains while 
retaining biocompatibility when coated on contact lenses placed in rabbit conjunctiva.19 
Covalent and non-covalent cross-linking of hydrophilic polymers into hydrogels 
and multilayer films has produced useful materials for therapeutic delivery, infection 
resistance, and tissue regeneration.25,68–70 Hydrogels and self-assembled structures formed 
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from polymers (discussed in Section 1.3) allow the physical encapsulation of therapeutic 
agents, circumventing the need for chemical modification.70 Notably, Heilshorn and 
coworkers designed injectable hydrogels for cell transplantation with two distinct cross-
linking mechanisms that protects cells during injection and results in nearly 50 % cell 
retention 7 days after injection.24 The Jiang group showed that incorporation of zwitterions 
(discussed in Section 1.2) into hydrogel implants resulted in a markedly lower response by 
inflammatory cells in mice three months after installation compared to hydrogels formed 
from poly(2-hydroxyethyl methacrylate) (polyHEMA, 6).7 Additionally, inclusion of 
stimuli-responsive units within hydrogels has been used to direct biodistribution, for 
example temperature-responsive poly(N-isopropyl acrylamide)-based hydrogel particles 
that circulate at normal body temperature and accumulate in locally heated tissue due to 
the coil-to-globule transition of poly(N-isopropyl acrylamide) above its lower critical 
solution temperature.71  
 
Figure 1.2 Examples of conventional hydrophilic polymers: poly(acrylamide) (1), 
poly(vinyl pyrrolidone) (2), poly(ethylene glycol) (PEG, 3), poly(hydroxypropyl 
methacrylamide) (4), poly(2-methyl oxazoline) (5), poly(hydroxyethyl methacrylate) (6), 
poly(acrylic acid) (7), poly(lysine) (8), poly(vinyl alcohol) (9), poly(ethylene imine) (10).   
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Despite their ubiquity and value in materials applications, conventional hydrophilic 
polymers, such as polyacrylamide (2) and PEG (3), as well as charged polymers, such as 
poly(acrylic acid) (7) and poly(lysine) (8) (Figure 1.2), have several shortcomings. The 
number and variety of functional groups are limited, for example, considering linear PEG 
with a maximum of two hydroxyl groups available for functionalization at the chain ends. 
Additionally, conventional hydrophilic polymers often lack stability in solutions with high 
salt concentrations, as in seawater or in physiological environments. While polyelectrolytes 
are highly soluble in pure water, adopting an expanded conformation due to repulsion 
between like charges, they collapse in solutions with high salt concentrations due to 
screened electrostatic interactions.72 PEG, a neutral polymer, is also known to “salt out” of 
solution due to the dehydration of the ethylene oxide units by highly hydrated ions, an 
effect which is enhanced at high temperature.73–75 
Advances in polymer chemistry have greatly expanded the variety of architectures 
of hydrophilic polymers as well as the functionality they present (Figure 1.3). These 
include bottle brush,76–78 cyclic,79 star,80,81 comb/brush,82–84 and branched polymers.85–88 
Architecture impacts the properties of hydrophilic polymers considerably, for example the 
residence time of a polymer in the blood stream. Fréchet and coworkers showed dendritic 
and branched polymers to have longer blood stream circulation times than linear polymers 
with similar molecular weights due to the higher energy penalty required to deform a 
branched polymer through the pores of the renal filtration system.89 Inclusion of functional 
groups with complementary reactivity, such as pentafluorophenyl ester/amine, 
azide/alkyne, and thiol/maleimide has enabled efficient conjugation of biomolecules and 
fluorophores as well as cross-linking under mild conditions.90–94 For example, mixtures of 
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telechelic PEG with thiol and maleimide end groups have been used to generated hydrogels 
with controlled molecular weight between cross-links.70 Esters,95–97 carbonates,98 
phosphoesters,99–101 and disulfides102 has imparted biodegradablity to hydrophilic 
polymers, dramatically reducing risks associated with accumulation of polymers in the 
body. Thiol-containing hydrophilic polymers anchored to gold nanoparticles and nanorods 
have allowed the dispersion of gold nanomaterials in water.36,40,103–105 Additionally, 
incorporation of oligopeptides has generated polymers that provide interesting mechanical 
properties, such as the rubber-like behavior imparted by peptide sequences from resilin, 
and enhanced interaction with cells.22,94,96,106–108 While this list is by no means 
comprehensive, it highlights the impact of architecture and functionality on the diverse 
applicability of hydrophilic polymers. Further advances will afford more sophisticated 
polymer systems that provide elegant solutions to numerous problems in biology and 
materials. 
 
Figure 1.3 (a) Architectures and (b) functional groups of hydrophilic polymers 
  
Features of hydrophilic polymers that have proved especially beneficial in the 
context of biomaterials are environmentally responsive components and the ability to 
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assemble into well-defined supramolecular structures. Inter- and intra-molecular 
association of hydrophilic polymers that are tunable through electrostatic, hydrogen 
bonding, and host-guest interactions has generated highly advanced materials that respond 
to environmental triggers.109–111 When combined with hydrophobic components, 
hydrophilic polymers self-assemble in water into intricate structures capable of 
encapsulation of both hydrophilic and hydrophobic materials.112–116 This chapter will 
discuss advances in functional hydrophilic polymers, including zwitterionic polymers, 
assembly of hydrophilic polymers in solution, and polymers designed for non-viral gene 
therapy. 
1.2 Polymer Zwitterions 
Zwitterionic polymers balance a positive and a negative charge on each repeat unit  
and provide excellent biocompatibility, stability in solutions with high salt concentrations, 
and, in some cases, stimuli-responsive behavior.117–119 The presence of charges within 
zwitterionic polymers renders them hydrophilic and stimuli-responsive, while the overall 
neutral character of the polymer repels bacteria and proteins.10,120 The most common 
zwitterionic polymers are synthesized from phosphorylcholine-, sulfobetaine-, and 
carboxybetaine-substituted methacrylates,118,119 specifically poly(2-methacryloyloxyethyl 
phosphorylcholine) (polyMPC, 11), poly(3-(2-methacryloyloxyethyl dimethylammonio)-
1-propane sulfonate) (polySBMA, 12), and poly(2-carboxy-N,N-dimethyl-N-(2’-
methacryloyloxyethyl ethanaminium) (polyCBMA, 13) (Figure 1.4). The 
phosphorylcholine zwitterion on polyMPC is found in mammalian cell membrane 
phospholipids121 and carboxybetaine zwitterions are similar to naturally occurring glycine 
betaine,122 while sulfobetaine zwitterions are synthetic structures.  
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Figure 1.4 Common zwitterionic polymers: poly(2-methacryloyloxyethyl 
phosphorylcholine) (polyMPC, 11), poly(3-(2-methacryloyloxyethyl dimethylammonio)-
1-propane sulfonate) (polySBMA, 12), and poly(2-carboxy-N,N-dimethyl-N-(2’-
methacryloyloxyethyl ethanaminium) (polyCBMA, 13) 
 
The first zwitterionic polymer was reported in 1957 by Ladenheim and Morawetz, 
a polycarboxybetaine prepared from 4-vinylpyridine.123 In 1958, Hart and Timmerman 
reported the first sulfobetaine polymer, synthesized by ring-opening of 1,4-butane sultone 
with 4-vinylpyridine and subsequent polymerization.124 Additional sulfobetaine 
derivatives followed, including methacrylate-, methacrylamide-, and pyridinium-based 
polymers sulfobetaines by Galin and coworkers,125–127 polyacrylamides by McCormick and 
coworkers,128,129 and vinyl imidazolium-based polymers by Raia and coworkers.130 Imoto 
and coworkers synthesized 2-methacryloyloxyethyl phosphorylcholine (MPC) in 1977.131 
From 1996-1999, Armes and coworkers synthesized the first well-defined zwitterions, 
polySBMA homopolymers and block copolymers, by group transfer polymerization of 
poly(2-dimethylamino ethyl methacrylate) followed by reaction with 1,3-propane 
sultone.132–134 Shortly thereafter, reports emerged by Armes135 describing the synthesis of 
well-defined polyMPC by atom transfer radical polymerization (ATRP), and by 
McCormick136 and Laschewsky137 demonstrating polymerization of sulfobetaine 
monomers by reversible addition fragmentation chain transfer (RAFT). Zwitterionic 
polymers have since diversified greatly, as described in a recent review by Laschewsky.119 
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Examples of new zwitterionic polymers include poly(amino acid)s,138 choline phosphate 
polymers,139,140 and zwitterionic dextrans141, polyphosphoesters,142 and polysiloxanes.143 
Zwitterionic polymers are diverse, spanning from those that are soluble under a 
wide range of conditions to those that undergo appreciable conformational transitions in 
response to changes in salt concentration, temperature, and pH. Many zwitterionic 
polymers exhibit salt-responsive behavior opposite to that of polyelectrolytes, which 
collapse upon addition of small molecule electrolytes.72 Electrostatic interactions between 
opposite charges and self-assembly of the dipoles present on each repeat unit confine many 
zwitterionic polymers to a collapsed configuration in pure water.144–146 Addition of salt 
disrupts these interactions and the polymer expands; this is known as the ‘anti-
polyelectrolyte effect’ (Figure 1.5).10,117,118,144 In addition to electrostatic and dipole 
interactions, Ivanov and coworkers discussed osmotic contributions to this behavior, 
wherein salt and water localize within the self-associated zwitterionic polymer coils.144 
Dupuis and coworkers similarly assert that when the concentration of salt outside the 
zwitterionic polymer coil results in a greater number of charges than present inside the coil 
(on the polymer chain), salt is osmotically driven into the zwitterionic polymer.145 Unlike 
sulfobetaine polymers with well-characterized anti-polyelectrolyte behavior in water, 
polyMPC is highly soluble both in pure water and at high salt concentrations.147 
Additionally, whereas phosphorylcholine and sulfobetaine polymers are zwitterionic at 
least from pH 1-13, carboxybetaine polymers are pH responsive (pKa ~3.3 for the 
carboxylic acid), wherein protonation of the carboxylate renders the polymer cationic.118,129 
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Figure 1.5 (a) Polyelectrolyte effect, wherein polymers collapse in solutions with high 
salt concentration due to screening of repulsive electrostatic interactions between like 
charges. (b) Anti-polyelectrolyte effect behavior of zwitterionic polymers that associate 
in pure water due to interaction between opposite charges and assembly of dipoles. 
Addition of salt screens these interactions, resulting in the expansion of the polymer and 
improved solubility.   
 
In addition to salt-responsive properties, sulfobetaine polymers display upper 
critical solution temperature (UCST) behavior in water due to screening of interactions 
between opposite charges and dipoles at elevated temperatures.118,148,149 The cloud point is 
highly tunable by varying the molecular weight, polymer and salt concentration, salt type, 
and polymer composition. In general, consistent with the anti-polyelectrolyte behavior of 
sulfobetaine polymers, the addition of salt at concentrations > ~10 mM decreases the cloud 
point.148,149 For 71 kDa polySBMA (12, 1 mg/mL), the cloud points were reported to be 
~38 and ~18 ºC in solutions with 0.17 M and 0.51 M NaCl(aq), respectively.148 However, 
several reports show an increase of the cloud point of sulfobetaine polymers in water as a 
function of salt concentration below a critical salt concentration (~10 mM).145,150 Schulz 
and coworkers found the cloud points of 43 and 71 kDa polySBMA to be ~ 35 and 55 ºC, 
respectively, at 1 mg/mL in pure water.148  Similarly, Roth and coworkers reported the 
cloud point of polySBMA to be 13 and 36 ºC for 15 and 28 kDa samples, respectively, at 
10 mg/mL in pure water.151 Well-defined polymers, such as those synthesized by RAFT 
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and ATRP,152–155 are generally lower molecular weight (Mn 20-30 kDa), and at this 
molecular weight the UCST of polySBMA is usually at or below room temperature. To 
overcome this limitation, Roth and coworkers synthesized polyacrylamides with 
sulfobetaine and benzyl pendent groups by post polymerization modification of 
poly(pentafluorophenyl acrylate) with sulfobetaine- and benzyl-substituted amines.149 
Increasing the loading of benzylacrylamide in the copolymers from 0 to 65 mol % 
increased the UCST from 10 to 80 ºC for polymers with Mn ~ 30 kDa. Interestingly, 
analogous copolymers with sulfobetaine and pentyl pendent groups showed the opposite 
trend, wherein addition of pentylacrylamide lowered the UCST. Additionally, Wischerhoff 
and coworkers found the spacer between the ammonium and sulfonate groups to impact 
the UCST behavior of sulfobetaine polymers.156 Low molecular weight polySBMAs (Mn 
~ 20 kDa) with four methylenes between the quarternary ammonium and sulfonate groups 
were found to have a UCST of 60 ºC, whereas a similar polymer with three methylenes has 
a UCST < 20 ºC.151 The facile synthesis of sulfobetaine polymers by controlled 
polymerization methods and finely tunable solution properties have afforded a wealth of 
salt- and temperature-responsive coatings,157 particles,88,158–161 and hydrogels162 with the 
desirable biocompatibility as well as the stimuli-responsive and anti-fouling properties 
inherent to zwitterionic polymers. 
Sulfobetaine, as well as carboxybetaine and phosphoryl choline polymers have 
been used extensively on surfaces,32,50,163–167 in hydrogels,162,168–172 and for the delivery of 
therapeutics.45,61–63,173–176 Jiang and coworkers have made significant contributions to anti-
fouling coatings from polysulfobetaines and polycarboxybetaines9,163,177 as well as the 
development of molecular models of these structures.178–180 Notably, they designed dually 
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functional anti-bacterial and anti-fouling coatings from a polycationic ester that undergoes 
hydrolysis into zwitterionic carboxybetaine polymers to provide non-fouling properties.181 
Several research groups in Japan prepared materials from zwitterionic polymers that have 
been highly successful as biocompatible medical implants, gene therapy reagents, and non-
fouling surfaces.4,14,63,182–188 For example, Kawaguchi and coworkers designed a polyMPC 
coating that prevented bone resorption, a common problem associated with prosthetics, 
following administration of coated polystyrene particles into mice.183 While many 
osteoclasts responsible for bone resorption were found on bone near uncoated particles, the 
number of osteoclasts found on bone near coated polymers was not significantly greater 
than that in untreated mice. Furthermore, experiments performed on simulators showed 
these coatings to impart superior wear resistance and lubrication properties to artificial hip 
and knee joints.183–185,187 These examples attest to the value of zwitterionic polymers as 
biomaterials, and suggest that research geared toward the synthesis, characterization, and 
application of these materials will lead to their widespread clinical and commercial 
implementation and enable new medical technologies. 
1.3 Assembly in solution 
Intra- and intermolecular association derived from electrostatic, hydrogen bonding, 
and hydrophobic interactions affords supramolecular assemblies of many hydrophilic 
polymers in water.114,115,189–194 The well-documented temperature responsive behavior of 
poly(N-isopropyl acrylamide), for example, results from the rupture of hydrogen bonds 
between the polymer and water at high temperatures.189,195 Incorporation of hydrophobic 
segments into hydrophilic polymers affords assembly in solution into a variety of 
structures, dictated by the hydrophobic/hydrophilic ratio, polymer architecture, and 
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processing conditions.104,112–116,133,194,196–202 Linear diblock copolymers assemble into 
micelles at low hydrophobic contents, cylindrical/worm-like micelles at intermediate 
compositions, and bilayer vesicles at high hydrophobic contents (Figure 1.6).112,116,194 
Introduction of responsive units produces phase changes, for example from micelles to 
vesicles, upon application of an external stimulus.108,114,159,161 McCormick and coworkers 
reported triblock copolymers composed of a zwitterionic sulfobetaine block (poly(3-[2-N-
methyl acrylamide)ethyldimethylammonio]propane sulfonate)), a non-responsive 
poly(N,N-dimethylacrylamide) middle block, and a pH-responsive poly(3-acrylamido-3-
methyl butanoic acid) block.159 The micelles transformed from unimers at pH 7 in the 
presence of salt (0.5 M NaCl(aq)), to micelles in at pH 4, and to physically cross-linked 
‘self-locked’ micelles upon removal of salt. Inclusion of reactive moieties on block 
copolymers has afforded core cross-linked203 and shell-cross-linked micelles197,198 that 
provide enhanced stability and mechanisms for controlled release of encapsulated 
materials. Wooley and coworkers report the assembly of cross-linked cationic spherical 
micelles encapsulating DNA onto cross-linked anionic cylindrical micelles encapsulating 
Paclitaxel.204 Tumor homing peptides were installed on the periphery of these assemblies 
for use in cancer treatment.  
In the presence of oil, polymers with both hydrophilic and hydrophobic components 
segregate to the oil-water interface to stabilize emulsions (Figure 1.6d).42 Cheng and 
coworkers prepared oil-in-water droplets stabilized by double brush copolymers, wherein 
PEG and poly(lactic acid) brushes extend from the backbone on each repeat unit.205 An and 
coworkers reported emulsions stabilized by poly(vinylphenyl boronic acid) that 
encapsulate high volumes of oil (>85 % by volume) in water.206 Subsequent removal of oil 
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led to the generation of highly porous structures. Using zwitteronic phosphorylcholine-
grafted polycyclooctenes,207 Emrick and coworkers stabilized oil-in-water droplets that 
encapsulate nanoparticles in oil for repair of damaged surfaces.208 
 
Figure 1.6 Solution assembly of hydrophilic polymers. Assembly of linear diblock 
copolymers having a hydrophilic block connected to a hydrophobic block into (a) 
micelles, (b) cylindrical micelles, and (c) bilayer vesicles. (d) Assembly of hydrophilic 
polymers with hydrophobic components at the oil-water interface on droplets. (e) 
Coacervation of oppositely charged polyelectrolytes. 
 
Liquid-liquid phase separation of polymers results in the dispersion of polymer-
rich coacervate droplets dispersed within a polymer-deficient phase.209 Simple coacervates, 
resulting from the liquid-liquid phase separation of single component in solution, have been 
formed from polyacrylamide derivatives having phenyl-210 and hydroxyl-
functionalized211,212 comonomers incorporated in a random manner. Mixing solutions of 
cationic and anionic polyelectrolytes leads to complex coacervation (Figure 1.6e), which 
is driven by electrostatic interactions and the entropically favorable release of 
counterions.209,213,214 Tirrell and coworkers demonstrated the complex coacervation of 
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oppositely charged polypeptides.213,215–217 Kataoka and coworkers found that mixing 
oppositely charged block copolymers, each with a hydrophilic neutral block, results in 
polyion complex micelles with the coacervate core surrounded by a neutral hydrophilic 
corona.196 Combining block copolymers with small neutral blocks and similarly sized 
oppositely charged polyelectrolyte blocks form polyion complex vesicles.200,218 The 
following section will discuss application of similar polyelectrolyte assemblies, in which 
cationic  polymers are used to complex nucleic acids into nanoparticles for gene therapy.  
1.4 Non-viral gene therapy using hydrophilic polymers 
Gene therapy involves the delivery of nucleic acids to cells to modify the gene 
expression profile for the treatement of diseases resulting from genetic mutations, 
including Alzheimer’s disease, Parkinson’s disease, and Duchenne Muscular 
Dystrophy.219–222 Additionally, gene therapy provides an opportunity for cancer treatment 
by the delivery of tumor-suppressor genes or suicide genes that trigger cell death.223–226 In 
2012, the adeno-associated virus (AAV), Glybera, was approved in Europe for treatment 
of a lipoprotein deficiency.227 The emergence of advanced gene editing systems, such as 
CRISPR-Cas9, has bolstered interest in gene-based therapies.228 For example, an AAV 
vector used with the CRISPR-Cas9 system demonstrated efficacy in vivo for treatment of 
Duchenne Muscular Dystrophy.222,229 While viral vectors are the most efficient gene 
carriers to date, drawbacks include a limited carrying capacity as well as possible 
introduction of undesired genetic mutations (insertional mutagenesis) and initiation of an 
immune response resulting in inflammation and/or clearance of the vector from 
circulation.230 Retroviral vectors delivered to patients with severe combined 
immunodeficiency (SCID) in a clinical trial resulted in restoration of a functional immune 
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system, however several patients developed leukemia after treatment.230,231 Non-viral 
vectors, including cationic polymers and lipids, offer safer alternatives to viruses, however 
currently afford lower protein expression levels.232–236 Cationic lipids generally yield the 
highest gene expression levels among non-viral vectors, however the toxicity of lipid-based 
gene carriers precludes their clinical translation.237–239 Polymers offer appealing 
alternatives to lipids and viruses, due to the potential to maximize both safety and efficacy 
owing to the highly tunable nature of polymeric materials.240–246 
 
Figure 1.7 Non-viral transfection process using polymers to delivery DNA, from 
polymer-DNA complex (polyplex) formation to cellular protein synthesis (transcription 
and translation) 
 
Application of polymers as virus replacements for gene therapy is a complex 
materials challenge that relies on polymer self-assembly, advanced polymer architectures, 
and installation of functional groups to overcome extensive extra- and intracellular 
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obstacles to afford successful delivery of genetic materials (Figure 1.7).246–252 Polymers 
that carry DNA must first condense it into nanoparticles, termed polyplexes, that are 
amenable to cell uptake and that provide protection from nucleases. In many cases, cell 
entry occurs by interaction with the cell membrane and subsequent uptake by endocytosis, 
resulting in the encapsulation of polyplexes in endosomal compartments. Polyplexes must 
then escape from endosomes to avoid degradation, diffuse through the cytoplasm, and enter 
the nucleus. Following nuclear entry, polymeric carriers must release DNA such that it is 
accessible to transcription factors for initiation of the protein synthesis process. Systemic 
delivery of DNA presents additional challenges, wherein polyplexes must resist protein 
adsorption and avoid recognition by the immune system.41,236,250  
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Figure 1.8 Synthetic polymers designed for gene therapy. Poly(15-pentadecanolide-co-N-
methyldiethanolamine-co-diethyl sebacate) (14),253 
poly(galactaramidopentaethylenetetramine) (15),254 poly(γ-(4-(((2-(piperidin-1-yl) ethyl) 
amino) methyl) benzyl-L-glutamate) (16),255 poly(2-hydroxypropyl methacrylamide-co-
dodecalysine hexyl methacrylamide) (17),256 PEG-SS-poly((N-(2-aminoethyl)-2-
aminoethyl)aspartamide) (18),257 and poly(carboxybetaine methacrylate ethyl ester)-b-
poly(carboxybetaine methacrylate) (19).258 
 
Synthetic hydrophilic polymers systems designed for gene therapy include 
poly(dimethylamino ethyl methacrylate)s,173,174,259–261 poly(ß-amino esters)97,226,253 (i.e., 
poly(15-pentadecanolide-co-N-methyldiethanolamine-co-diethyl sebacate), 14), 
derivatives of PEI, sugar-based polymers254,262–264 (i.e., 
poly(galactaramidopentaethylenetetramine), 15) and peptide-containing polymers, such as 
poly(benzyl-L-glutamates) (i.e., poly(γ-(4-(((2-(piperidin-1-yl) ethyl) amino) methyl) 
benzyl-L-glutamate), 16)255,265 and oligopeptide-functionalized poly(hydroxypropyl 
methacrylamide)s84,256 (i.e., poly(2-hydroxypropyl methacrylamide-co-dodecalysine hexyl 
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methacrylamide), 17) (Figure 1.8). Polymers with functional groups for recognition by cell 
surface receptors and endosomal escape include those with RGD sequences,84,266,267 
folate,268–270 and histidine.234,271 Kataoka and coworkers designed a particularly elegant 
micellar gene delivery platform from block copolymers of oligoamine-grafted 
polyaspartamide and PEG connected by a disulfide-containing linker (i.e., PEG-SS-
poly((N-(2-aminoethyl)-2-aminoethyl)aspartamide), 18).257,266,272  The PEG corona 
provides colloidal stability in the presence of salt and serum, anti-fouling properties, and 
biocompatibility. Intracellular cleavage of the disulfide bond reveals the oligoamines that 
assist in escape from endosomes. Chen and coworkers synthesized block copolymers of a 
cationic ester and a carboxybetaine zwitterion (i.e., poly(carboxybetaine methacrylate ethyl 
ester)-b-poly(carboxybetaine methacrylate), 19) that assemble into micelles, where DNA 
complexation occurs in the core and zwitterions shield the complex from aggregation and 
protein adsorption.258 Hydrolysis of the ester provides a mechanism for DNA release that 
yields a biocompatible zwitterionic carboxybetaine polymer. Emrick and coworkers 
showed polyplexes formed from comb shaped polymers having oligolysines pendent to a 
polycyclooctene backbone to outperform polyplexes from linear PLL.273 This result was 
attributed to more efficient DNA release, owing to the weaker DNA complexation by the 
lysine-based comb polymers compared to linear PLL. In contrast to the commercial lipid 
formulation, Lipofectamine® 2000, the comb polymers provided high cell viability 
following transfection. The beneficial DNA complexation properties and biocompatibility 
inspired further development of these comb polymers to include other oligopeptide 
sequences and functional groups, as will be described in Chapters 2-4.  
  20 
1.5 Thesis outline 
Hydrophilic polymers possess many favorable attributes that avail them for use in 
a diverse set of applications, particularly in medicine. Innovations in polymer chemistry 
and creative use of intra- and intermolecular interactions have produced highly functional 
materials that provide solutions to pressing biomaterials problems. This thesis exploits the 
unique properties of zwitterionic polymers, several solution assembly mechanisms, and 
straightforward monomer and polymer syntheses to increase understanding related to 
polymeric transfection reagents and functional interfacial assemblies. 
Chapters 2-4 describe the synthesis and characterization of new comb polymers 
designed to overcome barriers associated with delivery of DNA to cells for non-viral 
transfection. In Chapter 2, comb polymers that include the Simian Virus 40 large-T antigen 
nuclear localization sequence (SV40 NLS) to enhance nuclear entry are investigated as 
transfection reagents. The SV40 NLS oligopeptide orientation was found to markedly 
impact DNA binding strength, nuclear uptake of complexed plasmid DNA, and protein 
expression levels.274 These polymers outperform the commercial reagents Lipofectamine® 
2000 and jetPEITM in transfections in human ovarian cancer cells and demonstrate efficacy 
in vivo. The integration of zwitterions into polyplexes as pendent groups on comb polymers 
is discussed in Chapter 3. Experiments performed together with simulations by Jayaraman 
and coworkers at the University of Delaware provide insight into the size, surface charge, 
DNA binding strength, and composition of polyplexes containing zwitterionic groups.275 
Cell culture experiments showed red fluorescence protein expression level provided by 
these cation-zwitterion copolymers to exceed that by comb polymers without zwitterionic 
groups. Chapter 4 includes the synthesis and characterization of comb polymers and 
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corresponding polyplexes containing oligoarginine pendent groups. The arginine-rich 
monomers were amenable to copolymerization with NLS- and zwitterion-containing 
cyclcooctenes by ring-opening metathesis polymerization. Compared to analogous lysine-
based comb polymers, the arginine-based comb polymers provided markedly stronger 
DNA complexation. Notably, polymers incorporating 70 mol % sulfobetaine zwitterions 
capably condensed DNA into positively charged polyplexes ~70 nm in diameter. 
Chapters 5 and 6 describe the behavior of functional zwitterionic polymers at the 
oil-water interface on droplets. Stimuli-responsive, cross-linkable droplets are stabilized 
by alkene- and alkyne-substituted zwitterionic polymers, in which the placement of the 
functional groups was found to greatly impact the interfacial properties.276 Additionally, 
novel sulfur-based, reactive zwitterionic polymers are described that promote adhesion 
between droplets, encapsulate high oil volume fractions (~ 80 % by volume), and respond 
to multiple externally applied stimuli.  
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CHAPTER 2 
COMB POLYMERS WITH NUCLEAR LOCALIZATION SEQUENCES FOR 
NON-VIRAL DNA DELIVERY 
2.1 Introduction 
Gene therapy involving DNA cargo requires delivery into the cell nucleus for 
successful protein expression.1–5 Viruses have developed a number of strategies for 
delivery of DNA to the nucleus,6,7 however the immunogenicity presented by viral vectors 
prevent their widespread use.8–10 However, nuclear entry of non-viral vectors is a non-
trivial challenge, as shown by studies involving microinjection of DNA directly into the 
cytoplasm or nucleus.1,11,12 Capecchi reported protein expression in 50-100 % of cells 
following intranuclear injection of DNA, whereas no detectable expression was observed 
following microinjection of DNA into the cytoplasm.11 The development of non-viral DNA 
carriers that include mechanisms for nuclear entry is essential to achieve efficient 
transfection with these potentially safer gene carriers. 
In eukaryotic cells, the nucleus is separated from the cytoplasm by the nuclear 
envelope, which is composed of an inner and outer phospholipid membrane spaced ~30 
nm apart with dispersed cylindrical pores called nuclear pore complexes (NPCs) (Figure 
2.1).13 Each NPC contains ~30-50 proteins called nucleoporins, has a molecular weight of 
~ 125,000 kDa, and is approximately 100-150 nm in diameter.13–17 Non-specific nuclear 
transport occurs for salts, nucleotides, and proteins smaller than ~ 9 nm (or ~40-60 kDa) 
by passive diffusion through the nuclear pores.13,18,19 Transport of larger macromolecules, 
however, is mediated by the NPC.20,21 In non-dividing cell lines, nuclear entry is a more 
significant barrier to efficient transfection using non-viral vectors, as compared to 
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transfections in dividing cells, in which the nuclear membrane breaks down during mitosis 
and allows uptake of larger molecules.12,22–25  
Viruses benefit from nuclear localization signals (NLSs), or peptide sequences that 
facilitate nuclear import of macromolecular cargo through the NPC by interacting with a 
nuclear transport receptor.13 The heptapeptide NLS, 126PKKKRKV132, was isolated from 
the Simian Virus 40 (SV40) large T-antigen by Kalderon and coworkers in 1984.26,27 
Conjugation of synthetic peptides containing the SV40 NLS to cytoplasmic proteins, such 
as bovine serum albumin and immunoglobulin G, resulted in nuclear localization, 
demonstrating the utility of the SV40 NLS for the nuclear delivery of exogenous 
materials.28,29 Recombinant technology enabled the synthesis of SV40 large-T antigen with 
point mutations as well as insertions and deletions that elucidated the stretch of amino acids 
responsible for nuclear uptake (126PKKKRKV132) and the role of Lys-128.26,27,30 
Specifically, replacing Lys-128 with threonine (Thr, T)26,27  or asparagine (Asn, N)30 led 
to cytoplasmic, rather than nuclear localization of the mutant large-T antigen. This result 
was confirmed by other researchers, and used to confirm active nuclear uptake by using 
Thr or Asn mutations as control experiments that yield cytoplasmic localization.31–38 In 
addition to the Lys-28 mutations, several reports demonstrate the inverted SV40 sequence 
(VKRKKKP) to be transport deficient.31,39,40 These transport deficient sequences are 
valuable for establishing the function of the PKKKRKV sequence by comparing to 
analogous mutant sequences when attached to DNA and DNA carriers for Importin-
mediated nuclear uptake. 
The SV40 NLS facilitates nuclear localization of attached cargo by a nuclear import 
mechanism that involves NLS binding to a heterodimer of the Karyopherin proteins,  
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Importin-α and Importin-β, as shown in Figure 2.1.13,20,21,41–43 Specifically, the transport 
receptor Importin-β binds to the N-terminal Importin-β binding (IBB) domain of Importin-
α to activate its NLS binding pocket. SV40 NLS binds a C-terminal domain of Importin-
α, and Importin-β facilitates transport of the ternary NLS/Importin-α/Importin-β complex 
through the NPC. In the nucleus, the RanGTP protein binds the N-terminal domain of 
Importin-β, separating it from the Importin-α/NLS complex. Nup50, an NPC protein, then 
binds Importin-α to release the NLS and associated cargo. Upon binding RanGTP, the 
importins are recycled back to the cytoplasm, where hydrolysis of RanGTP to RanGDP 
releases them for use in subsequent import cycles. The gradient in the RanGAP protein 
concentration across the nuclear envelope determines the direction of transport (i.e. from 
the nucleus to the cytoplasm, or vice versa). Maintenance of this gradient relies on the 
nuclear import of RanGDP by nuclear transport factor 2 (NTF2) and subsequent conversion 
to RanGTP mediated by the RanGTP exchange factor (RanGEF) protein in the nucleus. 
Prevalence of this classical nuclear import mechanism was established by Lange and 
coworkers, wherein a search of GenBankTM (~5800 proteins) showed that 45 % of the 
proteins in the database contain NLSs that facilitate nuclear uptake by the classical 
mechanism.43  
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Figure 2.1 Nuclear import of cargo mediated by the Simian Virus 40 NLS. Importin-α 
(Imp-α) binds Importin-β (Imp-β) at the N terminal Importin-β binding domain to 
activate the C-terminal NLS binding pocket of Imp-α. Upon binding of the SV40 NLS to 
the Imp-α/ Imp-β complex, Imp-β facilitates translocation through the nuclear pore 
complex (NPC). In the nucleus, RanGTP binds Imp-β and Nup50, a nucleoporin that is 
part of the NPC, binds Imp-α to release the NLS and attached cargo. The importins bind 
RanGTP and are then recycled to the cytoplasm, where they are released by hydrolysis of 
RanGTP to GDP by RanGTPase activating protein 1 (RanGAP1). The RanGTP gradient 
is maintained by the continuous nuclear import of RanGDP by nuclear transport factor 2 
(NTF2) and nucleotide exchange to RanGTP in the nucleus mediated by RanGTP 
exchange factor (RanGEF).  
 
Since its discovery in the 1980s, SV40 NLS has seen widespread use in non-viral 
gene therapy.13,19,20,41,43,44 Conjugation of SV40 NLS to DNA and transfection reagents, as 
shown in Table 2.1, as well as non-covalent integration into polymer-based DNA 
complexes45–48 has been examined for improvement of nuclear uptake and subsequent 
protein expression, with mixed results reported. Behr and coworkers found that attaching 
SV40 NLS-containing oligopeptides to linear DNA capped with a hairpin oligonucleotide 
resulted in >100 times the protein expression of a similar DNA construct without the 
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NLS.36 Other reports involving the attachment of the SV40 NLS to DNA demonstrate the 
functionality of the NLS on the construct, either through Importin-α binding assays or by 
experiments showing nuclear uptake of the NLS attached to protein cargoes rather than to 
DNA.34,49–51 However, these conjugates failed to improve nuclear uptake. Alternatively, 
SV40 NLS has been conjugated to DNA-complexing agents such as oligopeptides39,52–60 
and synthetic polymers.38,61–68 Despite the benefits of polymers for non-viral gene 
delivery,69,70 including safety and ability to tailor the molecular weight, architecture, and 
composition, the only examples of SV40 NLS-polymer conjugates involve poly(L-lysine) 
(PLL),61 polyethylenimine (PEI),62,67 poly(ethylene glycol) (PEG),38,64 and poly(L-lactide-
co-glycolide) (PLGA).63 Typically, conjugation is accomplished through a flanking 
cysteine residue on an NLS-containing oligopeptide to an alkene or maleimide on the 
polymer.  
Table 2.1 Examples of SV40 NLS bioconjugates used in gene therapy  
Conjugate Ref. Conjugate Ref. 
 
26,27 
 
50 
 
29,32,40,71 
 
34,36,51 
 
28 
 
49 
 
39,52,55,57,
60  
37,72 
 
54,56,58 
 
37 
 
53–55,59 
 
38,61 
 
73 
 
62–64 
 
33,35 
 
65,66,68 
PNA = peptide nucleic acid;  = linker or oligopeptide; all sequences are listed 
from N terminus to C terminus (left to right) 
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Prior reports by Emrick and coworkers described the transfection performance of 
comb polymers having a polycyclooctene backbone and a mixture of pendent oligolysine 
and SV40 NLS groups. These polymers led to a marked improvement in transfection 
performance compared to linear polylysine. The benefit of the comb architecture was 
attributed to favorable DNA binding properties, wherein the comb polymers facilitated 
more efficient DNA release.65,74 The NLS groups were valuable attributes to this system as 
well, as copolymers having pendent NLS groups gave higher protein expression than those 
with having only oligolysine grafts. However, quantitative polymerase chain reaction 
(qPCR) experiments showed that comb polymers with SV40 NLS groups did not increase 
the number of plasmids delivered to the nucleus compared to comb polymers with only 
oligolysine pendent groups. Nonetheless, finding the comb architecture to improve 
transfection efficiency, my thesis work sought to further pursue optimal strategies 
involving NLS integration into polymer-based transfection systems.  
Two studies reveal effects of NLS orientation on transfection performance. 
Brandén and coworkers reported that Cy3-labeled DNA hybridized to a peptide nucleic 
acid (PNA)-NLS conjugate, with SV40 NLS attached to the PNA at the valine residue, 
facilitated nuclear uptake of DNA in live cells, as determined from fluorescence 
micrographs.72 In contrast, reorienting the conjugates with the NLS groups attached to 
PNA at the proline residue provided no detectable uptake of hybridized DNA. The lack of 
nuclear localization was attributed to the transport deficiency of the VKRKKKP 
sequence.31,39,40 In another study, N-stearylated and unstearylated oligoarginine-
PKKKRKV (oligoarginine-NLS) and oligoarginine-VKRKKKP (oligoarginine-rNLS) 
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constructs provided similar nuclear uptake regardless of the NLS orientation.55 Inspired by 
these findings, we investigated the orientation of SV40 NLS pendent groups on a 
polycyclooctene backbone, as shown in Figure 2.2 for NLS (proline attachment to 
backbone) and the reverse case (rNLS, valine attachment to backbone). Unlike other 
systems that combine the SV40 NLS with a second cationic moiety for DNA binding and 
cellular uptake,55,59,61,62,67 these polymers have copies of the SV40 NLS attached at every 
eighth carbon on the backbone, with lysine and arginine residues providing for both DNA 
complexation and cellular uptake in addition to nuclear uptake.  
 
Figure 2.2 Representation of synthetic comb polymer transfection reagents with ‘NLS’ 
and ‘rNLS’ groups pendent to the backbone. 
 
This chapter describes the synthesis and DNA complexation properties of comb 
polymers having the SV40 NLS as pendent groups, as well as the transfection performance 
of these polymers in SKOV3 (human ovarian adenocarcinoma) cells and in intramuscular 
gene delivery in vivo.  The impact of oligopeptide orientation on DNA complexation 
strength and transfection performance is discussed. Polyplexes formed from the rNLS 
comb structures outperformed PLL, jetPEI™, and Lipofectamine™ 2000 in transfections 
in SKOV3 cells, and demonstrated efficacy in vivo as well.75 Comparison of DNA binding 
and nuclear uptake properties of polymer-DNA complexes (‘polyplexes’) formed from the 
NLS and rNLS polymers leads to further understanding of these comb polymer transfection 
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reagents, which were found to outperform commercial transfection reagents. The 
experiments presented here establish improved methodology for comb polymer 
transfection reagents and confirm their stability for animal studies.  
2.2 Synthesis of NLS and rNLS comb polymers  
Polycyclooctenes with pendent SV40 NLS groups were synthesized by ring-
opening metathesis polymerization (ROMP) of oligopeptide-subsituted cyclooctenes.65,75 
Macromonomer 24, having the t-butyloxycarbonyl (Boc)- and 
pentamethyldihydrobenzofuran (Pfp)-protected sequence 
VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P attached to cyclooctene at the valine residue, was 
prepared by Fmoc solid-phase peptide synthesis (SPPS).76 As shown in Scheme 2.1, 9-
fluorenylmethoxycarbonyl (Fmoc)-protected proline (Fmoc-Pro-OH) was coupled to 2-
chlorotrityl chloride resin (20) in the presence of diisopropylethylamine (DIPEA), which 
deprotonates the carboxylic acid on proline without cleaving the Fmoc group, and the 
remaining sites on the resin were blocked using a mixture of CH2Cl2/CH3OH/DIPEA 
(80/15/5 v/v/v). The Fmoc group was then removed with piperidine (25 % v/v in N,N-
dimethyl formamide, DMF) to yield 21. Subsequent amino acids were added by 
hydroxybenzotriazole (HOBt) hydrate/2-(1H-benzotriazol-1-l)-1,1,3,3,-
tetramethyluronium hexafluorophosphate (HBTU)-mediated coupling of Fmoc- and 
Boc/Pbf-protected amino acids (Fmoc-AA-OH in Scheme 2.1) to the free amine on the 
resin-bound peptide, followed by removal of Fmoc in a piperidine/DMF mixture (1/3 v/v) 
to give 22. Conveniently, the use of both acid- and base-cleavable protecting groups allow 
the removal of base-labile Fmoc groups with piperidine while leaving the acid-labile Boc 
and Pbf groups intact on the lysine and arginine side chains. (Z)-cyclooct-4-ene-1-
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carboxylic acid (23) was coupled to the N-terminal valine residue of 22 using identical 
HOBt/HBTU conditions. The macromonomer 24 was then removed from the resin using a 
weakly acidic mixture of 2,2,2-trifluoroethanol (TFE) and dichloromethane (1/4 v/v) such 
that side chain Pbf and Boc groups remained intact, and isolated by precipitation into 
diethyl ether. The structure of 24 was confirmed by 1H and 13C NMR spectroscopy in 
DMSO-d6 and fast atom bombardment (FAB) mass spectrometry ([M+H]+ calculated 
1672.00, found 1672.01).  
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Scheme 2.1 Solid phase peptide synthesis of rNLS-COE, 24, and the 1H NMR spectrum 
of 24 acquired in DMSO-d6. 
 
Macromonomer 24 was polymerized by ROMP, selecting a mixture of TFE and 
dichloromethane and the bromopyridine-substituted Grubbs metathesis catalyst 2624 to 
afford rNLS 28 (Scheme 2.2). After the polymerization, the mixture of polymer and 
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residual monomer was precipitated into diethyl ether, and isolated as a solid by 
centrifugation. Monomer conversion was determined by 1H NMR spectroscopy, 
integrating the cyclic olefin proton resonance at 5.6 ppm against the polymer olefin 
resonance at 5.3 ppm. As shown in Table 2.2, monomer conversion decreased with 
increasing monomer:catalyst ratios ([M]:[I]) (28a-c). Polymerizations conducted at room 
temperature and 40 °C resulted in monomer conversions of 37 (28b) and 64 % (28e), 
respectively. Polymers 27a-c were synthesized similarly, using  macromonomer 25 having 
the SV40 NLS attached to cyclooctene through the proline residue as previously reported.65  
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Scheme 2.2 Ring-opening metathesis polymerization (ROMP) of SV40 NLS 
macromonomers, NLS-COE (25) and rNLS-COE (24). 
 
The molecular weights and polydispersities of the Boc- and Pbf-protected polymers 
were estimated by gel permeation chromatography (GPC) eluting with N,N-
dimethylformamide (DMF) in the presence of 0.01 M LiCl (Table 2.2). Removal of the 
Boc and Pbf protecting groups in trifluoroacetic acid (TFA)/ triisopropylsilane (TIPS)/ 
water (95/2.5/2/5 v/v/v) gave the corresponding cationic polymers, NLS (27) and rNLS 
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(28). Except for 27c-TFAc and 28d-TFAc, where TFAc indicates trifluoroacetate 
counterions, dialysis in 30 % acetic acid in water was performed to exchange TFAc 
counterions to acetate, and the polymers were isolated first by dialysis in water and then 
by lyophilization to produce white powders typically in 50-70 % yield. The polymer 
structures were confirmed by 1H and 13C NMR spectroscopy. Though comb polycations 
with several counterions were prepared, the counterion exerted no impact on transfection 
efficiency.75 Molecular weights and molecular weight distributions of NLS and rNLS 
polymers, with both acetate and TFAc counterions, were estimated by GPC eluting with 
TFE having 0.02 M sodium trifluoroacetate (Table 2.2). TFE proved useful as an eluent 
for SEC of these cationic polymers, as well as for polymers having hydrophilic, 
hydrophobic, and zwitterionic moieities (described in Chapters 3-6 of this thesis). The GPC 
chromatograms in Figure 2.3 are nearly Gaussian in shape, suggesting minimal polymer-
to-column interactions. Given the chain transfer to polymer and cyclization occurring 
during the ROMP of cyclooctenes due to intra- and intermolecular secondary metathesis 
,77,78 the narrow molecular weight distributions observed for 28 and 29 were unanticipated. 
The narrow molecular weight distributions (as low as 1.2-1.4, Table 2.2) of the Boc- and 
Pbf-protected polymers, evaluated by GPC in DMF (PMMA standards), and of deprotected 
cationic polymers, evaluated by GPC in TFE (PMMA standards), are attributed to the steric 
bulk of the macromonomer that acts to reduce secondary metathesis events.79 This series 
of NLS and rNLS comb polymers synthesized with a range of molecular weights was 
employed to study the impact of SV40 NLS orientation on DNA complexation, nuclear 
uptake, and transfection performance. 
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Table 2.2 Polymerization data for the synthesis of NLS (27) and rNLS (28) 
Sample [M]:[I] [M] T Conv. Protected polymers 
(GPC in DMF) 
Deprotected polymers 
(GPC in TFE) 
  (M) (°C) (%) Mn (g/mol) Mw/Mn Mn (g/mol) Mw/Mn 
27a 25 0.27 RT 88 59800 1.16 40400 1.15 
27b 50 0.27 RT 80 81800 1.28 58300 1.24 
27c-TFAc 100 0.61 RT 34 114000 1.50 74400 1.57 
28a 25 0.25 RT 89 50400 1.17 41500 1.18 
28b 100 0.29 RT 37 78200 1.31 63300 1.40 
28c 50 0.55 RT 71 90900 1.23 70800 1.39 
28d-TFAc 100 0.61 RT 46 104600 1.51 78900 1.73 
28e 100 0.29 40 64 114000 1.36 89900 1.61 
 
 
Figure 2.3 (a) Structure, (b) GPC traces (eluting with TFE), and (c) 1H NMR spectrum 
acquired in D2O of 28.  
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2.3 Polyplex formation and characterization.  
Polyplexes, or polymer-DNA complexes, were formed by mixing solutions of 27 
or 28 with plasmid DNA (reporter mRFP-IRES-Puro, 4.5 kbp, 0.02 g/L) in a 1:1 v/v ratio 
for 40 minutes. The polymer concentration used for polyplex formation was determined by 
the desired N/P ratio, the ratio of protonatable nitrogens on the polymer (cations) to DNA 
phosphates (anions). Calculations of the polymer concentration required to achieve a given 
N/P ratio are given in Chapter 8. Polyplex formation was monitored using the Quant-iT 
Picogreen® double-stranded DNA intercalating reagent that fluoresces upon binding 
DNA.80,81 The plot in Figure 2.4a shows the the percentage of DNA accessible to 
Picogreen, calculated as the percentage of Picogreen® fluorescence intensity compared to 
the Picogreen® fluorescence in the absence of polymer (representing 100 % accessible 
DNA). The decrease of DNA accessibility as a function of time occurs as polymer binds 
to DNA and displaces Picogreen®. Appendix A provides further detail about this 
competitive binding assay.  
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Figure 2.4 (a) Schematic of the Picogreen®-based polyplex formation assay; (b) polyplex 
formation monitored upon mixing rNLS polymer (28c) with plasmid DNA (reporter 
mRFP-IRES-Puro, 4.5 kbp, 0.02 g/L) in a 1:1 v/v ratio at N/P 4.0 in the presence of 
PicoGreen®. Picogreen® fluorescence was measured at 520 nm, exciting at 480 nm 
using a plate reader in fluorescence mode and error bars indicate ± standard deviation. (c) 
Atomic force microscopy (AFM) of polyplexes formed from 28c at N/P 5.0, with an inset 
showing the particle size distribution as the inset. 
 
Polyplexes should be ~20-200 nm in diameter to avoid renal clearance and 
phagocytosis.82–84 Atomic force microscopy of polyplexes formed from 28c and plasmid 
DNA at N/P 5 revealed approximately spherical particles, with a majority being smaller 
than 100 nm in diameter (Figure 2.4b). Dynamic light scattering of the polyplexes (N/P 5) 
formed from PLL, NLSc, rNLSa-e, and jetPEITM, and diluted with 100 mM NaCl(aq) to a 
final concentration of 10 mM NaCl, showed structures with an intensity-average 
hydrodynamic diameter ranging from 50-80 nm (Table 2.3). In the absence of a specific 
cell targeting ligand, a net positive surface charge is desired to facilitate interaction of the 
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polyplex with the negatively charged phospholipid membrane to promote uptake by 
endocytosis.3,4,69 Zeta potential measurements of the polyplexes (N/P 5) in 10 mM NaCl(aq) 
at 25 °C indicate net positively charged surfaces, with zeta potentials ranging from +26-41 
mV (Table 2.3).  
Table 2.3 Polyplex characterization at N/P 5 by dynamic light scattering (DLS) and zeta 
potential in 10 mM NaCl. Error bars indicate ± S.D. 
Polymer Polyplex size  
(nm) 
Polyplex zeta potential  
(mV) 
PLL 62 ± 2 41 ± 4 
jetPEITM 50 ± 4 28 ± 3 
27c-TFAc 73 ± 1 33 ± 1 
28a 76 ± 1 33 ± 1 
28b 78 ± 2 28 ± 2 
28c 74 ± 2 32 ± 1 
28d-TFAc 76 ± 2 26 ± 2 
28e 76 ± 2 28 ± 5 
 
2.4 DNA accessibility 
Polymeric transfection reagents should bind DNA strongly enough to protect DNA 
from nucleases during delivery, yet weakly enough so that the DNA is available for use by 
transcription machinery to initiate protein expression. DNA complexation strength plays a 
crucial role in transfection performance of polymer-based DNA delivery vehicles.85–87 
Previous work published by Emrick and Jayaraman showed that reconfiguring linear PLL 
into a comb architecture produced a marked increase in gene expression, attributed to the 
more efficient DNA release for use by the cell’s transcription machinery.65,74  
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Figure 2.5 Determination of DNA accessibility using a PicoGreen® plate reader assay 
(a), wherein polyplexes formed from PLL, NLS, and rNLS (N/P 5) were incubated with 
Picogreen® (1X) and heparin (40 units, 10 units/well). (b) Percentage of DNA DNA 
accessible to PicoGreen® 16 h after exposure of polyplexes to Picogreen® and heparin. 
Picogreen fluorescence was measured at 520 nm, exciting at 485 nm using a plate reader 
in fluorescence mode. Error bars indicate ± standard deviation.  
 
Given the importance of DNA complexation properties for transfection 
performance, we investigated the influence of oligopeptide orientation on DNA 
accessibility in the polyplexes using the Quant-iT PicoGreen® dsDNA reagent.80,81 
Polyplexes were formed at N/P 5 then incubated with Picogreen® and heparin, an anionic 
polymer that competes with DNA for polycations. The plot in Figure 2.5b shows the 
relative percentage of DNA accessible to Picogreen® 16 h after incubation polyplexes 
formed from the comb polymers, PLL, jetPEITM, and Lipofectamine 2000 with heparin 
(shown schematically in Figure 2.5a).  This assay is described in detail in Appendix A. 
Strong DNA-polymer interactions for PLL are evident from the low percentage of DNA 
accessible after 16 h, while NLS-containing structures show higher DNA accessibility. The 
oligopeptide orientation greatly impacted DNA accessibility to Picogreen®. NLS polymers 
(27a-c) allowed only slightly greater accessibility of Picogreen® to DNA (15-20 %) than 
PLL (10-15 %). The modest increase of DNA accessibility of NLS compared to PLL is 
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consistent with the results previously by our group, showing the percentage of DNA 
accessibility to Picogreen in polyplexes formed from NLS and PLL and incubated with 
heparin to be approximately 10 and 20 %, respectively.65 The rNLS comb polymers (9), 
however, provide much higher accessibility of DNA to Picogreen (25-40 %).  
Orientation-dependent DNA binding properties were also observed in molecular 
simulations of these comb polymers with pendent SV40 NLS and several variations of 
similar heptapeptide groups performed by Dr. Robert Elder in the Jayaraman group.88 
Simulations showed that in the absence of DNA, comb polymers having a proline residue 
adjacent to the polycyclooctene backbone and a valine residue at the end of the graft 
furthest from the backbone, as in NLS polymers, formed more  hydrophobic contacts than 
similar polymers with with valine attached to the backbone, as in rNLS polymers. Upon 
binding DNA, comb polymers with proline attached to the backbone gained fewer 
hydrophobic contacts, which resulted in a smaller conformational entropy loss and more 
favorable binding free energies for NLS polymers compared to rNLS polymers with valine 
connected to polycyclooctene. Despite the similar composition of the NLS and rNLS 
polymers, experiments and simulations indicate that oligopeptide orientation greatly 
impacts DNA complexation properties.  
2.5 Effect of NLS orientation on nuclear translocation 
Nuclear uptake has been studied using fluorescence and confocal microscopy with 
fluorescently labeled plasmids27,51,55,72,89 and also more recently by the quantitative 
polymerase chain reaction (qPCR) technique that measures the number of plasmids per 
nucleus.90,91 The qPCR method involves the addition of DNA with polymers or lipids, 
followed by homogenization of cells and isolation of the nuclei by iodixanol density 
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gradient ultracentrifugation.91,92 PCR is then used to determine the number of plasmids per 
nucleus by comparing the total number of plasmids of interest to the number of copies of 
a gene present as a single copy in the genone (i.e. β-actin or gapdh).   
 
Figure 2.6 qPCR analysis of plasmid abundance per SKOV3 (a) cell nucleus, and (b) 
whole cell, 24 h post transfection with PLL, NLSc, and rNLSd polyplexes at N/P 5 and 
Lipofectamine 2000 (LP2K). Error bars indicate ± standard deviation and ‘ns’ indicates 
no statistically significant difference of plasmids / cell relative to cells transfected with 
PLL. 
 
Quantitative PCR was performed by S. Parelkar following delivery of polyplexes 
(N/P 5) to SKOV3 cells to determine the impact of the SV40 oligopeptide orientation on 
the number of plasmids delivered per cell and per nucleus (Figure 2.6).75 Transfection of 
SKOV3 cells with comb polymers containing SV40 NLS led to a higher nuclear abundance 
of plasmids compared to transfections performed with PLL. The rNLS polymer 28d 
provided a three-fold greater plasmid copy number per cell nucleus (~8.7 x 106) than the 
NLS polymer 27c (~2.3 x 106). This result cannot be attributed to cell uptake, as 
transfection of SKOV3 cells with PLL, 27c, and 28d showed no significant difference in 
the number of plasmids delivered per whole cell (Figure 2.6b). Lipofectamine™ 2000 
(LP2K) gave an approximately 50 times higher abundance of plasmids per cell, which 
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resulted in 3-10 times higher nuclear abundance compared to the comb polymers. 
However, the toxicity of LP2K precludes its clinical application,93–95 so while LP2K serves 
as an excellent benchmark, it is important to make further strides in the transfection 
performance of safer delivery vehicles. From these results, it is evident that the SV40 
oligopeptide orientation impacts nuclear uptake of plasmids in addition to DNA 
complexation strength.  
In the context of prior reports on non-viral gene delivery using the SV40 NLS, these 
results are interesting for a number of reasons. First, our results are consistent with those 
of Brandén and coworkers in that attachment of NLS by the valine residue to a polymer or 
peptide nucleic acid (PNA) results in superior nuclear uptake of plasmids. However, unlike 
Brandén and coworkers who find no nuclear translocation following the addition of 
fluorescently labeled plasmids with peptide nucleic acids having the SV40 NLS attached 
by the proline residue, the comb polymers presented here facilitate nuclear uptake 
regardless of of NLS orientation. An additional important difference between the PNA-
NLS conjugates and the comb polymers is the N-terminal to C-terminal orientation of the 
SV40 NLS. The wild type SV40 T-antigen contains the PKKKRKV sequence as residues 
126-132, having proline closer to the N terminus. The functional PNA-NLS conjugate 
reported by Branden and coworkers has the SV40 NLS oriented such that proline is at the 
N terminus. The NLS comb polymers described here, however, are synthesized such that 
the N terminus is attached to the polymer backbone and therefore the rNLS polymers, 
having the valine attached to the backbone, contain the SV40 NLS oriented such that the 
valine residue is N terminal. Given the reports that demonstrate the inverted SV40 
(VKRKKKP) as being transport deficient,31,39,40 the finding that multiple copies of this 
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sequence  attached to a polymer to facilitate more nuclear uptake than analogous structures 
with the PKKKRKV sequence is interesting. Wang et al. reported conjugates of 
oligoarginine-PKKKRKV (oligoarginine-NLS) and oligoarginine-VKRKKKP 
(oligoarginine-rNLS) that also provided nuclear translocation with both PKKKRKV and 
VKRKKKP sequences.55 It has been proposed that complexation of DNA with NLS may 
inhibit NLS activity by precluding its accessibility to the nuclear import machinery.51 The 
differences in DNA complexation strength observed comparing NLS to rNLS polymers, 
wherein NLS polymers with the wild-type SV40 NLS exhibit stronger DNA binding, 
further support this hypothesis. Testing this hypothesis would require a binding assay to 
examine the interaction of the NLS with its receptor, Importin-α, such as those that 
determine the functionality of NLS conjugates.34,96 Another possible role of the NLS 
orientation is the accessibility of the lysine residue 2 units away from proline (Lys-128).30  
2.6 Transfection performance  
The effect of oligopeptide orientation on transfection performance was investigated 
in cell culture and in vivo, and compared to the performance of the commercial reagents, 
PLL, jetPEI, and LP2K. S. Parelkar compared the protein expression resulting from 
polyplexes formed from the comb polymers and commercial transfection reagents in 
SKOV3 cells, a human ovarian cancer cell line selected for its therapeutic relevance. 
Complexes of polymer and plasmid DNA coding for red fluorescent protein (reporter 
mRFP-IRES-Puro, 4.5 kbp) were formed at N/P ratios ranging from 3-7 (described in 
Section 2.3). The polyplexes were diluted with serum-free cell culture medium and added 
to cells seeded at ~40 % cell density in 96 well plates. Serum-free conditions were 
employed when adding polyplexes to cells in order to minimize interactions with serum 
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proteins that may induce aggregation of polyplexes.97–99 Such conditions are not unrealistic 
in vivo, for example in cases where local injection of polyplexes is used rather than 
intravenous injection that introduces polyplexes to serum proteins.66,100 Since serum-free 
transfections often offer optimal conditions for cationic polymer-mediated gene therapy,99 
this allows selection of a reagent that provides high gene expression levels in the absence 
of serum that can potentially be tailored to provide serum stability for systemic 
administration. Six hours after addition of polyplexes to cells, the serum-free medium was 
supplemented with medium containing fetal bovine serum (FBS). Forty-eight hours after 
addition of polyplexes to cells, a plate reader in fluorescence mode was used to assess red 
fluorescent protein (RFP) expression. Figure 2.7a shows RFP expression in SKOV3 cells 
provided by the polyplexes derived from the comb polymers, jetPEITM, and PLL as well as 
by LP2K. The rNLS polymers yielded higher levels of protein expression than the NLS 
comb polymers, as well as PLL, jetPEITM, and LP2K.  
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Figure 2.7 Transfection performance of polyplexes in SKOV3 cells: (A) RFP expression; 
(B) cell viability 48 h post transfection. Cells in each well of a 96-well plate were 
exposed to 27a-c or 28a-e polyplexes (N/P 3-5). Error bars indicate ± standard error of 
the mean. 
 
These transfection experiments indicate that the oligopeptide orientation impacts 
the gene expression levels provided by the SV40 NLS-containing comb polymers.  Five 
different molecular weight rNLS polymers (28a-e) were compared with three different 
molecular weight NLS polymers (27a-c), and even the lowest expressing rNLS polymer 
28e gave higher RFP expression than the best expressing NLS polymer 27c. While 
polymers with different molecular weights afforded differing amounts of protein 
expression, no discernable impact of molecular weight was found. Consistent with the 
increased nuclear uptake and DNA release afforded by rNLS- compared to NLS-based 
  71 
polyplexes, the superior protein expression of rNLS-based polyplexes formed from 28a-e 
relative to 27a-c suggests that reorienting the PKKKRKV sequence improved transfection 
efficiency. Cell viability was also determined 48 hours after addition of polyplexes to cells 
using the Cell-Titer Glo luminescent cell viability assay from Promega on a plate reader in 
luminescence mode (Figure 2.7b). PLL, NLS, and rNLS polyplexes exhibited high cell 
viability, in contrast to jetPEI™ and LP2K. Despite the fewer number of plasmids 
delivered to the nucleus by rNLS compared to LP2K (Figure 2.6), rNLS provides superior 
RFP expression, likely due to the toxicity of the LP2K-DNA complexes. The RFP 
expression measurements account for live cells only, as dead cells float and are washed 
away prior to RFP expression measurements. Taken together, these cell culture results are 
encouraging in that the rNLS comb polymers exceed both the protein expression and cell 
viability levels provided by jetPEI™ and LP2K. 
The high transfection efficiency of rNLS-based polyplexes in cell culture 
encouraged us to evaluate the performance of these polyplexes in vivo. Transfection 
experiments in mice were performed in M. Figueiredo’s laboratory (University of Texas 
Medical Branch, Galveston, TX) using ultrasound mediated delivery.101,102 For these 
experiments, polyplexes were formed from rNLS and NLS polymers and Renilla 
Luciferase reporter plasmid DNA (pRluc) at N/P 6.1, and at two different DNA doses (12.5 
and 45 µg). The polymers 28c and 28d were selected for their transfection efficiency in 
SKOV3 cells. Polyplexes were co-injected with microbubbles, lipid-coated gas-in-liquid 
emulsions ~1-10 µm in size,101,102 into muscle cells in the right and left hind legs of each 
mouse. Ultrasound stimulus was applied to the right hind legs at 1 MHz, 2 W/cm2 for 1 
minute while the left leg was used as a non-ultrasound control. In response to the ultrasound 
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waves, the microbubbles rupture, generating shear stresses in the vasculature and shock 
waves that create transient pores in the cell membrane.101,102 This leads to increased uptake 
of extracellular fluid and polyplexes in the vicinity of the  impacted cells. Luminescence 
imaging of the mice was performed 3, 6, 9, 15, and 30 days following polyplex 
administration to evaluate luciferase expression from the luminescence intensities of the 
hind legs. Figure 2.8a shows the luminescence images acquired 9 days after polyplex 
injection for the 12.5 µg DNA dose. From these images, it is evident that the rNLS polymer 
28d provided higher luminescence intensities, and thus luciferase expression levels, than 
the NLS comb polymer 27c. Additionally, the application of ultrasound increased gene 
expression levels, as judged from the higher luminescence intensities of the right hind legs, 
where ultrasound was applied, relative to the left hind leg to which no ultrasound was 
applied. The improved transfection performance provided by rNLS relative to NLS was 
consistently observed in the images collected over 30 days for both DNA dosing levels 
(Figure 2.8b). Polyplexes formed from 28d gave 2-10 times greater protein expression than 
those formed from 27c using sonoporation. These results are especially encouraging 
considering that rNLS outperformed ‘NLS2’,75 a copolymer of 5-PKKKRKV-1-
cyclooctene (NLS) and 5-tetralysine-1-cyclooctene,65 that has, in two reports, provided 
higher gene expression levels than jetPEITM in ultrasound mediated intramuscular delivery 
in mice.66,68  
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Figure 2.8 Intramuscular ultrasound-mediated gene delivery in mice by NLS (27c)- and 
rNLS (28d)-based polyplexes. (A) Representative bioluminescence images of mice 
transfected with luciferase reporter plasmid after 5 min acquisition time using a Xenogen 
IVIS100 CCD camera (9 days after sonoporation). The right hind legs represent protein 
expression resulting from intramuscular ultrasound-mediated delivery; the left hind legs 
represent intramuscular delivery in the absence of ultrasound. The color bar indicates the 
luminescence intensity in photons/sec/cm2/steradian (p/s/cm2/sr). (B) Luciferase 
expression from right hind legs. Error bars indicate mean ± standard error of the mean. 
2.7 Conclusions and outlook 
Comb polymers were synthesized with SV40 NLS sequences attached by either the 
proline or the valine residue to a polycyclooctene backbone every 8 carbons. The cationic 
residues of the SV40 NLS allowed the complexation of DNA by these polymers without 
the need for additional cationic components. The oligopeptide orientation with respect to 
the polymer backbone profoundly impacted the properties of the corresponding polyplexes. 
Compared to NLS comb polymers, the rNLS structures exhibited weaker DNA binding 
strength, higher nuclear uptake, and higher transfection performance in cell culture and in 
vivo. Both NLS and rNLS comb polymers fomed polsitively charged polyplexes, ~50-80 
nm in diameter at N/P 5 in 10 mM NaCl(aq). The results in cell culture demonstrating the 
superior performance and cell viability of these comb polymers relative to LP2K, as well 
as the in vivo performance of these comb polymers shown here and in co-authored 
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publications by the Emrick and Figueiredo laboratories,66,68,75 encourage the further 
development of these comb polymer systems. All improvements of polymer-based 
transfection reagents with respect to transfection performance and safety, relative to 
cationic lipids and viral vectors are important advances as they bring the clinical 
application of gene therapies closer to fruition. Expansion of this comb polymer platform 
through new syntheses, biological assays, and molecular simulations that provide deeper 
understanding of these materials will lead to the development of clinically useful reagents 
for use by the gene therapy community. 
The function and presentation of the SV40 NLS in these comb polymers warrants 
further exploration. Considering reports showing the VKRKKKP sequence to be transport 
deficient,31,39,40 changing the presentation of the wild type sequence, as in the NLS comb 
polymers 8a-c, within the polyplex may lead to further improvements in the nuclear uptake, 
and by extension, the gene expression afforded by these polymers.  Spatial separation of 
the NLS from DNA to prevent interaction with DNA that may hinder access of the nuclear 
import machinery may enhance the activity of the NLS. For example, Kataoka and 
coworkers formed polyplexes from block copolymers of oligoamine-functionalized 
polyaspartamides and polyethylene glycol (PEG), wherein the DNA complexation by the 
amine-containing block occurs in the interior of the micelle and the PEG chains are 
sequestered to the outside of the polyplex and act as a shield to block the adsorption of 
serum proteins.103,104 By the installation of functional groups at the periphery of the 
micelles (i.e. by placing a functional group on the end group of external PEG chains such 
as was done for cyclic oligopeptide ligands103), decoration of polyplex micelles with NLS 
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groups can be accomplished to avail them to Importin-α for transport through the nuclear 
pore complex. 
Additionally, while qPCR provides an accurate way to assess nuclear uptake, the 
assay is time intensive and requires expertise. Replacing qPCR with assays that evaluate 
the interaction of NLS-containing polyplex interaction with its receptor, Importin-α,34,96 
may allow more rapid and high-throughput screening of multiple polyplex formulations 
for those that contain functional nuclear localization sequences. For additional 
understanding of the impact of the SV40 NLS within polymers for DNA delivery, 
transfection experiments can be performed in the presence of free NLS peptide as a 
competitive binding assay. Transfections performed in the presence wheat germ agglutinin 
that binds N-acetyl-b-D-glucosamine, which precludes nuclear pore formation105 and shuts 
down nuclear uptake mediated by Importin-α and Importin-β, may also shed light on the 
intracellular activity of the NLS within polyplexes. Molecular simulations of NLS 
availability within polyplexes as a function of polyplex structure and composition can be 
used in concert with experiments to provide additional understanding of the impact of 
polymer composition on polyplex structure. As an added benefit, simulations have the 
ability to screen more polyplex compositions than feasible experimentally, and by doing 
so guide the rational design of new materials. The data presented in the chapter taken 
together with literature on other SV40 NLS bioconjugates for non-viral gene therapy 
suggests that learning more about the intracellular activity of NLS groups present on 
polyplexes will lead to new polymer designs that further improve the comb polymer 
platform that has already demonstrated efficacy rivaling that of benchmark commercial 
reagents. 
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CHAPTER 3 
DISPERSING ZWITTERIONS WITHIN COMB POLYMERS: IMPACTS ON 
DNA COMPLEXATION AND DELIVERY 
3.1 Introduction 
Polymeric gene carriers offer safe and versatile alternatives to viruses,1–4 however 
there are several significant extra- and intracellular obstacles limiting successful gene 
delivery.5,6 Prior to cell entry, polymers must condense DNA into polyplexes, which should 
optimally be nanoscale structures that prevent DNA degradation by nucleases, resist 
aggregation in the presence of salt and serum proteins, and elicit minimal immune response 
and toxicity. The same polymer must facilitate cellular and nuclear entry, as well as DNA 
release. Polymer features that overcome one of these obstacles might hinder their ability to 
overcome another, therefore a delicate balance is required in the design of polymer-based 
DNA delivery reagents. One such conflict is the balance between DNA binding and release 
required to complex DNA during delivery and eventually release it for use by the cell in 
protein synthesis.7 Additionally, while cationic polymers bind DNA and interact with the 
cell membrane, they are often toxic and prone to aggregation in the presence of salt and 
serum.8,9 
 The introduction of neutral hydrophilic components into cationic polymers is 
particularly appealing as they promote colloidal stability of polyplexes under physiological 
conditions, mitigate the toxicity and immune response triggered by cationic polymers, and 
allow modulation of polymer-DNA binding strength.4,9–18 As such, there is an abundance 
of examples of cationic polymers designed for gene therapy incorporating neutral moieties, 
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such as poly(ethylene glycol) (PEG),10,11,15,19–28 oligoethylene glycol,15,24,29–31 
pluronics,32,33 hydroxypropyl acrylamide (HPMA),10,21,34–38 hydroxyethyl methacrylate,39 
sugars,14,40–48 and zwitterions.12,13,16,17,49–52 Several studies have demonstrated the 
monomer sequence and polymer architecture to dictate the role of neutral units within 
polyplexes. Narain14 and Reineke46 published studies comparing block and statistical 
copolymers of amine- and sugar-functionalized methacrylamides. Statistical copolymers 
formed polyplexes with higher surface charge than analogous block copolymers that led to 
higher cell uptake and gene expression levels at the expense of lower colloidal stability due 
to the absence of a shielding layer and, in some cases, lower cell viabilities. One way to 
circumvent this tradeoff between maximizing polyplex interaction with cell membranes to 
lead to high transfection levels and minimizing interactions with blood components is to 
install degradable linkers between neutral hydrophilic components and the polycation.26,27 
A second strategy is to employ a different polymer architecture in an effort to find a 
medium between the two extremes presented by linear copolymers with random and block 
sequences. Functionalization of branched polyethylenimine (PEI) with PEG led to 
improved gene expression levels at low PEG loadings or high loadings of short PEG chains, 
however higher PEG loadings and longer PEG chains led to reduced transfection 
efficiency.22,53 
PEG has been studied extensively, where it has been used to modify PEI,22,53–55 
poly-L-lysine (PLL),10,19–21,23 poly(N,N-dimethylaminoethyl methacrylate or 
methacrylamide) (polyDMAEMA),24,27,32,56 polyaspartamides26,28,57,58 and many other 
polymer systems for non-viral gene delivery.9 Unfortunately, PEGylated reagents often 
suffer from reduced cellular uptake, and by extension low transfection efficiencies.11,33,59,60 
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Additionally, the potential of PEG to oxidize may produce undesirable side effects.61  As 
alternatives to PEG, zwitterionic polymers have been shown to be valuable neutral 
hydrophilic components of polymer-based gene delivery vehicles.12,13,17,51,52,62 Zwitterionic 
polymers bear a positive and a negative charge on each repeat unit, and are often utilized 
as surface coatings and biomaterials due to their excellent anti-fouling properties.63–67 The 
most commonly reported zwitterion-containing polymers for gene therapy applications are 
diblock copolymers with a cationic block for DNA condensation and a zwitterionic block, 
typically with sulfobetaine (SB), phosphorylcholine (PC), or carboxybetaine (CB) 
zwitterions, for reduced toxicity and polyplex stability.12,13,16,49,52,62,68–73 Liu and coworkers 
found the type of zwitterion to impact transfection performance, wherein a block 
copolymer having a DMAEMA cationic block and a SB zwitterionic block to outperform 
those with a PC zwitterionic block in transfections conducted in solutions containing 10 
and 30 % serum.13 This result was attributed to the extreme hydrophilicity of PC-based 
polymers decreasing both cellular uptake and polymer-DNA binding strength to a greater 
extent than SB-based polymers. Additionally, they found the amount of zwitterion in the 
block copolymers to impact transfection performance; gene expression and cell viability 
increased as the SB block length was increased from 30 to 80. 
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Table 3.1 Arrangement of zwitterions (blue) within polymer structures (black) designed 
for gene therapy 
Structure References Structure References 
    
linear diblock copolymers 
 
12,13,16,49,52,62,68–
73 
branched polymers decorated 
with individual zwitterions 
 
51,74–76 
linear statistical copolymers 
 
49,62,77 
branched polymers 
decorated with polymer 
zwitterions 
 
78 
comb polymers
 
50,79 
carbon nanoparticles (gray) 
with polymer ligands 
 
80 
 
Zwitterion-containing polymers used in gene therapy have been designed with a 
variety of architectures and monomer sequences. As shown in Table 3.1, zwitterions are 
arranged in diblock12,13,16,49,52,62,68–73 and statistical sequences49,62,77 within linear and comb 
polymers50,79 and placed on the periphery of branched polymers51,74–76,78 and particles.80 
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Similarly as other copolymers with cationic and neutral hydrophilic components, the 
polymer structure dictates the role of the zwitterions within polyplexes. A comparison of 
copolymers with an ε-polylysine backbone and polyDMAEMA-co-polySB grafts in either 
a block or a random configuration showed the block copolymer brushes to impart colloidal 
stability in the presence of salt and serum while the random copolymer brushes served only  
to decrease polymer-DNA binding strength.50 Unlike linear copolymers, however, the 
comb polymers with diblock brushes provided higher gene expression relative to those with 
statistical brushes. Additionally, PEI-SB conjugates afforded a higher percentage of 
transfected cells than PEI alone,51 but without the stability in salt and serum typically 
displayed by diblock copolymers containing zwitterionic groups.  
Our group81–84 and others50,79,85–91 have recognized the benefits of polymers with a 
comb architecture in non-viral gene therapy, including oligopeptide-grafted 
polymethacrylates,85 polymethacrylamides,86–88 and polyolefins81–84 as well as polymer-
grafted lysines20,21,40,50,89,90 and dextrans.79,91 We compared linear PLL to polycyclooctene 
with pendent oligolysines in cell culture and found a comb polymer with tetralysine (K4) 
grafts to provide the highest levels of gene expression.83 Molecular dynamics simulations, 
performed by A. Jayaraman, and experiments explained this result by the looser DNA 
complexation of the K4 comb polymer.92 A subsequent series of polycyclooctene-based 
comb polymers included nuclear localization sequences (NLSs) derived from the Simian 
Virus 40 large-T antigen (PKKKRKV) (Chapter 2). Oligopeptide orientation significantly 
impacted transfection performance, wherein comb polymers with the NLS attached by the 
valine residue (rNLS) provided high gene expression levels both in cell culture and in 
  91 
mice.84 Additionally, polyplexes formed from the comb polymers exhibited high cell 
viabilities, in contrast to commercial reagents such as jetPEITM and Lipofectamine®.  
This chapter investigates the effects of dispersing zwitterionic groups into comb 
polymers having a pendent polycyclooctene backbone and cationic oligopeptide pendent 
groups. Comb polymers with cationic rNLS and tetralysine (K4) oligopeptides and 
zwitterionic sulfobetaine and phosphorylcholine groups were synthesized by ring opening 
metathesis polymerization (ROMP) of substituted cyclooctenes. Recognizing the 
drastically different roles of zwitterions incorporated in polymers with various 
architectures, we employ experiments and molecular dynamics simulations to 
systematically examine the effect of zwitterions in comb polymers on polyplex size, 
surface charge, DNA binding strength, and stability in solutions with salt and serum. 
Evaluation in human ovarian cancer (SKOV3) cells showed these zwitterion-containing 
comb polymers to afford high gene expression levels, cell viability, and cell uptake.  
3.2 Polymer Synthesis 
Zwitterions were integrated into comb polymers with cationic oligopeptide pendent 
groups by ring-opening metathesis polymerization (ROMP) of substituted cyclooctenes. 
Cationic oligopeptides selected for this study include the inverted Simian virus nuclear 
localization sequence, VKRKKKP (rNLS-COE, 24) and tetralysine (K4). As discussed in 
Chapter 2 of this thesis, comb polymers with rNLS sequences provided high gene 
expression levels in cell culture and in mice.84 The oligolysine comb polymers are 
particularly amenable to coarse-grained molecular dynamics simulations, greatly 
simplifying molecular model construction due to the presence of only one type of amino 
acid. The K4 sequence was specifically selected due to its superior transfection in cell 
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culture among a series of comb polymers with 1-5 oligolysine units pendent to a polymer 
backbone.83 Sulfobetaine and phosphorylcholine zwitterions were selected for this study. 
Sulfobetaine (SB)-substituted cyclooctene (32) was synthesized in two steps, as shown in 
Figure 3.1. Carbodiimide-mediated coupling of (Z)-cyclooct-4-ene-1-carboxylic acid (23) 
and N,N-dimethylethylenediamine (29) yielded (Z)-cyclooct-4-ene-1-N,N-
dimethylaminoethyl ester (30). The reaction of 30 with 1,3-propanesultone (31) in CH3CN 
at 50°C afforded (Z)-cyclooct-4-ene-1-propylsulfonate-N,N-dimethylammonio ethyl ester 
(32) a white powder in 48 % yield (m/z 347.2003, calculated = 347.2005 [M+H]+). 1H 
NMR spectroscopy provided further confirmation of the desired monomer structure, 
showing a multiplet at 5.5-5.8 ppm corresponding to the cyclic olefin protons and a triplet 
at 2.9 ppm corresponding to the methylene protons adjacent to the sulfonate group (Figure 
3.1). Phosphorylcholine (PC)-substituted cyclooctene (33) was synthesized by C. Chang 
as previously reported.93  
 
Figure 3.1 (a) Synthesis and (b) 1H NMR spectrum acquired in D2O of (Z)-cyclooct-4-
ene-1-propylsulfonate-N,N-dimethylammonio ethyl ester cyclooctene (SB-COE, 32)  
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The zwitterionic cyclooctenes, 32 and 33, were copolymerized with SV40 NLS-
substituted cyclooctene (rNLS-COE, 24), having Boc and Pbf protecting groups, by ROMP 
in a mixture of 2,2,2-trifluoroethanol (TFE)/CH2Cl2, as shown in Scheme 3.1. Given the 
significantly smaller molecular weights of SB-COE and PC-COE (346 g/mol and 291 
g/mol, respectively) relative to that of rNLS- COE (1671 g/mol), the rNLS-COE: catalyst 
(26) molar ratio was held at 50:1 to keep the molecular weight of the copolymers 
approximately constant while the amount of zwitterion was varied from ~10-40 mol %.  
For comparison, copolymers containing PEG pendent groups were synthesized by 
copolymerization of 24 with poly(ethylene glycol)-substituted cyclooctene (34, Mn 4400 
g/mol). Since the Mn of the pendent PEG chains was 4400 g/mol, approximately 10 times 
the molecular weight of the zwitterionic pendent groups, 1 and 2 mol % PEG-COE was 
copolymerized with rNLS-COE for comparison with copolymers having 10 and 20 mol % 
smaller zwitterionic pendent groups, respectively. 
The conversion of the Boc- and Pbf-protected copolymers was determined by 1H 
NMR in DMSO by comparing the integrations of the peaks from the polymeric olefins 
(~5.3 ppm) and the cyclic olefins (~5.6 ppm), and ranged from 75 to >95 % (Table 3.2). 
Interestingly, the PEG-based polymerizations reached >95 % conversion (37a-b), 
surpassing SB- and PC-based copolymerizations with rNLS-COE (~70-85 %, 35a-d and 
36a-d) and homopolymerization of rNLS-COE (~40-90 %) (28a-e, Chapter 2). The 
molecular weight and molecular weight distribution of the Boc- and Pbf-protected 
polymers was determined by gel permeation chromatography (GPC) eluting in N,N-
dimethyl formamide (DMF), as shown in Table 3.1. The low dispersities may be attributed 
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to the bulky oligopeptide groups acting to prevent secondary metathesis events. Though 
SB-COE is insoluble in DMF, the oligopeptide pendent groups rendered the copolymers 
with 0-50 mol % SB soluble for GPC characterization. Boc- and Pbf-protecting groups 
were removed in a mixture of trifluoroacetic acid (TFA), triisopropylsilane (TIPS), and 
water (95/2.5/2.5 v/v/v). Following deprotection, the solutions were precipitated into ether 
and the polymers isolated by dialysis in water (once), 30 % acetic acid(aq) (once), and water 
(3 times) against a 6-8 kDa molecular weight cut-off membrane, then lyophilized to afford 
the polymers as white powders in 50-80 % yield. The molecular weight and molecular 
weight distribution of the deprotected, cationic polymers were determined by GPC eluting 
in TFE (Table 6.1). Low Mw/Mn values (<1.4) are attributed to bulky Boc- an Pbf-protected 
oligopeptide side chains that minimize secondary metathesis events. For comparison, 
homopolymers of SB-COE and PC-COE synthesized similaraly had dispersities of 1.52 
and 1.91, respectively measured relative to PMMA standards in GPC eluting in TFE. The 
structure and composition of the copolymers was determined by 1H NMR in D2O, and the 
spectra are shown in Figure 3.2. The composition of SB and PC copolymers was 
determined from the relative integrations of the valine methyl proton resonance (n) at 0.8 
ppm and the peak at 3.2 ppm containing the arginine δ protons and the ammonium methyl 
protons from SB and PC (g, e’). Loading of PEG was calculated similarly, integrating the 
valine proton resonances at 0.8 ppm to the peak at 3.7 ppm containing the tertiary hydrogen 
on cyclooctene and the oxymethylene protons on PEG (389). The number-average 
molecular weight of the PEG-based copolymers was ~60 kDa, ~10-20 kDa lower than SB- 
and PC-copolymers (Table 3.2). The copolymers are named as the type and loading of 
neutral hydrophilic group incorporated (mol %). For example, the copolymer of rNLS-
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COE with 11 mol % SB-COE is named SB-11. While copolymerizations of SB and rNLS-
substituted cyclooctenes produced comb polymers with SB loadings similar to the targeted 
values (within 3 mol %), the PC polymers had higher loadings. For example, 
polymerizations targeting 20, 30, and 40 mol % PC afforded polymers with final 
compositions of 27, 37, and 50 mol % PC, respectively. Possibly this is due to the higher 
water solubility of PC relative to SB, which would result in higher PC integrations by 
NMR. Nevertheless, a series of comb polymers with comparable molecular weights (Mn 
~70-80 kDa) incorporating 0-50 mol % zwitterionic pendent groups was generated.  
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Scheme 3.1 Copolymerization of rNLS-COE (24) with zwitterionic and PEGylated 
cyclooctenes, SB-COE (32), PC-COE (33), and PEG-COE (34), by ROMP to afford SB-
X (35), PC-X (36), and PEG-X (37), where X = mol % R. 
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Table 3.2 Polymerization data for the synthesis of SB-X (35), PC-X (36), and PEG-X 
(37), where X = mol % SB, PC, or PEG incorporated 
Sample Name Target  Conv. Protected polymers 
(GPC in DMF) 
Deprotected polymers 
(GPC in TFE) 
 
Yield 
  (mol % R) (%) Mn 
(g/mol) 
Mw/Mn Mn 
(g/mol) 
Mw/Mn (%) 
35a SB-11 10 86 72600 1.23 69100 1.28 62 
35b SB-21 20 80 89400 1.29 72100 1.40 63 
35c SB-31 30 82 69400 1.30 72800 1.41 61 
35d SB-43 40 77 65400 1.42 83700 1.57 63 
36a PC-14 10 75 83100 1.38 83100 1.41 61 
36b PC-27 20 84 66500 1.42 76900 1.46 51 
36c PC-37 30 72 59500 1.45 76900 1.58 59 
36d PC-50 40 75 58500 1.30 83700 1.57 55 
37a PEG-1.5 1 >95 83100 1.30 58200 1.34 66 
37b PEG-3 2 >95 80100 1.25 55500 1.33 59 
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Figure 3.2 Structures and 1H NMR spectra of (a) SB-43 (35d) and (b) PC-50 (36d). 1H 
NMR spectra were acquired in D2O.  
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The rNLS-based comb polymers are intended to improve performance in cell 
culture by inclusion of rNLS oligopeptides previously shown to be advantageous 
components of transfection reagents. Additionally, a series of comb polymers having K4 
and SB pendent groups was synthesized for the investigation of comb polymers with 
cationic and zwitterionic pendent groups in a simple manner, without hydrophobic 
oligopeptide residues or different types of cationic oligopeptides. Using a similar method 
to that used for rNLS-based comb polymers, K4-COE and SB-COE were copolymerized 
by ROMP in a TFE/CH2Cl2 mixture with catalyst 26 (Figure 3.3). The K4-COE-to-catalyst 
ratio was held constant at 50, and the amount of SB-COE was varied from 0-45 mol%. As 
shown in Table 3.3, these polymerizations proceeded to >95 % monomer conversion, 
notably higher than the rNLS-based polymerizations (Table 3.2). For example, copolymers 
targeting ~ 50 mol % SB and K4-COE (39d) and rNLS-COE (35d) reached >95 % and 77 
%, respectively. The Boc protecting groups were removed by acidification (4 M HCl 
dioxane: methanol 2/5 v/v) and the copolymers isolated by dialysis in water followed by 
lyophilization in 50-70 % yield as white powders. Table 3.3 lists the composition, 
molecular weight, and molecular weight distribution of the copolymers, named K4SB-X, 
where X indicates SB composition (mol %). The GPC-estimated molecular weights of the 
deprotected copolymers ranged from 55-75 kDa, with polydispersity indices from 1.5-1.9, 
and the GPC trace of K4SB-49 (39d) is shown in Figure 3.3b. The composition of SB was 
within 5 % of the targeted values, as determined by 1H NMR spectroscopy in D2O by the 
relative integrations of the peaks at 3.0 ppm (lysine ε protons, e, and SB methylene protons 
adjacent to the sulfonate, e’) and 3.2 ppm (SB ammonium methyl protons, e’) (Figure 3.3c). 
Ring-opening metathesis polymerization of substituted cyclooctenes at a constant molar 
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ratio of oligopeptide macromonomer to catalyst afforded polymers incorporating different 
loadings of zwitterions but with similar molecular weights and architectures, allowing the 
investigation of the effects of zwitterions on various aspects of the transfection process.  
 
Figure 3.3 Synthesis of K4SB-X (39), copolymers of (Z)-cyclooct-4-ene-1-
tetralysine(boc) (K4-COE, 38) and (Z)-cyclooct-4-ene-1-propylsulfonate-N,N-
dimethylammonio ethyl ester (SB-COE, 32) by ROMP (a). X = mol % SB. 1H NMR 
spectrum(b) and GPC chromatogram (c) of K4SB-49 (39d). The NMR spectrum was 
acquired in D2O and GPC was performed with TFE as the eluent. 
 
Table 3.3 Polymerization data for the synthesis of SB-X (35), PC-X (36), and PEG-X 
(37), where X = mol % SB, PC or PEG incorporated 
Sample Name 
 
Target  
 
Conv. Deprotected polymers 
(GPC in TFE) 
Yield 
 
 (K4SB-X) (mol % SB) (%) Mn (g/mol) Mw/Mn (%) 
39a K4SB-0 0 >95 57600 1.49 56 
39b K4SB-17 15 >95 58900 1.89 51 
39c K4SB-34 30 >95 70100 1.69 61 
39d K4SB-49 45 >95 72800 1.73 66 
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3.3 Polyplex size and surface charge 
The size and surface charge of nanoparticles for gene delivery dictate circulation 
time, toxicity, cellular uptake, and endosomal escape.4,5,9,94  Particles should be between 
~20-200 nm, respectively to avoid renal clearance by size exclusion of small particles and 
spleen filtering of particles larger than ~200 nm.95,96 Neutral particles generally exhibit low 
toxicities and longer circulation times relative to particles that display positive surface 
charge due to shielded interactions of polyplexes with blood components that promote 
aggregation, immune response, and rapid clearance from the blood stream.9,17,97 Associated 
draw backs of neutral particles include lower cell uptake due to decreased electrostatic 
interaction with the negatively charged cell membrane and decreased endosomal escape in 
the absence of protonatable moieties that promote proton and counterion influx in the low 
pH environments of endosomes that causes rupture and particle release.9 The comb 
polymers capably condensed DNA into nanoscale complexes (polyplexes) with a net 
positive surface charge when mixed with DNA (mRFP-IRES-Puro, 4.5 kBp) at N/P 4, 
where N/P is the ratio of protonatable nitrogens on the polymer to DNA phosphates.  A 
detailed description of polymer and DNA solution preparation for the formation of 
polyplexes at a given N/P ratio is provided in Chapter 7. Dynamic light scattering (DLS) 
of polyplexes in 10 mM NaCl(aq) revealed structures 50 to 90 nm in diameter (Table 3.4).  
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Table 3.4 Polyplex size and zeta potential measured at N/P 4 in 10 mM NaCl(aq) 
Sample Name 
 
Size 
(nm) 
ζ 
(mV) 
28 rNLS 62 ± 11 29 ± 6 
35a SB-11 84 ± 13 30 ± 6 
35b SB-21 77 ± 9 33 ± 6 
35c SB-31 67 ± 11 31 ± 5 
35d SB-43 86 ± 14 31 ± 5 
36a PC-14 61 ± 9 31 ± 6 
36b PC-27 77 ± 11 31 ± 6 
36c PC-37 62 ± 9 31 ± 6 
36d PC-50 84 ± 13 33 ± 6 
37a PEG-1.5 76 ± 9 17 ± 6 
37b PEG-3 66 ± 11 13 ± 6 
39a K4SB-0 60 ± 8 40 ± 6 
39b K4SB-17 64 ± 9 34 ± 7 
39c K4SB-34 56 ± 9 37 ± 8 
39d K4SB-49 64 ± 11 35 ± 8 
 
AFM images of polyplexes (N/P 4) formed from PLL, jetPEITM, and K4SB-X comb 
polymers (39) showed nanoscopic structures ~70-80 nm in diameter, consistent with the 
DLS results (Figure 3.4). Polyplexes formed from 39d, having the highest loading of SB 
zwitterions (43 mol %), showed larger flat structures ~2-3 nm thick. Since the mica 
substrates are rinsed with water after allowing polyplexes to adsorb, it is possible that the 
polyplexes are partially washed off, leaving behind a thin adsorbed layer, owing to the 
increased water solubility imparted by the zwitterions. Given that mica has a negative 
surface charge,98 these experiments suggests that high loadings of zwitterions reduce 
charge interactions, since up to ~35 % loading polyplexes adsorb to mica and resist 
washing. Zeta-potential characterization of the polyplexes (N/P 4) from PLL, jetPEITM, and 
comb polymers including up to 50 mol % SB or PC groups (28, 35, 36, 39) in 10 mM 
NaCl(aq) gave values ranging from +27 to 37 mV (Table 3.3). This suggests that the benefits 
of zwitterions, such as biocompatibility, can be harnessed without sacrificing the positive 
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surface charge that facilitates cellular and nuclear entry. Interestingly, measurements on 
polyplexes PEG-based comb polymers, 37a and 37b, showed zeta potentials of 17 and 13 
mV, respectively, suggesting the ability of PEG, unlike either SB or PC zwitterions (ζ ~ 
30 mV), to partially screen the surface charge of polyplexes formed from these comb 
polymers. A notable difference between the PEG and zwitterionic pendent groups is the 
molecular weight: PEG-COE is 4400 g/mol while SB and PC-COE are ~300 g/mol. It is 
entirely possible that the polymeric grafts extend out of the polyplex, due merely to size or 
phase separation from the charged moieties and provide shielding. Kissel and coworkers 
reported the zeta potential (in 10 mM NaCl(aq)) of polyplexes formed from PEI with short 
(550 g/mol) PEG grafts to exceed that of polyplexes from long chain (5k) PEG grafts at 
high loading (>15 PEG grafts per PEI) .22 Taken together, the DLS, AFM, and zeta 
potential data show the polycyclooctene comb polymers with cation and zwitterion grafts 
(up to 50 mol %) produced positive zeta potential and similarly sized structures when 
mixed with DNA at N/P 4. Given the appropriate sizes and surface charge of the polyplexes 
to facilitate DNA complexation and delivery under these conditions, polymer-DNA 
binding was then characterized.  
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Figure 3.4 AFM of polyplexes formed from K4SB-X and plasmid DNA (mRFP-IRES-
Puro, 4.5 kbp) at N/P 4 in DNase-free water. Prior to imaging, mica substrates were 
rinsed with water ~10 min after dropcasting polyplexes. (a) K4SB-0, (b) K4SB-17, (c) 
K4SB-34, and (d) K4SB-49. Insets show size distribution and average polyplex diameter. 
3.4 DNA binding strength 
DNA accessibility in the polyplexes was quantified using a fluorescence-based 
competitive binding assay in which polyplexes (N/P 4) were incubated with PicoGreen®, 
a dye that undergoes fluorescence enhancement upon binding DNA,99,100 and heparin, an 
anionic polymer. Heparin competes with DNA for binding with the polymer, while 
Picogreen® competes with polymer for DNA binding. Figure 3.5 shows the relative 
percentage of DNA accessible to Picogreen® following incubation of polyplexes with 
Picogreen® and heparin for 16 h at 37 °C. The values in Figure 3.5 convey relative, rather 
than absolute, percentages of accessible DNA upon incubation of the polyplexes with 40 
units of heparin since the percentage of accessible DNA increases with increasing heparin 
concentration (data shown in Appendix A). Picogreen® fluorescence showed SB and PC 
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zwitterions as well as PEG to impact PicoGreen® access to the plasmid DNA (Figure 3.5). 
Despite the large error bars, resulting from the percentages of accessible DNA obtained on 
different days and with different batches of heparin, DNA accessibility increased with the 
incorporation of zwitterionic or PEG pendent groups. This is consistent with reports on 
other polycations incorporating neutral components that show DNA complexation strength 
to decrease with increasing amounts of neutral hydrophilic moieties.9,12,69  
 
Figure 3.5 Determination of DNA accessibility using a PicoGreen® plate reader assay, 
wherein rNLS-based polyplexes formed at (N/P 4) were incubated with Picogreen® (1X) 
and heparin (40 units, 10 units/well) for 16 h at 37 °C. Picogreen fluorescence was 
measured at 520 nm, exciting at 485 nm using a plate reader in fluorescence mode. Error 
bars indicate ± standard deviation. 
 
 The finding that zwitterions decrease polymer-DNA binding strength extended to 
K4-based comb polymers, as shown by Picogreen® fluorescence experiments and coarse-
grained simulations performed on polyplexes formed from DNA (mRFP-IRES-Puro, 4.5 
kBp) and comb polymers with K4 and SB pendent groups (Figure 3.6). The comb polymers 
were found to bind DNA more loosely than linear PLL, consistent with our previous 
reports.83,84 Adding SB zwitterions into the K4-based comb polymers increased the percent 
accessible DNA from 33 % for K4SB-0 to 66 % for K4SB-49, confirming that the 
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zwitterionic groups markedly decrease polymer-DNA binding strength. Simulations 
performed by the Jayaraman group (University of Delaware) corroborate these results, 
showing that Helmholtz binding free energy becomes less negative (less favorable) with 
increasing SB content in the comb polymers (Figure 3.6b).101 The simulations show that 
the entropic contribution to DNA binding mainly comes from the release of counterions. 
Other entropic contributions to polymer-DNA binding include conformational entropy loss 
of the polymer chains and DNA upon complexation, however this is negligible compared 
to the entropy gain due to ion dissociation. The enthalpic contribution to polymer-DNA 
binding is dominated by electrostatic interactions between the negatively charged DNA 
and net positively charged polymer, as well as interactions between the solvent and charged 
species in the polyplex. At a constant N/P ratio, zwitterions did not impact polyplex size 
or surface charge, however they had appreciable influence on polymer-DNA binding 
strength.   
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Figure 3.6 Effect of SB content on polymer-DNA binding affinity: (a) Polymer-DNA 
complexation strength assessed by heparin-induced polyplex decomplexation 
experiments, wherein polyplexes formed from K4SB-X (39a-d) and mrfp-purop plasmid 
DNA at N/P 5 are incubated with heparin (40 units) and Picogreen® dye (1X). The 
percentage of accessible DNA is determined relative to Picogreen® fluorescence with no 
polymer added. (b) Helmholtz free energy of polymer-DNA binding determined using 
coarse-grained simulations at N/P 4. Experiments and simulations were conducted in the 
absence of salt. 
3.5 Polyplex serum stability 
Polyplex stability in solutions with salt and serum determines their suitability for 
in vivo applications, particularly when systemic administration is desired.6,10,30,102 In pure 
water, electrostatic repulsion between charged particles imparts stability. Addition of salt 
screens these electrostatic interactions and results in polyplex aggregation.1 Adsorption of 
serum proteins also promotes aggregation and can label exogenous materials for 
opsonization and clearance from the blood stream.12,103,104 Particles shielded by neutral 
hydrophilic polymers often resist aggregation in the presence of salt and prevent adsorption 
of serum proteins, however at a price of lower cell uptake due to decreased electrostatic 
interaction with the cell membrane.11,33,59,60   
Polyplexes formed from rNLS-based comb polymers were evaluated for stability 
in salt and serum by incubation with Dulbecco’s modified eagle medium (DMEM, 1X) and 
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fetal bovine serum (FBS, 10 %) at 37 °C. PLL, jetPEITM, and the rNLS comb polymers 
were mixed with DNA (mRFP-IRES-Puro, 4.5 kBp) at N/P 4 for 40 minutes in DNase-free 
water to form polyplexes (total volume = 0.8 mL). DMEM (10X, 0.1 mL) and fetal bovine 
serum (FBS, 0.1 mL) were added to the polyplexes and the intensity-average polyplex 
diameter measured by DLS (0 h, Figure 3.7). Subsequent measurements of polyplex 
diameter were acquired every 12 h for 48 h. DLS revealed a mixture of differently sized 
structures in solution, as the plot of percent intensity of scattered light as a function of 
hydrodynamic diameter showed peaks for serum proteins (~ 10 and ~50 nm), free polymer 
(~ 200 nm in 10 % FBS and 1X DMEM), and polyplexes (> 200 nm), therefore the largest 
size peak detected in each measurement is plotted. Polyplexes formed from rNLS (28) 
increased from ~300 to ~700 nm within 12 h, and thereafter no particles above ~10 nm 
were detected. Loss of light scattering intensity after an initial steep increase in particle 
size likely results from either sedimentation of micron scale aggregates or polyplex 
dissassembly. A similar increase in size followed by a decrease was observed for SB-43, 
PC-14, and PC-50 (Figure 3.7a and b). DLS of polyplexes formed from the other 
zwitterion-containing comb polymers showed particle sizes ~ 300 nm initially that 
increased to ~500-700 nm within the first 12 h and remained relatively constant for 
subsequent measurements (Figure 3.7a and b). Notably, polyplexes formed from PEG-3 
remained between 200-400 nm for 48 h after incubation with 1X DMEM and 10 % FBS 
(Figure 3.7c). Considering that polyplex diameters are < 100 nm in water or 10 mM 
NaCl(aq), salt and serum have appreciable effects on particle size and stablity. 
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Figure 3.7 Intensity average hydrodynamic diameter (Dh) of polyplexes (N/P 4) formed 
from (a) SB-X, (b) PC-X, and (c) PEG-X as a function of time after incubation in 1X 
DMEM and 10 % fetal bovine serum (FBS) at 37 °C.  Control experiments showing 
intensity average hydrodynamic diameter (Dh) of polyplexes (N/P 4) formed from SB-X 
as a function of time after incubation in (d) 1X DMEM and (e) 10 % FBS at 37 °C.  (d) 
Error bars represent the square root mean variance of three measurements performed on 
the same sample. 
 
The effects of salt and serum on polyplex size were examined independently by 
dilution of polyplexes formed in water (0.8 mL) with water (0.1 mL) and either DMEM 
(10X, 0.1 mL) or FBS (0.1 mL) to bring the final concentration to 1X DMEM or 10 % 
FBS, respectively. Polyplex solutions were incubated at 37 °C and the particle size 
measured by DLS every 12 h for 48 h. Figure 3.7d shows polyplexes incubated in 1X 
DMEM range from 100-400 nm in diameter within several minutes after addition of salt. 
Subsequent measurements of polyplex size differed greatly, however mostly showed 
showed a decrease in size of the highest intensity peak. Apart from polyplexes formed from 
SB-31, only particles < 100 nm in diameter were detected after 48 h, indicative of 
sedimentation or polyplex disassembly. Polyplexes formed from SB-21 aggregated to >900 
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nm in diameter within 12 h after addition of 1X DMEM, which suggests that some 
sedimentation occurs. DLS measurements on polyplexes incubated with 10 % FBS showed 
a modest increase in particle size from ~100-200 nm to ~300 nm within 48 h. Polyplexes 
formed from SB-21 and SB-31 showed slightly larger particle sizes (~400-500 nm) 48 h 
after FBS addition. These results indicate that while serum proteins cause polyplex 
aggregation to some degree, salt plays a larger role to promote either polyplex disassembly 
or aggregation to micron scale particles that sediment. Given that the presence of multiple 
populations of particle sizes in the solutions measured by DLS may complicate data 
analysis, AFM was used to examine polyplex size. 
AFM on polyplexes formed before and after incubation with 1X DMEM confirms 
the presence of larger aggregates ~300 nm in diameter following incubation with DMEM 
(Figure 3.8b-d), however no micron scale polyplex aggregates were observed. Figure 3.8a 
shows polyplexes formed from SB-11 in water, dropcast onto mica substrates, and allowed 
to adsorb ~5-10 minutes prior to rinsing with filtered DNase-free water and imaging. 
Polyplexes less than 100 nm in diameter were observed. Images of polyplexes formed from 
SB-11, rNLS, and SB-43 and incubated in DMEM for 12 h at 37 °C were acquired 
similarly, wherein polyplexes were dropcast onto mica substrates, allowed to adsorb for 5-
10 minutes, and then rinsed with filtered DNase-free water to remove unadsorbed 
polyplexes and DMEM. Only larger particles > 100 nm in diameter were observed 
following incubation with DMEM. Images of polyplexes formed from SB-43 show smaller 
aggregates (~200 nm), indicating that SB zwitterions act in some capacity to resist 
aggregation. These results confirm that aggregation of polyplexes into larger structures 
occurs upon addition of salt and provide evidence against the formation of micron scale 
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aggregates, suggesting that polyplex disassembly occurs to some extent. While the data 
presented herein suggests that polyplexes formed from comb polymers including up to 50 
mol % SB or PC zwitterions undergo both aggregation and disassembly in the presence of 
salt and serum, they maintain positive charge crucial for cell uptake. The following sections 
discuss the behavior of comb polymers in human ovarian cancer (SKOV3 cells) and relate 
the physical properties of the polyplexes (size, surface charge, DNA binding strength, 
stability) to cell uptake, toxicity, and ability to afford gene expression. 
 
Figure 3.8 AFM of polyplexes from SB-11 in water (a) and after incubation  for 12 h in 
1X DMEM at 37 °C (b). Polyplexes formed from (c) rNLS and (d) SB-43 after 
incubation 12 h in 1X DMEM at 37 °C. Polyplexes shown here were formed by 
equilibrating polymer solution and DNA (mRFP-IRES-puro plasmid, 4.5 kBp) at N/P 4 
for 40 minutes prior to addition of DMEM. 
3.6 Evaluation in SKOV3 cells 
Polyplexes formed from comb polymers with cationic and zwitterionic groups were 
then evaluated in SKOV3 cells, an ovarian cancer cell line selected for its therapeutic 
relevance, to determine their cell entry, transfection efficiency, and toxicity. S. Parelkar 
determined cell uptake by flow cytometry. In these experiments, polyplexes were formed 
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from comb polymers and fluorescent plasmid DNA (Label IT®) at N/P 4 and the 
intracellular abundance of the fluorescent plasmid measured by flow cytometry. Similar 
experiments were performed on using the commercial reagents, jetPEITM and 
Lipofectamine® 2000, to complex the fluorescent plasmids. Figure 3.9 shows the median 
fluorescence intensity per cell measured 3 h after addition of polyplexes to SKOV3 cells 
in serum-free DMEM (1X). Notably, polyplexes from SB-11, SB-43, PC-14, and PC-50 
did not decrease intracellular abundance of fluorescently labeled DNA compared to those 
from rNLS, demonstrating that incorporation of zwitterions as pendent groups on comb 
polymers does not impede cellular uptake of polyplexes. However, polyplexes from both 
copolymers having PEG pendent groups provided reduced intracellular abundance of 
fluorescein-labeled DNA relative to rNLS. These results are consistent with polyplex zeta 
potential results presented in Table 3.4, wherein SB-X and PC-X, including up to 50 mol 
% zwitterionic pendent groups, maintain positive surface charge with zeta potentials in 
excess of + 30 mV and polyplexes formed from PEG-X have greatly reduced zeta 
potentials (~ +15 mV). Whereas LP2K and jetPEITM afforded the highest intracellular 
accumulation of plasmid DNA, their documented toxicity restricts their clinical 
implementation.1,8,105–107  
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Figure 3.9 Evaluation of polyplex uptake in SKOV3 cells by flow cytometry. 
Intracellular abundance (median fluorescence intensity per cell) measured 3 h after 
addition of polyplexes formed from fluorescein-labeled DNA and rNLS, SB-X, PC-X, 
and PEG-X (N/P 4), jetPEITM at N/P 5, and  Lipofectamine® 2000 (LP2k) at 1:4 µg 
DNA: µL LP2k solution to SKOV3 cells in serum-free DMEM. The sample size is 
10,000 cells and the error bars indicate the standard error of the mean.  
 
Transfection experiments in SKOV3 cells were performed by S. Parelkar by 
incubation with polyplexes (N/P 4-6), composed of polymer or LP2K and plasmid DNA 
coding for red fluorescent protein (RFP) (mRFP-IRES-Puro, 4.5 kBp), in serum-free media 
(DMEM). The medium was supplemented with FBS 6 h after cell exposure to polyplexes 
such that the final concentration was 10 % FBS. Gene expression and cell viability were 
gauged 48 h after cell exposure to polyplexes using a plate reader in fluorescence and 
luminescence mode, respectively. The gene expression and cell viability measurements in 
Figures 3.10-3.12 are compiled from three separate transfection experiments conducted on 
different days with a different batch of SKOV3 cells, where each experiment consisted of 
5-8 replicate measurements at each N/P ratio. LP2k was used in 2 different ratios, 1 µg 
DNA per 4 µL LP2k solution (1:4) and 1:6.  Polyplexes formed from SB-11 gave the 
highest protein expression levels, surpassing those obtained with rNLS, jetPEITM, and 
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LP2K (Figure 3.10a). The gene expression decreased with higher SB loadings, yet 
maintained expression levels comparable to LP2k and jetPEITM.  Polyplexes formed from 
rNLS and SB-11 exhibited not only the highest transfection efficiencies, but also the 
highest cell viabilities (>80 %) (Figure 3.10b). Interestingly, lower cell viabilities were 
measured for comb polymers with higher percentages of SB pendent groups in the polymer 
increased. This may be due to looser DNA complexation causing release of polymers with 
a net positive charge, known to promote toxicity due to a strong interaction with the cell 
membrane,8  into solution. As expected, jetPEITM and LP2K resulted in low cell viabilities 
(< 50 % apart from jetPEITM at the lowest N/P ratio).  
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Figure 3.10 (a) Red fluorescent protein (RFP) expression and (b) cell viability measured 
in SKOV3 cells 48 h after addition of polyplexes composed of DNA (mRFP-IRES-Puro 
plasmid) and rNLS, SB-X, jetPEITM, and Lipofectamine® 2000 (LP2k). Polymeric 
transfection reagents were used at 3 different N/P ratios, or the protonatable nitrogens on 
the polymer to DNA phosphates, and LP2k was used at 1:4 and 1:6 µg DNA: µL LP2k 
solution. Error bars are standard error of the mean.  
 
Transfections using PC-containing comb polymers showed the polymer with the 
lowest PC loading (PC-14) did not provide the highest transfection efficiency, as in SB 
transfections. As shown in Figure 3.11a, PC-14 and PC-50 both afforded red fluorescent 
protein expression levels comparable to rNLS and higher than jetPEI and LP2k. Polyplexes 
formed from comb polymers having intermediate PC compositions, PC-27 and PC-37, 
gave lower RFP expression levels. Polyplexes formed from comb polymers including 14-
50 mol % PC groups resulted in lower cell viabilties than rNLS comb polymers without 
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zwitterion (Figure 3.11b). While PC groups are well-known to be biocompatible, in the 
context of cation-zwitterion copolymers complexed with DNA, PC may act to promote 
polyplex disassembly and release of a polymer with net positive charge into solution. The 
results presented in Figure 3.5 on DNA accessibility as a function of zwitterion content in 
comb polymers show that comb polymers with increasing amounts of PC allow higher 
percentages of accessible DNA, supporting this hypothesis. As the zwitterion content is 
increased further, for example to 50 mol % as in PC-50, the copolymer becomes less 
positively charged and therefore likely imparts lower toxicity when released into solution. 
This hypothesis is further supported by the cell viability results in Figure 3.11b that show 
cell viability to increase as the percentage of PC groups in the comb polymer increases 
from 27 to 50 %. 
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Figure 3.11 (a) Red fluorescent protein (RFP) expression and (b) cell viability measured 
in SKOV3 cells 48 h after addition of polyplexes composed of DNA (mRFP-IRES-Puro 
plasmid) and rNLS, PC-X (X = mol % PC), jetPEITM, and Lipofectamine® 2000 (LP2k). 
Polymeric transfection reagents were used at 3 different N/P ratios, or the protonatable 
nitrogens on the polymer to DNA phosphates, and LP2k was used at 1:4 and 1:6 µg 
DNA: µL LP2k solution. Error bars are standard error of the mean. 
 
Introduction of PEG grafts (4.4 kDa) into polyplexes reduced transfection 
efficiency, as shown in Figure 3.12a. PEG-1.5 and PEG-3 contain ~10 and 20 weight % 
PEG, respectively, and were designed as comparisons to comb polymers containing ~10-
20 mol % SB and PC zwitterions. Unlike polyplexes formed from comb polymers having 
a low percentage of zwitterion that provided transfection levels comparable to or 
surpassing rNLS, those formed from PEG-1.5 and PEG-3 both showed reduced 
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transfection levels relative to rNLS. Despite the reduced transfection levels, these PEG-
based comb polymers provided transfection levels comparable. Furthermore, polyplexes 
formed from PEG-based comb polymers showed higher cell viabilities equal to or slightly 
higher than those formed from rNLS (Figure 3.12b).  
 
Figure 3.12 (a) Red fluorescent protein (RFP) expression and (b) cell viability measured 
in SKOV3 cells 48 h after addition of polyplexes composed of DNA (mRFP-IRES-Puro 
plasmid) and rNLS, PEG-X (X = mol % PEG), jetPEITM, and Lipofectamine® 2000 
(LP2k). Polymeric transfection reagents were used at 3 different N/P ratios, or the 
protonatable nitrogens on the polymer to DNA phosphates, and LP2k was used at 1:4 and 
1:6 µg DNA: µL LP2k solution. Error bars are standard error of the mean. 
 
While PEG-1.5 (with ~10 mol % PEG) contains a similar weight percentage of 
neutral hydrophilic groups as SB-11 and PC-14, the slight difference in polymer 
architecture may be responsible for the differences in zeta potential, cell uptake, and 
transfection efficiency observed between rNLS comb polymers containing PEG and 
zwitterionic SB and PC grafts. SB-X and PC-X contain a higher percentage of smaller 
molecular weight zwitterionic pendent groups (as in Figure 3.13a), while PEG-X contains 
a small percentage of long, polymeric grafts (as in Figure 3.13b). From the zeta potential 
results in Table 3.4, it is evident that polyplexes formed from comb polymers containing 
small SB or PC zwitterions as pendent groups retain a net positive surface charge, while 
those formed from comb polymers with longer PEG grafts display a less positive surface 
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charge. It is possible that the PEG grafts protrude from the polyplex, as shown in Figure 
3.13b, and act to partially shield the net positive charge of the polyplex. This is supported 
by the lower zeta potential, cell uptake, and transfection efficiency of the PEG-based 
relative to the zwitterion-based polyplexes.  
 
Figure 3.13 Possible polyplex structures formed from (a) SB-X and PC-X with single, 
monomeric zwiterions as pendent groups and (b) PEG-X with polymeric neutral 
hydrophilic grafts. 
 
Zwitterionic pendent groups also benefited the transfection performance of K4-
based comb polymers in SKOV3 cells (experiments by S. Parelkar). As shown in Figure 
3.14a, K4SB-17 provided higher RFP expression levels than K4SB-0, having no SB 
groups. High cell viabilities (>90 %) were observed following transfection with K4 comb 
polymers having 0 and 17 mol % SB zwitterions (Figure 3.14b). Flow cytometry 
experiments to gauge cell uptake (Figure 3.14c) showed K4SB-17 to afford nearly double 
the fluorescence intensity per cell 3 h after addition of polyplexes composed of comb 
polymers and fluorescent plasmid DNA (Label IT®) at N/P 4. This is an interesting result 
when compared to the cell uptake results with rNLS comb polymers (Figure 3.9), wherein 
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addition of zwitterions maintained the cell uptake levels of the rNLS homopolymers but 
did not produce the dramatic improvement seen with K4SB-17 relative to K4SB-0. 
 
 
Figure 3.14 Evaluation of K4SB-X in SKOV3 cells. (a) Red fluorescent protein (RFP) 
expression and (b) cell viability measured in SKOV3 cells 48 h after addition of 
polyplexes composed of DNA (mRFP-IRES-Puro plasmid) and K4SB-X (39, X = mol % 
SB) at 3 different N/P ratios, or the protonatable nitrogens on the polymer to DNA 
phosphates. (c) Intracellular abundance of polyplexes formed from fluorescein-labeled 
DNA and K4SB-X (39, X = mol % SB) at N/P 4 3 h after incubation with SKOV3 cells 
(sample size = 10,000 cells) in DMEM. Error bars are standard error of the mean. 
3.7 Conclusions and outlook 
Comb polymers were synthesized by ROMP having both cationic oligopeptides 
and zwitterions as pendent groups and evaluated for their ability to complex and deliver 
DNA to cells for non-viral gene delivery. SB- and PC-substituted cyclooctene were 
copolymerized with rNLS-COE to afford cationic comb polymers with Mn ~70-80 kDa and 
0-50 mol % zwitterionic pendent groups. Additionally, a series of comb polymers with K4 
and SB pendent groups was synthesized with similar molecular weights (~ 60-70 kDa) and 
varied SB loadings (0-50 mol %) for comparison with molecular simulations.   
Complexation of plasmid DNA with comb polymers including up to 50 mol % 
zwitterion in water at a constant N/P ratio produced polyplexes < 100 nm in diameter that 
displayed positive surface charge. Intended initially as a comparison to zwitterions, PEG-
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substituted cyclooctene was copolymerized with rNLS-COE and the resultant polymers 
provided substantially different properties to polyplexes. Zeta potential measurements on 
zwitterion-based and PEG-based polyplexes showed PEG to reduce the net positive surface 
charge (ς ~ 15 mV) relative to rNLS homopolymers (ς ~ 30 mV), while polyplexes from 
comb polymers including up to 50 mol % SB and PC groups maintained that surface 
charge. Experiments and molecular dynamics simulations showed zwitterions to decrease 
polymer-DNA binding strength at a constant N/P ratio. A fluorescence-based competitive 
binding assay, in which polyplexes were formed and then challenged with Picogreen® dye 
that competes with polymer for DNA binding and with heparin that competes with DNA 
for polymer binding, showed that comb polymers with increasing amounts of zwitterions 
allow increasing amounts of DNA accessible to Picogreen®. Consistent with these results, 
coarse-grained molecular dynamics simulations showed binding free energy to become less 
negative (less favorable) as the amount of zwitterion in the comb polymers increased. 
Simulations showed entropic and enthalpic contributions that favor DNA binding to be 
release of small molecule counterions and a combination of electrostatic and polymer-
solvent interactions, respectively.   
Surrounding polyplexes with neutral hydrophilic polymers, as in polyplexes formed 
from diblock copolymers with a cationic block connected to a neutral hydrophilic block, 
provides resistance to aggregation induced by salt and adsorption of serum proteins of 
positively charged polyplexes, reducing the toxicity of the polyplex and prolonging 
circulation in the bloodstream. Drawbacks of shielding the positive charge of polyplexes 
include decreased interaction with negatively charged cellular membranes and ability to 
escape endosomes that in turn reduce transfection performance. DLS and AFM show 
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appreciable aggregation of zwitterion-based polyplexes in the presence of salt and serum, 
however flow cytometry shows the same zwitterion-based polyplexes to maintain or 
exceed the cell uptake levels of rNLS comb polymers without zwitterions.  
The favorable cell uptake properties of the zwitterion-based polyplexes translated 
to transfection performance in human ovarian cancer (SKOV3) cells. A copolymer of 
rNLS- and SB-substituted cyclooctenes incorporating ~10 mol % SB provided gene 
expression levels surpassing those of rNLS and the commercial reagents, jetPEITM and 
LP2k. Similar results were obtained from transfections using copolymers of tetralysine and 
sulfobetaine, wherein inclusion of ~15 mol % SB groups increased the gene expression 
levels relative to K4 homopolymers without zwitterions. In general, decreased levels of 
gene expression resulted from transfections with comb polymers incorporating higher 
amounts of zwitterion, yet all of the comb polymers afforded gene expression levels 
comparable to or exceeding those of jetPEITM and LP2k.  While cell viability was generally 
high in transfections using comb polymer-based polyplexes compared to jetPEITM and 
LP2k, rNLS comb polymers with ~20-40 mol % SB or PC groups resulted in lower cell 
viabilities than comb polymers outside of that composition range. Comb polymers 
incorporating 1-3 mol % 4.4 kDa PEG grafts afforded lower transfection efficiencies than 
rNLS, however exhibited negligible toxicity (cell viability >95 %) even when containing 
upwards of 20 mol % PEG (PEG-3). The significant improvement in transfection efficiency 
achieved by incorporation of zwitterions into comb polymers, especially considering the 
performance of SB-11 relative to rNLS, jetPEITM, and LP2k in SKOV3 cells, represents a 
step further toward overcoming the low transfection efficiency of non-viral gene therapy 
reagents.  
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The work presented in this chapter points to several open questions and future 
directions. First, transfection experiments with zwitterion-based polyplexes showing a 
decrease in cell viability at intermediate zwitterion loadings was unexpected given the 
biocompatibility of zwitterionic groups. Exploring the cause of this phenomena will lead 
to further understanding of the impacts of polymer structure on transfection performance. 
Secondly, the drastically different properties of rNLS comb polymers containing PEG and 
individual zwitterions as grafts suggests investigation of new comb polymers having 
zwitterionic polymer grafts that introduce biocompatibility and additional functionality. 
Finally, the inclusion of responsive units within the comb polymers will provide 
opportunities for a next generation of polymeric transfection reagents that possess 
functionality to overcome the various barriers currently limiting the clinical 
implementation of gene therapy. 
Transfection experiments with zwitterion-based polyplexes in SKOV3 cells 
showed comb polymers with low loadings of zwitterion (10-15 mol %) to exhibit high cell 
viability, which decreased at slightly higher zwitterion loadings (~20 mol %). Increasing 
the zwitterion content further resulted in higher cell viability, where cell viability increased 
as function of zwitterion. Taken together with experiments and simulations showing 
polymer-DNA binding strength to decrease with zwitterion loading, these results suggest 
that decreased cell viability of comb polymers with ~20-40 mol % zwitterion may stem 
from release of net positively charged polymers, which pose significant toxicity. As the 
zwitterion content is increased further, polyplex binding strength is lowered further 
however the released polymer has less positive charge and is therefore less toxic. 
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Experiments examining the toxicity of polymers, rather than polyplexes, can be performed 
to test this hypothesis.  
The striking difference between dispersing individual zwitterions and PEG into 
comb polymers on the surface charge, stability, cellular uptake, and transfection 
performance of the resulting polyplexes suggests an opportunity to optimize these materials 
by tuning the structure, molecular weight, and composition of the grafts. First, a more direct 
comparison between zwitterionic and PEG-based grafts on comb polymers can be 
conducted by the synthesis of comb polymers with oligoethylene glycol grafts to elucidate 
the impact of the chemistry of small (monomeric) neutral hydrophilic moieties dispersed 
within comb polymers. More interestingly, comb polymers can be synthesized with 
polyzwitterion grafts in which functional groups can be introduced within the chain or at 
the chain ends for conjugation of targeting groups or cross-linkers. Figure 3.15a shows an 
example of such a comb polymer featuring cationic oligolysine sequences and 
polyzwitterions with functional groups for attachment of oligopeptides that facilitate 
specific cellular and nuclear entry. Copolymerization of oligopeptide-substituted 
cyclooctenes with isobutyryl bromide-substituted cyclooctene followed by atom transfer 
radical polymerization (ATRP) of zwitterionic sulfobetaine methacrylate and alkyne-
functionalized sulfobetaine methacrylate can be performed to generate the polymer shown 
in Figure 3.15a. Adjustment of graft length, density, and composition will allow tunable 
polyplex surface charge and functional group loading. Optimally, attachment of targeting 
moieties on the periphery polyplexes containing polyzwitterion grafts, as shown in Figure 
3.15b, will provide the desirable characteristics of shielded polyplexes, such as 
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biocompatibility and stability in the presence of salt and serum, without compromising 
cellular uptake and transfection efficiency. 
 
Figure 3.15 Proposed structures of (a) comb polymers and (b) polyplexes containing 
functional zwitterionic polymer grafts. Cationic K4 oligopeptides provide for DNA 
condensation and zwitterionic polymer grafts modulate DNA binding, surface charge, 
and serum tolerance of polyplexes. Alkyne groups embedded in zwitterionic polymer 
grafts facilitate post-polymerization modification with azide-functionalized 
oligopeptides, such as the SV40 NLS that provide cellular and nuclear entry. 
 
 
Integration of stimuli-responsive moieties into polymers for gene therapy allows 
polyplexes to display different features at various points during the delivery process. For 
example, Kataoka and coworkers designed block copolymers wherein PEG is connected 
to a polycation by a cleavable disulfide linkage that affords polyplex stability during 
circulation, followed by removal of the neutral periphery to yield positively charged 
polyplexes that enter cells and facilitate gene expression. Using a similar strategy, comb 
polymers can be designed with zwitterionic pendent groups and cationic oligopeptides 
attached to the polycyclooctene backbone by a disulfide linkage, as shown in Scheme 3.2. 
A similar strategy has been employed by Seymour and coworkers to conjugate nuclear 
localizing adenovirus hexon protein to PEI using disulfide bonds.108 After treatment of 
polymers with 1,4-dithiothreitol (DTT) to reduce the disulfide bonds and cleave the NLS, 
nuclear locazliation is inhibited. Synthesis can be accomplished by copolymerization of 
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PC-COE (33) with GGC-substituted cyclooctene followed by oxidative coupling of 
cysteine (C)-terminated SV40 NLS.  Disulfide reduction by glutathione present in elevated 
levels within the cell and nucleus following delivery of DNA will generate a zwitterionic 
polymer with free thiol groups and a cationic oligopeptide (CPKKKRKV), which is 
anticipated to be less toxic than a free cationic polymer in solution. Furthermore, Bellomo 
and coworkers indicate that concentrations of glutathione are higher in the nucleus in the 
nucleus than in the cytoplasm,109 and this may lead to release of DNA where it is desired. 
 
Scheme 3.2 Comb polymers with detachable cationic oligopeptides.  
 
Inclusion of zwitterions within comb polymers for DNA complexation and delivery 
imparts polyplexes with numerous beneficial features, including tunable DNA binding 
strength and surface charge, both of which impact biocompatibility, cell uptake, and 
transfection efficiency. Depending on the polymer architecture, zwitterions may act to 
interrupt polymer-DNA interactions or to provide a neutral shield around the polyplex that 
prevents aggregation and protein adsorption, which unfortunately often results in reduced 
cell uptake and gene expression. Comb polymers with individual zwitterions (up to 50 mol 
%) dispersed as pendent groups formed polyplexes with net positive surface charge and 
cell uptake levels comparable to or exceeding those of rNLS homopolymers without 
zwitterions. Dispersion of small amounts of zwitterions within cationic comb polymers 
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resulted in improved transfection efficiency, exceeding expression levels achieved with 
rNLS, which has demonstrated efficacy in vivo and outperforms jetPEITM and LP2k in 
SKOV3 cells. These results encourage further development of comb polymers including 
biocompatible zwitterionic components through new polymer syntheses, biophysical 
characterization techniques, and molecular simulations toward next generation materials 
for non-viral gene delivery.  
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CHAPTER 4 
COMB POLYMERS WITH OLIGOARGININE PENDENT GROUPS: 
SYNTHESIS AND CHARACTERIZATION OF POLYMER-DNA COMPLEXES 
4.1 Introduction 
Arginine, a cationic amino acid, is a component of many cell penetrating1–6 and 
antimicrobial7–9 peptides. Electron delocalization across three nitrogens of the guanidinium 
group on arginine stabilizes its positive charge.10,11 Accordingly, arginine has the highest 
pKa (~12-13.7) among the cationic amino acids, whereas lysine and histidine have pKa 
values of ~10.5 and ~6, respectively.12,13 The guanidinium moiety of arginine also forms 
more hydrogen bonds than the primary amine of lysine, facilitating strong interactions with 
phosphates and sulfates, such as those on DNA, within glycosaminoglycans in the 
extracellular matrix, and present on the cell membrane.11,14–16 Additionally, arginine-rich 
sequences are known to facilitate cell entry by endocytosis or direct/non-endocytotic 
mechanisms.4,5,17  
The highly charged nature and strong hydrogen bonding ability of guanidinium 
groups render them useful components of non-viral gene delivery vehicles, as these 
properties lead to stronger DNA binding, improved cellular uptake, endosomal escape, and 
ultimately enhanced transfection performance of arginine-containing reagents relative to 
lysine analogues.18–21 Guanidinium-containing polymers designed for gene delivery 
include poly(amido amine),22,23 lysine-based,24 and poly(propylene imine) dendrimers,25 
as well as polypeptides,26 poly(disulfide amine)s,27 poly(norbornene)s,28,29 poly(benzyl-L-
glutamates),21 poly(methacrylate)s,30,31 and oligoarginine-grafted polymethacrylamides.20 
In particular, Pun and coworkers synthesized comb polymers with oligolysine and 
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oligoarginine grafts pendent to a polymethacrylamide backbone and found the arginine-
based comb polymers to provide higher gene expression levels, but unfortunately also 
higher toxicity.20 Mitigating the toxicity of arginine, observed in a number of arginine-
containing polymers,20,21,25 will allow polymer-based gene delivery reagents to harness the 
benefits of the strong DNA and cellular interactions imparted by arginine without its 
associated drawbacks in order to maximize therapeutic efficacy. 
Guanidinium groups are beneficial in transfection reagents when combined with 
neutral hydrophilic units and nuclear localizations sequences. Incorporation of high 
loadings (60-80 mol %) of hydroxypropylmethacrylamide (HPMA) units into 
oligoarginine-grafted poly(methacrylamide)s imparted stability to polyplexes in solutions 
with physiological salt concentration while retaining positive surface charge that aids 
cellular uptake.20 The stronger charge of guanidine-containing polymers relative to amine-
based analogues was especially apparent within block copolymers having a PEG block 
connected to amine- or guanidine-functionalized polymethacrylates reported by Liang and 
coworkers.30 These guanidinium-containing block copolymers formed polyplexes with 
positive surface charge despite the presence of the PEG shielding block. In contrast, 
analogous lysine-based structures formed polyplexes with neutral surface charge. The 
combination of oligoarginine moieties with NLS sequences, specifically the Simian Virus 
40 (SV40) nuclear localization sequence (NLS) described in Chapter 2 of this thesis, shows 
potential benefit in non-viral gene therapy applications as well. For example, Zhang and 
coworkers reported that polymers incorporating both octaarginine sequences and SV40 
NLS groups yielded optimal transfection efficiency, cell viability, and nuclear uptake when 
the two sequences were combined at an intermediate ratio.26  
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Motivated by the possibility of generating polyplexes with improved cellular 
uptake and tunable DNA binding strengths, oligoarginines were integrated into comb 
polymers by ring-opening metathesis polymerization of tetraarginine-substituted 
cyclooctene. Tetraarginine pendent groups allow for comparison with the comb polymers 
having tetralysine pendent groups discussed in Chapter 3 of this thesis. As shown in 
Scheme 4.1, two series of copolymers were generated by copolymerization of 
tetraarginine-cyclooctene with various amounts of sulfobetaine-cyclooctene (SB-COE, 32) 
and SV40 NLS-substituted cyclooctene (rNLS-COE, 24). Compared to comb polymers 
having tetralysine and rNLS pendent groups, those with tetraarginine pendent groups 
exhibited significantly stronger DNA binding properties. The stronger DNA binding 
strength of the tetraarginine sequences allowed the opportunity to incorporate unusually 
large amounts of biocompatible zwitterionic groups (up to 60 %) into polyplexes while 
maintaining positive surface charge and DNA binding strength comparable to or exceeding 
that of analogous lysine-based structures.  
 
Scheme 4.1 Tetraarginine-containing comb polymers integrating (a) sulfobetaine 
zwitterions and (b) Siman Virus 40 (SV40) nuclear localizations sequences (NLS) 
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4.2 Polymer synthesis 
Comb polymers with oligoarginine pendent groups were synthesized by ROMP of 
tetraarginine-substituted cyclooctene 40, selected specifically for comparison with the 
tetralysine-based comb polymers (39a-d)32,33 described in Chapter 3. The tetraarginine 
macromonomer (R4-COE, 40) was synthesized by solid phase peptide synthesis of  
pentamethyldihydrobenzofuran (Pbf)-protected tetraarginine-cyclooctene on a 2-
chlorotritylchloride resin, followed by coupling of carboxylic acid-substituted cyclooctene 
at the N terminus. Removal of the macromonomer from the resin with a CH2Cl2/2,2,2-
trifluoroethanol (TFE) mixture, followed by precipitation into ether and centrifugation 
afforded 40 as an off-white powder in 71 % yield on a 2 g scale. 1H NMR spectroscopy of 
40 (Figure 4.1) showed the cyclic olefin proton resonance at 5.6 ppm (d), the resonance 
from the arginine γ  protons at 3.0 ppm (g), and resonances from the methyl protons of the 
Pbf protecting groups at ~1.5, 2.0, and 2.4 ppm (h, l, m). Additionally, three proton 
resonances per arginine residue associated with the guanidium group appear between 6-7.5 
ppm (c). Mass spectroscopy provided further confirmation of the desired structure: [M+H]+ 
calculated from C85H126N16O18S4, 1787.84; found, 1787.85. 
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Figure 4.1 1H NMR spectrum of R4-COE (40) acquired in DMSO-d6 
 
ROMP of R4-COE was performed in a mixture of TFE and CH2Cl2, using the 
bromopyridine-substituted Grubbs’ catalyst (26) (Figure 4.2a), similarly as done for the 
oligolysine and SV 40 NLS-based comb polymers32,33 described in Chapters 2 and 3 of this 
thesis. Homopolymerization of 40 proceeded to 45 % conversion, as determined by 1H 
NMR, integrating the resonances at 5.3 ppm, and 5.6 ppm, corresponding to polymeric and 
cyclic olefin proton resonances, respectively. Removal of the Pbf protecting groups in a 
mixture of trifluoroacetic acid (TFA), triisopropylsilane (TIPS), and water (90/5/5 v/v/v), 
followed by dialysis in water (1x), 30 % acetic acid(aq), and water (3x) in a 6-8 kDa 
molecular weight cut-off membrane and lyophilization afforded the corresponding 
homopolymer, (R4, 41). In contrast to homopolymers of tetralysine-substituted 
cyclooctene (K4SB-0, 39a) and SV40 NLS-substituted cyclooctene (27 and 28) that are 
highly water soluble, 41 exhibited limited water solubility. Allen and coworkers 
determined the difference in the hydration free energies of lysine and arginine to be -72 
and -62 kcal/mol, respectively,12 offering one possible explanation for the reduced water 
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solubility of the tetraarginine-based comb polymers. Apart from water, 41 is soluble in 
TFE. The 1H NMR spectrum of 41 confirms the removal of Pbf protecting groups and 
monomer during the purification process by the absence of monomeric olefin proton 
resonances at 5.6 ppm and the multiple resonances between 1.5-2.5 ppm corresponding to 
methyl protons on the Pbf groups, respectively (Figure 4.2b). The molecular weight and 
molecular weight distribution of 41 was determined by GPC eluting in TFE relative to 
PMMA standards to be 35 kDa and 1.26, respectively (Figure 4.2c).  
 
Figure 4.2 Synthesis and characterization of R4 (41). (a) Homopolymerization of R4-
COE (40) by ROMP in a mixture of TFE and CH2Cl2 with catalyst 26. (b) 1H NMR 
spectrum of 41 acquired in D2O and (c) GPC trace of 41 using TFE as the eluent. 
 
Copolymerization of 40 with rNLS-COE (24) and SB-COE (32) by ROMP yielded 
R4SB-X (42) and R4rNLS-X (43), where X = mol % 32 and 24, respectively (Scheme 4.2). 
Conveniently, similar conditions were employed for these polymerizations as for the 
synthesis of 41 owing to the mutual solubility of 24, 32, and 40 in the TFE/CH2Cl2 mixture. 
In general, the monomer conversion increased with the loading of either 24 or 32 (Table 
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4.1). For example, polymerizations including 10 and 40 mol % SB-COE proceeded to 42 
and 58 % conversion, respectively (42a,d) and those including 25 and 75 mol % rNLS-
COE (24) reached 45 and 75 %, respectively (43a,c). The moderate conversions achieved 
for R4-based comb polymers contrasts the almost quantitative conversion achieved during 
the synthesis of K4-based comb polymers (39a-d, Chapter 3) and more closely resembles 
the ~40-90 % conversions reached during the synthesis of SV40-based comb polymers (27 
and 28, Chapter 2) bearing one arginine per pendent group. There are multiple reports of 
ROMP of norbornene-based monomers containing guanidinium groups,28,29,34–36 though 
these polymerizations were reported exhibit living characteristics in solvents ranging from 
N,N-dimethyl formamide (DMF) to mixtures of CH2Cl2/methanol. In particular, Grubbs 
and coworkers reported polymerizations of RGD-functionalized norbonenes to proceed to 
full conversion, where the arginine residues were protected with Pbf groups similarly as 
the arginine residues in 28 and 40 and the polymerizations used catalyst 26.35 Notably, the 
solvent system (CH2Cl2/MeOH) and monomer type differed from the conditions employed 
for the polymerization of 28 and 40, suggesting one of these factors to play an important 
role in the polymerization of arginine-containing cyclooctenes.  
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Scheme 4.2 Synthesis of R4SB-X (42) and R4rNLS-X (43) by copolymerization of R4-
COE (40) with SB-COE (32) and rNLS-COE (24), respectively.  
 
 The Boc and Pbf protecting groups were removed using a TFA/TIPS/water mixture 
(90/5/5 v/v/v) and the copolymers isolated by precipitation into ether, followed by dialysis 
(6-8 kDa molecular weight cut off membrane, water (1x), 30 % acetic acid(aq) (1x), water 
(3x)) and lyophilization. The water solubility of the R4-based comb polymers increased 
with comonomer (24 or 32) content. Loadings of SB and rNLS comonomer were 
determined by 1H NMR in D2O from the relative integrations of the peaks at 3.0 ppm, 
corresponding to the resonances from arginine γ protons (d) and methyl protons on the 
ammonium group of SB (e’), and at 2.9 ppm, corresponding to the methylene protons 
adjacent to the sulfonate group of SB (f’) (Figure 4.3). Interestingly, the incorporation of 
SB into R4SB-X was appreciably higher than the targeted values (Table 4.2). 
Copolymerizations targeting 10 and 40 mol % SB pendent groups resulted in 
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incorporations of 36 and 70 mol % SB, respectively (42a,d). This situation differs greatly 
from the polymerizations of tetralysine-substituted cyclooctene (K4-COE, 38) and 32 that 
resulted in SB incorporations within 5 % of the targeted values (Chapter 3, 39a-d). These 
results suggest a drastically lower reactivity of R4-COE relative to SB-COE. On the other 
hand, copolymerization of 40 with rNLS-COE afforded polymers with rNLS compositions 
within 10 mol % of the targeted values.  
Table 4.1 Polymerization data for the synthesis of R4 (41), R4SB-X (42), and R4rNLS-X 
(43), where X = mol % SB and rNLS for 42 and 43, respectively 
Sample Name 
 
Target X  
 
X Conv. Deprotected polymers 
(GPC in TFE) 
  (mol %) (mol %) (%) Mn (g/mol) Mw/Mn 
41 R4 0 0 45 35000 1.26 
42a R4SB-36 10 36 42 32400 1.21 
42b R4SB-48 20 48 42 35900 1.26 
42c R4SB-58 30 58 55 42800 1.30 
42d R4SB-70 40 70 58 44300 1.31 
43a R4rNLS-33 25 33 45 41500 1.26 
43b R4rNLS-57 50 57 63 47700 1.32 
43c R4rNLS-80 75 75 75 51400 1.23 
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Figure 4.3 1H NMR spectra of (a) R4SB-70 (42d) and (b) R4rNLS-57 (43b) acquired in 
D2O 
 
The number-average molecular weight of the R4-based comb polymers increased 
slightly with comonomer content (24 and 32), in accord with the increasing percent 
monomer conversion (Table 4.1). For example, the Mn of R4 and R4SB-X was determined 
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to be 35 and 43 kDa, respectively, relative to PMMA standards by GPC eluting with TFE 
(42a,d). A similar trend was observed for R4rNLS-X, where the Mn of copolymers with 
33 and 75 mol % rNLS pendent groups was 42 and 51 kDa, respectively (43a,c). Despite 
this slight variation in molecular weight with composition, the R4 comb polymers have 
comparable molecular weights ranging from 30-50 kDa. Figure 4.4 shows GPC traces of 
R4SB-58 and R4rNLS-57, both having monomodal molecular weight distributions with a 
symmetrical peak shape. Similarly as the other oligopeptide-based comb polymers 
described in Chapters 2 and 3, the R4-based comb polymers have low molecular weight 
distributions (Mw/Mn 1.2-1.3, Table 4.1). These two series of R4 copolymers, having 
similar molecular weights and incorporating various loadings of zwitterionic SB groups 
and SV40 NLS oligopeptides, provide an ideal set of materials for determining the effects 
of oligoarginine groups within comb polymers on the resulting polyplex properties. The 
sections that follow investigate the size, surface charge, and DNA binding strength of 
polyplexes formed from the R4-based comb polymers.  
 
 
Figure 4.4 GPC traces of (a) R4SB-58 (42c) and (b) R4rNLS-57 (43b) eluting in TFE 
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4.2 Polyplex size and surface charge 
Polyplexes were formed from the R4 comb polymers by mixing with plasmid DNA 
DNA (reporter mRFP-IRES-Puro, 4.5 kbp, 0.02 g/L) in DNase-free water (1:1 v/v ratio). 
Following equilibration for 40 minutes at room temperature, polyplex size was measured 
by dynamic light scattering (DLS) and atomic force microscopy (AFM). DLS of polyplexes 
measured in 10 mM NaCl(aq) showed structures with hydrodynamic diameters (Dh) ranging 
from ~60-80 nm (Figure 4.5). While Dh increased slightly with SB and rNLS content in the 
copolymers, the change in Dh as a function of polymer composition is not statistically 
significant. Zeta potential measurements on the same polyplex solutions showed all 
polyplexes to exhibit positive surface charge (ζ >30 mV), even when formed from comb 
polymers including 70 mol % SB groups (i.e., R4SB-70, 42d). Notably, the zeta potential 
of polyplexes formed from R4 homopolymer (41) was higher that of the copolymers. As 
the comonomer content increased in both R4SB-X and R4rNLS-X, the zeta potential of the 
resulting polyplexes decreased. The zeta potential of polyplexes formed from 41 and 
R4rNLS-80 was measured to be 45 and 30 mV, respectively (Figure 4.5b). As a 
comparison, the tetralysine-based polyplexes discussed in Chapter 3 (formed from 39a-d) 
have zeta potentials ~30-35 mV, similar to polyplexes formed from rNLS comb polymers 
(28, Chapter 2). This result is consistent with Cheng21 and  Liang,30 showing polymers with 
guanidinium groups to form polyplexes with a higher zeta potential than analogous 
polymers with amine groups. However, Pun and coworkers find amine-containing block 
copolymers, having a hydrophobic polyester block connected to a statistical copolymer of 
amine-functionalized glycidyl methacrylate and PEG methacrylate, to form polyplexes 
with a higher surface charge than those from analogous guanidinium structures in one 
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case31 and no significant difference in surface charge was observed between polyplexes 
formed form poly(oligolysine methacrylamide)s and analogous guandinium derivatives in 
another instance.20 The higher surface charge of polyplexes formed from 41 is reasonable 
given the higher pKa of arginine (~12-13.7) relative to lysine (~10.5)12 that may result in 
a higher charge density of structures with higher arginine contents. The positive surface 
charge of polyplexes formed from R4SB-70 is especially interesting considering the high 
content of net neutral zwitterions. Such structures incorporating high loadings of 
biocompatible zwitterions without compromising surface charge are promising structures 
for non-viral transfection since they have the potential to exhibit high levels of gene 
expression by electrostatic interaction with the cell membrane while retaining high cell 
viability. 
 
Figure 4.5 Size and zeta potential of polyplexes formed from (a) R4SB-X (42) and (b) 
R4rNLS-X (43) comb polymers and plasmid DNA (reporter mRFP-IRES-Puro, 4.5 kbp) 
at N/P 5, then diluted to 10 mM NaCl(aq).  
 
AFM provided additional insight into polyples size distribution and interaction with 
the negatively charged mica substrates used for imaging. Prior to imging, polyplex 
solutions were dropcast onto freshly cleaved mica substrates, equilibrated ~10 minutes to 
allow polyplexes to adsorb to the substrate, and rinsed with water to remove unadsorbed 
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polyplexes. Height images of polyplexes formed from R4 showed sub-100 nm structures 
interspersed with larger 100-200 nm aggregates (Figure 4.6a). Similarly sized structures 
were observed in images of polyplexes formed from R4rNLS-X comb polymers (Figure 
4.6b and c). Particle size analysis (insets of Figures 4.6a-d) show the average particle 
diameter (d) to exceed that found by DLS measurements, however the size distributions 
derived from AFM have long tails on either side of the main peak between 70-90 nm. 
Polyplexes formed from R4SB-X exhibited interesting morphologies that varied with SB 
content in the polymer. While polyplexes formed from R4SB-36 formed relatively compact 
structures (Figure 4.6d), those formed from R4SB-58 formed flower-like structures where 
DNA loops emanate from a central particle (Figure 4.6e). Stolnik and coworkers noted 
flower-like morphologies of polyplexes poly(dimethylamino ethyl methacrylate)-b-
poly(2-methacryloyloxyethyl phosphorylcholine) obtained from AFM performed in 
solution.37 A striking difference was observed between polyplexes formed from R4SB-36 
and R4SB-58 when compared to an analogous lysine-based polymer (K4SB-49 (39d). 
Figure 4.6f shows flat structures, ~3-5 nm in height, of polyplexes formed from the lysine-
based comb polymer. This finding was attributed to partial desorption of polyplexes from 
the mica substrate during the rinsing step. In contrast, polyplexes formed from R4SB-58 
remained adsorbed to the mica substrate after the rinsing step as evidenced by the presence 
of flower-like structures mostly ~15-20 nm in height (Figure 4.6d and e). The increased 
adsorption of the R4-based polyplexes to the negatively charged mica substrates bodes well 
for their application in non-viral gene delivery, wherein polyplexes must facilitate cell 
entry by interaction with negatively charged cell membranes.38–40 
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Figure 4.6 AFM of polyplexes (N/P 5) formed with plasmid DNA (mRes-Ires-Puro, 4.5 
kbp) and (a) R4, (b) R4rNLS-33, (c), R4rNLS-57, (d) R4SB-36, (e) R4SB-58, and (f) 
K4SB-49. Size distributions and the average diameter, d, of polyplexes determined from 
each image are shown as insets in a-d. The inset in e magnifies three flower-like 
polyplexes formed from R4SB-58. 
4.3 DNA binding strength 
DNA binding strength of the polymers was evaluated using a fluorescence-based 
assay wherein polyplexes are incubated with heparin, an anionic polymer that competes 
with DNA for binding with the polymer, and Picogreen®, a dye that undergoes 
fluorescence enhancement upon binding DNA. This assay provides a measure of the 
percentage of DNA either loosely associated with or free from the polymer and is described 
in detail in Appendix A. Results comparing the percentage of accessible DNA 16 h after 
incubation of polyplexes with heparin and Picogreen® show that an unusually high (>60 
mol %) zwitterion content can be incorporated into comb polymers with tetraarginine 
groups without compromising DNA binding, i.e. by comparing polyplexes formed from 
K4SB-0 and R4SB-58 that resulted in 33 and 29 % accessible DNA, respectively (Figure 
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4.7). A direct comparison between lysine- and arginine-based homopolymers shows 
polyplexes formed from K4 and R4 to allow 33 and 4 % accessible DNA, respectively. 
This appreciable difference in DNA binding strengths (~ one order of magnitude difference 
in accessible DNA) between lysine- and arginine-based polymers becomes less 
pronounced when the oligopeptides are diluted with sulfobetaine zwitterions on the comb 
polymers. Polyplexes formed from K4SB-49 afforded 66 % accessible DNA 16 h after 
incubation with heparin and Picogreen®, three times greater than that by R4SB-48 (18 %). 
The strong binding strength of arginine-based comb polymers relative to analogous lysine-
based structures provides an opportunity to incorporate high amounts of zwitterions for 
their potential biocompatibility and stability benefits, without compromising ability of the 
polymer to complex DNA.    
 
Figure 4.7 DNA binding strength of R4-containing comb polymers compared to K4-
based comb polymers, PLL, and jetPEITM determined percentage DNA accessible to 
Picogreen® following incubation of polyplexes (N/P 5) with Picogreen® and heparin (40 
units) for 16 h at 37 °C.  
 
These results are consistent with the stronger DNA interactions of  arginine 
compared to lysine,15 as well as the work of several groups showing arginine-based 
polymers to exhibit stronger DNA complexation properties relative to analogous lysine-
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based polymers.16,21,30 Simulations by Elder and Jayaraman further support the observation 
that arginine-based comb polymers exhibit stronger DNA binding, where they find 
polymers without arginine residues to have less favorable binding energies than those with 
one arginine per repeat unit.41 In contrast, the binding results presented in Figure 4.7 differ 
from work by Pun and coworkers, showing guanidinum-based polyplexes to release more 
DNA than amine-based polyplexes in the presence of heparin and heparan sulfate, anionic 
proteoglycans found in the extracellular matrix of cells.31  
A similar trend was observed for polyplexes formed from R4rNLS-X, wherein the 
percentage of DNA accessible to Picogreen® increased with the incorporation of rNLS 
comonomer in the tetraarginine comb polymers. For example, polyplexes formed from R4 
and R4rNLS-80 provided 4 and 23 % accessible DNA, respectively (Figure 4.7). Increasing 
the amount of rNLS, having only one arginine residue, in the comb polymers decreased the 
density of arginine groups and likely is responsible for the weaker DNA binding observed 
with comb polymers having higher incorporations of rNLS groups. Notably polyplexes 
formed from R4 exhibited stronger DNA binding properties (4 % accessible DNA) than 
linear PLL (9 %). Given that the benefit of the comb architecture was found to stem from 
its weaker DNA interaction relative to linear polymers (i.e PLL),32,42 R4 may complex 
DNA too strongly to facilitate sufficient DNA release required for high transfection 
efficiencies. However, given that DNA complexation strength was found to be a strong 
function of polymer composition, copolymers such as R4SB-58 and R4SB-70 are 
promising transfection reagents as they exhibit DNA binding properties similar to K4 while 
incorporating high amounts of biocompatible zwitterions to alleviate polycation toxicity 
and stabilize polyplexes in solutions with salt and serum.  
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4.4 Conclusions and outlook 
Comb polymers with tetraarginine groups were synthesized by ROMP of Pbf-
protected tetraarginine cyclooctene, prepared on a multi-gram scale by solid phase peptide 
synthesis. Copolymerization with zwitterionic sulfobetaine- and SV40 NLS-substituted 
cyclooctenes afforded two series of comb polymers with comparable molecular weights 
and varying compositions suitable for the investigation of the impact of tetraarginine 
sequences within polyplexes. The first series of comb polymers contains tetraarginine and 
up to 70 mol % sulfobetaine zwitterions as pendent groups, while the second contains 
tetraarginine and rNLS oligopeptides, ranging from 0-100 mol % rNLS. 
All of the arginine-containing comb polymers generated polyplexes that were 
positively charged and mostly sub 100 nm, though AFM showed several larger aggregates 
ranging from 100-200 nm in diameter. Interestingly, AFM of polyplexes following 
dropcasting onto mica substrates, equilibration for 5-10 minutes to allow adsorption to the 
substrate, and rinsing with water revealed flower-like morphologies of polyplexes formed 
from a copolymer of tetraarginine- and sulfobetaine-substituted cyclooctenes having ~60 
mol % zwitterionic sulfobetaine groups (R4SB-58). In contrast, only thin, flat structures 
(~3 nm in height) were observed in images of polyplexes formed from analogous lysine-
based comb polymers having only ~50 mol % sulfobetaine groups, suggesting the arginine-
based comb polymer form polyplexes that adsorb more strongly to the negatively charged 
mica substrates. Comb polymers with higher arginine contents formed polyplexes with 
slightly higher zeta potential. Notably, polyplexes formed from R4SB-X with up to 70 mol 
% sulfobetaine zwitterions displayed positive surface charge (ζ ~ 30 mV). 
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The tetraarginine grafts most significantly impacted the DNA binding properties of 
the comb polymers, especially when compared to analogous lysine-based structures. For 
example, incubation of polyplexes formed from K4SB-0 and K4SB-49 with heparin and 
Picogreen® resulted in 33 and 66 % DNA accessible to Picogreen®, respectively. 
Analogous arginine polymers, R4 and R4SB-48, resulted in 4 and 29 % accessible DNA, 
respectively. Combination of tetraarginine grafts with rNLS resulted in stronger polymer-
DNA interactions as well, wherein R4rNLS-33 allowed 7 % and R4rNLS-80 allowed 23 
% accessible DNA. The ability to finely tune polymer-DNA binding strength, both by 
enhancing polymer-DNA interactions with arginine moieties and decreasing them with 
zwitterions, holds promise for non-viral gene delivery applications, wherein DNA carriers 
must both complex DNA during extra- and intracellular transport and subsequently release 
it in the nucleus for transcription and translation. 
A particularly pressing question is whether incorporation of > 50 mol % zwitterionic 
groups into comb polymers will yield polyplexes with superior cell viability and colloidal 
stability in physiological environments relative to the lysine and rNLS-based analogues 
presented in Chapter 3 of this thesis. DLS and AFM techniques can be used to determine 
polyplex size in the presence of salt in serum. Pun and coworkers reported cationic 
oligopeptide-grafted polymethacrylates having a majority of neutral hydrophophilic 
hydroxypropylmethacrylamide units (60-80 mol %) incorporated in a statistical manner to 
afford polyplexes smaller than 200 nm in solutions with 150 mM phosphate buffered saline 
(PBS).20 Taken together with the experiments discussed herein, R4SB-58 and R4SB-70 
may similarly exhibit stability in salt and serum, thereby promoting biocompatibility and 
enabling systemic administration in vivo, while sufficiently complexing DNA and retaining 
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positive surface charge. Furthermore, given the documented toxicity of arginine-based 
reagents relative to lysine-based analogues,20,21,25 it will be essential to evaluate the impact 
of polymer composition on cell viability. Specifically, experiments investigating the 
impact of zwitterionic groups within arginine-based polyplexes on the cell viability will 
elucidate whether zwitterions can sufficiently alleviate the toxicity of these arginine-based 
structures to avail them for use in gene therapy. 
Evaluation of the tetraarginine-containing comb polymers presented here as 
transfection reagents in a therapeutically relevant cell line will complement and enhance 
the physical characterization described in this chapter. Given that oligoarginine is known 
to enhance cellular uptake, the R4rNLS-X series is intended to determine whether 
incorporation of tetraarginine moieities can improve the cell uptake and transfection 
performance of the rNLS-based comb polymers, that have demonstrated efficacy in cell 
culture and in mice (Chapter 2). Flow cytometry experiments can be used to determine the 
impact of tetraarginine pendent groups within polyplexes formed from comb polymers on 
cell uptake. Additionally, comb polymers combining tetraarginine, zwitterions, and rNLS 
pendent groups can be synthesized to enhance both cellular and nuclear uptake, while 
optimizing biocompatibility, DNA binding strength, and toxicity. 
The introduction of helical structures and hydrophobic moieties may also serve to 
to improve cellular uptake. Cheng and coworkers demonstrated the importance of helical 
oligopeptides in polymers for non-viral transfection.21 High molecular weight 
polypeptides, such as polyR and polyK assume random coil conformations due to 
electrostatic repulsions between side chains.43 By spacing the guanidinium group away 
from the peptide backbone, Cheng and coworkers maintained the helical structure, 
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resulting in polymers that greatly exceeded the gene expression of polyR (random coils).21 
Circular dichroism meaurements of the polycyclooctene comb polymers with a varety of 
oligopeptide and zwitteronic pendent groups can be used to determine the structure of 
oligopeptide graft structures within comb polymers. Such expeirments will inform future 
polymer design, for example extending the oligopeptide graft length to to encourage the 
formation of helical conformations within the comb polymers. In the same report, Cheng 
and coworkers showed hydrophobicity to aid cellular uptake. Copolymerization of 
tetraarginine with substituted or unsubstituted cyclooctenes can be performed to provide 
comb polymers with increased hydrophobic character in an effort to further improve 
cellular uptake and transfection performance. Alternatively, hydrophobic spacers could be 
placed between the oligoarginine grafts and the cyclooctene backbone. Fmoc-based solid 
phase peptide synthesis is amenable to addition of linkers, for example Fmoc-NH-(CH2)5-
COOH, after the addition of the last amino acid residue and prior to the addition of 
carboxylic acid-substituted cyclooctene. Understanding the impact of additional functional 
features onto the comb polymer platform, both in terms of the physical polyplex properties 
and the resultant performance in cell culture, will lead to improved polymer design and 
accelerate translation of promising gene-based therapies into clinical practice. 
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CHAPTER 5 
INTERFACIAL ASSEMBLY OF FUNCTIONAL ZWITTERIONIC POLYMERS 
5.1 Introduction 
Emulsions, complex fluids in which one liquid is encapsulated inside a second 
immiscible liquid,1,2 are used in foods,3,4 oil recovery,5 and as templates for the synthesis 
of particles,6,7 porous materials,8–10 and capsules.11–14 Surfactants, surface-active 
compounds that balance solubility in water and oil, enable the encapsulation of oil droplets 
in water (or vice versa) by reducing interfacial tension and by providing steric and/or 
electrostatic stabilization against coalescence of individual droplets. Examples of 
surfactants include sodium dodecyl sulfate (SDS), phospholipids, and amphiphilic block 
copolymers, such as polystyrene-b-polyethylene oxide.1,5 To form an oil-in-water 
emulsion, a water-soluble surfactant such as SDS is required, while inverse (water-in-oil) 
emulsions require an oil-soluble surfactant, such as a phospholipid. Once an emulsion is 
formed, the properties of the surfactant dictate stability and provide opportunities for 
tunable droplet disruption to afford on-demand release of encapsulated material,15–17 cross-
linking at the oil-water interface,18,19 and complex inter-droplet interactions that allow the 
formation of droplet networks.20–22 
Polymer surfactants provide increased emulsion stability relative to small molecule 
surfactants and the opportunity to introduce a wide range of functionality to expand the 
scope of emulsions.5,23 Classes of polymer surfactants include macrosurfactants, having 
spatially separated hydrophilic and hydrophobic regions within the same molecule, and 
polysoaps, which include polymers of surfactant monomers or random copolymers of 
hydrophilic and hydrophobic monomers (Figure 5.1). Macrosurfactants are typically block 
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copolymers that form intricate intramolecular assemblies in aqueous solution, where the 
resulting structure depends highly on the volume fraction of hydrophobic component. 
Spherical micelles form at low hydrophobic volume fractions in water, while worm-like 
micelles and vesicles form from block copolymers with higher hydrophobic volume 
fractions.2,24 As shown in Figure 5.1, polysoaps are capable of intramolecular assembly in 
dilute aqueous solutions such that the hydrophobic moieties are sequestered to the interior 
of the polymer structure.5 At higher concentrations, polysoaps form intermolecular 
aggregates. Advances in polymer chemistry have produced polymeric surfactants, having 
a variety of architectures and functional groups, that capably stabilize emulsion droplets 
wherein the hydrophobic moieties on the polymer are generally localized within the oil 
phase and hydrophilic moieities within the aqueous phase (Figure 5.1d).5,25–27 For example, 
Cheng and coworkers designed polynorbornenes having a hydrophilic and hydrophobic 
group pendent to the polymer backbone on each monomer unit for the stabilization of oil-
in-water emulsions.26 Functional polymers on droplets allow click chemistry28 and cross-
linking at the oil-water interface,25,29 interaction with a variety of surfaces,30–32 and stimuli-
triggered emulsion inversion or disruption.16,33,34 
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Figure 5.1 Polymer surfactants: (a) macrosurfactants, having spatially separated 
hydrophilic (blue) and hydrophobic (red) segments, and polysoaps, classified further into 
(b) statistical copolymers of hydrophilic and hydrophobic monomers and (c) polymers of 
surfactant-containing monomers. (d) Stabilization of oil-in-water droplets by random 
copolymers composed of hydrophilic and hydrophobic monomers. 
 
This chapter investigates functional sulfobetaine polymers at oil-water interfaces 
due to their interesting stimuli-responsive behavior in water.35–39 Sulfobetaine polymers 
feature anionic sulfonate and cationic quaternary ammonium groups on each repeat unit. 
In pure water, dipole-dipole interactions confine the sulfobetaine polymers to a collapsed 
configuration. Addition of salt screens these interactions and increases water solubility, a 
phenomenon known as the “anti-polyelectrolyte effect.”40,41 The solubility is further 
promoted by an osmotic gradient upon addition of salt, wherein the excess of charge 
outside the polymer coils results in an influx of salt into the coils and swelling of the 
polymer chains.41,42 Furthermore, sulfobetaine polymers exhibit upper critical solution 
temperature (UCST) behavior in water, where the UCST depends on salt concentration, 
molecular weight, and structure (i.e., number of methylene units between charged groups 
and percentage of hydrophobic comonomers).36–39 The salt- and temperature-dependent 
properties of sulfobetaine polymers are utilized in ‘smart’ micelles,43–45 polymer 
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nanoparticles,46 hydrogels,47–51 and polymer brushes.52–55 In 1991, Laschewsky and 
coworkers synthesized polysoaps with sulfobetaine connected to a polymethacrylate 
backbone by a hydrocarbon spacer and investigated their surface activity.56,57 The 
interfacial tension of the water-air interface in the presence of the zwitterionic polysoap 
was found to be greater in 0.1 M NaBr(aq) than in pure water. Here we describe the stimuli-
responsive stabilization of oil-in-water droplets by a more common sulfobetaine polymer, 
polySBMA (12). While oil-in-water droplets stabilized by 12 remain stable for at least 12 
h in water at room temperature, increasing the salt concentration or temperature leads to 
droplet coalescence. 
The impact of functional groups on the interfacial properties of sulfobetaine 
polymers is studied as well. Copolymerization of sulfobetaine methacrylate (SBMA, 44) 
with functional methacrylates afforded functional zwitterions incorporating alkenes and 
alkynes, either attached to the polymethacrylate backbone or to the zwitteronic moiety, as 
shown in Scheme 5.1. The introduction of functional groups increased the affinity of the 
zwitterionic polymers for the oil-water interface. Notably, this effect was far more 
pronounced in polymers having functional groups attached to the backbone, wherein 
copolymers with alkene loadings as low as 10-15 mol % interrupted the salt-responsive 
emulsion destruction observed with the polySBMA homopolymer (12). On the other hand, 
embedding functional groups into the zwitterionic moiety allowed incorporation of high 
loadings (50 mol %) of alkenes and alkynes while preserving the salt-responsive emulsion 
destruction. Moreover, inclusion of functional groups enabled the fabrication of robust 
capsules by thiol-ene cross-linking at the oil-water interface. 
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5.2 Synthesis of functional sulfobetaine polymers  
Functional sulfobetaine polymers were synthesized by reversible addition 
fragmentation chain transfer (RAFT) polymerization of sulfobetaine methacrylate (44) 
with n-butenyl methacrylate (45) or with novel sulfobetaine methacrylates having alkene 
and alkyne groups embedded into the zwitterionic moiety (i.e., allyl-SBMA, 51). Alkene 
and alkyne groups were selected to enable post polymerization modification and cross-
linking using facile thiol-ene and thiol-yne chemistry.58 Work published by the Wooley 
and Hawker groups demonstrated the amenability of controlled radical polymerization 
techniques to the polymerization of alkene-containing monomers.59,60 The calculated 
reactivity ratio of the methacrylate to the alkene in 45 is ~104,59 which enabled the highly 
selective polymerization of the methacrylate in the presence of the alkene. Spacing the 
alkene group at least two carbons away from the methacrylate was found to be critical, as 
allyl methacrylate cross-linked upon polymerization.60 Accordingly, the reactivity ratio 
between the methacrylate and alkene groups of allyl methacrylate was determined to be 
~30, more than two orders of magnitude lower than that of 45 with 2 methylenes separating 
the alkene from the methacrylate.59  
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Scheme 5.1 Depictions of functional zwitterionic polymer designs, in which functional 
groups (FGs, i.e., alkenes and alkynes) are incorporated (a) as comonomers and (b) 
directly into the zwitterionic moiety 
 
Copolymerization of 44 with n-butenyl methacrylate (45) was performed by RAFT 
in 2,2,2-trifluoroethanol (TFE), using 4-cyano-4-(phenylcarbonothiolylthio)pentanoic acid 
(46) as the chain transfer agent (CTA) and 4,4’-azobis(4-cyanovaleric acid) (ACVA) as the 
radical initiator (I) at [CTA]:[I] = 10 (Figure 5.2a). After stirring 12 h at 70 °C, the solutions 
were precipitated into acetone to remove unreacted n-butenyl methacrylate. The 
copolymers were then isolated by dialysis and lyophilization to afford butenyl-X 
copolymers (47a-f), where X = mol % n-butenyl methacrylate, as light pink powders. 
Composition was determined by 1H NMR acquired in D2O with 0.2 M NaCl or NaNO3, 
comparing the relative integrations of the peaks at 3.2 ppm, corresponding to the 
resonances of the methyl protons of the ammonium groups of 44 (j), and 5.9 ppm, 
corresponding to one alkenyl proton of 45 (d) (Figure 5.2b). As shown in Table 5.1, the 
compositions were within 5 mol % of the targeted values, suggesting similar reactivities of 
44 and 45. Notably, copolymers incorporating as high as 48 mol % n-butenyl methacrylate 
were soluble in water at 1 mg/mL. This is consistent with the report by Roth and coworkers 
showing sulfobetaine polymers with aliphatic hydrophobic comonomers to exhibit higher 
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solubility in water (decreased upper critical solution temperatures) compared to 
sulfobetaine homopolymers.37 Given that the solubility of sulfobetaine polymers is limited 
to salted aqueous eluents and fluorinated polar solvents,35,36,61 TFE was selected to co-
solubilize 44 and 45. The choice of TFE as a solvent required the use of high monomer 
concentrations to achieve appreciable monomer conversion. For example, 
homopolymerization of 44 in TFE at a monomer concentration [M] = 0.5 M and 
[M]:[CTA]:[I] = 107:1:0.1 resulted in negligible conversion, whereas increasing [M] to 1.8 
M under the same conditions afforded 87 % conversion. In aqueous solution containing 0.5 
M NaBr, RAFT polymerization of 44 at a monomer concentration [M] = 0.7 M and 
[M]:[CTA]:[I] = 480:1:0.05 proceeded to >95 % conversion. Additionally, while 
copolymerizations of 44 and 45 including up to 15 mol % 45 in the feed resulted in well-
defined copolymers with narrow molecular weight distributions (<1.2) and yields 
exceeding 50 %, those incorporating higher mol % 45 resulted in markedly lower yields, 
lower number-average molecular weights (Mn), and higher molecular weight distributions 
(Table 5.1). While conversion was not determined due to the insolubility of 45 in aqueous 
solution, which would necessitate the use of deuterated TFE for each conversion NMR 
spectra, the decreasing yield with increasing loadings of n-butenyl methacrylate suggest 
adverse effects associated with the alkene-containing monomers on these polymerizations. 
Polymerizations including 30 and 50 mol % 45 resulted in yields of 16 and 2 %, 
respectively (47e-f, Table 5.1). The GPC traces in Figure 5.3c show the broader molecular 
weight distributions and decreasing molecular weights that result from increasing amounts 
of 45 in the monomer feed. Despite these obstacles, RAFT polymerization of 44 and 45 in 
TFE produced a series of polymers incorporating 0-48 mol % n-butenyl methacrylate for 
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investigation of the influence of alkene groups on the behavior of zwitterionic sulfobetaine 
polymers at the oil-water interface. 
 
Figure 5.2 Synthesis of butenyl-X (47) by RAFT polymerization of SBMA (44) and n-
butenyl methacrylate (45), where X = mol % 45; (b) 1H NMR spectrum of 47e acquired 
in D2O with 0.2 M NaCl; (c) GPC traces of 12 and 47d-f using TFE as the eluent 
 
Table 5.1 Polymerization data for polySBMA (12) and butenyl-X (47) 
Sample Name 
 
Feed 45 
(mol %)  
Incorporated 45 
(mol %) 
Mn  
(g/mol) 
Mw/Mn Yield 
(%) 
12 polySBMA 0 0 27300 1.12 47 
47a butenyl-2 1 2 31500 1.13 74 
47b butenyl-5 5 5 27900 1.17 76 
47c butenyl-11 10 11 37850 1.16 60 
47d butenyl-13 15 13 26600 1.15 54 
47e butenyl-33 30 33 14900 1.21 16 
47f butenyl-48 50 48 10500 1.27 2 
 
In a second design, C. Chang synthesized novel sulfobetaine polymers with alkenes 
and alkynes embedded directly into the sulfobetaine zwitterions. As shown in Scheme 5.2a, 
deprotonation of 31 with n-butyl lithium (n-BuLi) at -78 °C and subsequent addition of 
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allyl bromide afforded the allyl-substituted sultone 49. Alkene-functionalized sulfobetaine 
methacrylate (allyl-SBMA, 51) was then synthesized by the reaction of 49 with 50, and 
copolymerized with 44 by RAFT, using similar conditions as for the synthesis of butenyl-
X, to yield allyl-SB-X (52), where X = mol % allyl-SBMA (Scheme 5.2a-b). An analogous 
synthetic route was employed to produce alkyne-substituted sulfobetaine polymers, 
alkyne-SB-X (53) (Scheme 5.2c), except in this case the alkynes were protected with 
trimethylsilyl (TMS) groups during polymerization and later removed with potassium 
fluoride.62 Similarly as in the synthesis of butenyl-X (Table 5.1), the molecular weight 
distribution of allyl-SB-X increased appreciably with the loading of allyl-SBMA (Table 
5.2). This is consistent with the report of Wooley and coworkers that showed a broadening 
of the molecular weight distribution at 63 % conversion during the polymerization of 
alkene-substituted styrene by RAFT.59 Copolymerization of 44 with TMS-alkyne-
substituted SBMA for the synthesis of 53 resulted in narrower molecular weight 
distributions (≤ 1.3), despite high loadings of functional groups, likely due to the presence 
of the TMS protecting groups during the polymerization. Apart from broad molecular 
weight distributions in polymers incorporating high loadings of alkene groups, RAFT 
polymerization in TFE produced a set of polymers displaying alkenes and alkynes attached 
either to the backbone, as in the case of butenyl-X, or to the zwitterion, as in allyl-SB-X 
and alkyne-SB-X, for examination of the impact of functional group loading and placement 
on interfacial activity. 
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Scheme 5.2 Synthesis of functional polysulfobetaines having alkene and alkyne groups 
embedded directly into the zwitterion (a) Synthesis of allyl-SBMA (51), (b) RAFT 
polymerization of 51 with SBMA (44) to yield allyl-SB-X (52), where X = mol % allyl-
SB. (c) Structure of alkyne-SB-X (53), where X = mol % alkyne-SB.  
 
Table 5.2 List of allyl-SB-X (52) and alkyne-SB-X (53) copolymers used for droplet 
experiments 
Sample Name 
 
allyl-SB or 
alkyne-SB 
Mn  
(g/mol) 
Mw/Mn 
  (mol %)   
52a allyl-SB-20 21 17200 1.4 
52b allyl-SB-50 46 21100 2.1 
52c allyl-SB-100 100 26700 4.9 
53a alkyne-SB-50 50 14500 1.1 
53b alkyne-SB-100 100 17800 1.3 
 
5.3 Evaluation of functional sulfobetaine polymers at the oil-water interface 
The salt and temperature responsive properties of sulfobetaine polymers were 
employed to prepare stimuli-responsive oil-in-water droplets, and the effect of functional 
groups on the behavior of these polymers at the oil-water interface on droplets investigated. 
Interactions between the ammonium and sulfonate groups of sulfobetaine reduces the 
hydrophilicity of polySBMA sufficiently to permit stabilization of oil droplets in pure 
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water (Figure 5.3a). Shaking a vial containing polySBMA (12, 1 mg/mL in pure water, 1 
mL) and 1,2,4-trichlorobenzene (TCB, 0.2 mL) produced oil-in-water droplets, as seen by 
the white emulsion layer at the bottom of the vial in Figure 5.3b. Optical microscopy 
showed the droplets to range from ~30-100 µm in diameter.  Addition of NaCl(aq) (1 M, 0.1 
mL) to the droplets led to coalescence of the droplets into a large TCB drop, as shown in 
Figure 5.3c. A control experiment showed droplets stabilized by polySBMA to remain 
stable 12 h following the addition of the same volume of pure water (Figure 5.3d). The 
UCST behavior of polySBMA provided an additional opportunity to create temperature-
responsive droplets. In the experiment shown in Figure 5.3e, TCB-in-water droplets 
stabilized by polySBMA in pure water, initially at room temperature, were heated 10 °C 
every 20 minutes in a water bath. The droplets started to coalesce when the temperature 
was increased above 50 °C and almost completely coalesced into a large TCB droplet at 
80 °C. The white color of the TCB droplet observed at 80 °C may be due to the presence 
of several smaller TCB droplets coating the larger droplet that have not yet coalesced. 
Droplets held at room temperature throughout the duration of this experiment (2 h) 
remained stable.  
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Figure 5.3 Responsive oil-in-water droplets stabilized by polySBMA (12). (a) Schematic 
of droplet formation, wherein TCB (0.2 mL) is added to a solution of 12 (1 mL, 1 
mg/mL). (b) Photograph and optical micrograph of TCB-in-water droplets. Photographs 
of droplets before and 12 hr after adding NaCl(aq) (1 M, 0.1 mL) (c) or (d) water (0.1 mL). 
(e) Temperature responsive destabilization of TCB-in-water droplets, shown by 
photographs of droplets while heating from room temperature to 80 °C. 
 
The functional sulfobetaine polymers were then investigated on oil-in-water 
droplets. While all of the copolymers stabilized TCB-in-water droplets in pure water, the 
functional group placement was shown to markedly impact the salt-responsive properties 
of the polymers. Impressively, allyl-SB-X and alkyne-SB-X containing as much as 50 mole 
% of functional groups retained the salt-responsive properties of the polySBMA 
homopolymer (12) on oil-in-water droplets.  In contrast, droplets stabilized by butenyl-13, 
with just 13 mol % of n-butenyl methacrylate, showed no such salt-responsiveness. Figure 
5.4a shows that TCB-in-water droplets stabilized by polySBMA, allyl-SB-50, and alkyne-
SB-50 (outlined in blue) coalesced in 0.1 M NaCl(aq), whereas those stabilized by butenyl-
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13 (outlined in red) remained stable under the same conditions. Thus, while attachment of 
alkenes directly to the methacrylate backbone strongly impacts interfacial properties, 
attaching the alkene and alkyne groups directly to the zwitterionic moiety allows 
incorporation of a significant amount of functionality (up to 50 mol %) without impeding 
the salt-responsive behaviour inherent to sulfobetaine methacrylate polymers. 
 
Figure 5.4 Effect of functional group placement on interfacial properties. (a) Photographs 
of TCB-in-water droplets stabilized by polySBMA (12), allyl-SB-50 (52b), alkyne-SB-50 
(53a), and butenyl-13 (47d). (b) Mean equilibrium interfacial tension (γeq) of the TCB-
water interface measured by pendant drop tensiometry in the presence of polymers (1 
mg/mL). Error bars represent the standard deviation of at least three independent 
measurements. 
 
The equilibrium interfacial tension (γeq) of TCB and water in the presence of the 
functional sulfobetaine polyemrs was measured by pendant drop tensiometry (Figure 5.4b) 
to gauge their affinity for the oil-water interface, where lower values correspond to stronger 
affinity for the interface. In these experiments, a drop of TCB was dispensed into a solution 
of polymer in water and the interfacial tension determined every 20 s for 10 min. A 
MATLAB routine was used to iteratively solve the Laplace equations to generate the shape 
of the drop in order to minimize the error between the imaged and calculated values. 
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Averaging the interfacial tension values calculated from the Laplace equations between 
500-600 s after the start of the measurement gave γeq. Since the interfacial tension did not 
change appreciably during these measurements, this average likely represents an 
equilibrium value. PolySBMA reduced the TCB-water interfacial tension slightly (from 43 
to 39 mN/m), while copolymers containing alkene and alkyne groups gave γeq values lower 
than 33 mN/m. Increasing the amount of functional comonomer decreased γeq, for example 
allyl-SB-20 and allyl-SB-100 resulted in γeq values of 32 and 27 mN/m, respectively, and 
similar results were observed for alkyne-SB-X.  This trend was far more pronounced for 
the butenyl-X, where butenyl-13 and butenyl-50 resulted in γeq values of 26 and 6 mN/m, 
respectively. Interestingly, even with less alkene incorporation, γeq in the presence of 
butenyl-13 was lower than that in the presence of allyl-SB-50. The importance of FG 
placement became especially apparent when comparing allyl-SB-50 and alkyne-SB-50, 
which both give γeq values of ~30 mN/m, with butenyl-48, that gives γeq = 6 mN/m at the 
TCB-water interface. This suggests that direct attachment of the alkenes to the zwitterion 
may temper their hydrophobicity, allowing inclusion of reactive functionality without 
interrupting the stimuli-responsive behaviour imparted by sulfobetaine polymers on 
droplets. Moreover, the pendent drop measurements provide an explanation for the stability 
of TCB-in-water droplets formed from allyl-SB-100, alkyne-SB-100, and butenyl-X in the 
presence of salt. The blue and red bars in Figure 5.4b indicate droplet coalescence and 
stability in 0.1 M NaCl(aq), respectively. The observed lack of salt-responsiveness for 
droplets stabilized by allyl-SB-100 and butenyl-X is attributed to their lower interfacial 
tension than the polymers facilitating droplet coalescence upon addition of salt (i.e., 
polySBMA, allyl-SB-20, allyl-SB-50, alkyne-SB-50). Droplets stabilized by alkyne-SB-
  177 
100 that coalesce in 0.1 M NaCl(aq) are an exception, since pendent drop tensiometry 
experiments show alkyne-SB-100 to exhibit similar interfacial affinity as butenyl-13 and 
allyl-SB-100 that form stable droplets under the same conditions.  
We expected that salt-triggered emulsion disruption was the result of enhanced 
solubililty of the sulfobetaine polymers in the aqueous phase and a corresponding reduction 
in interfacial activity. However, interfacial tension measurements of the polymers at the 
TCB/water (100 mM NaCl(aq)) interface showed no significant difference from 
measurements in pure water (Figure 5.5). Thus, we suspect that the disruption in emulsion 
stability must come from a change in the dynamics of the adsorbed polymers in the 
presence of salt rather than in their equilibrium level of surface activity.  
 
Figure 5.5 Effect of salt on the TCB-water interfacial tension in the presence of 
functional sulfobetaine polymers. Mean equilibrium interfacial tension (γeq) of the TCB-
water interface measured by pendant drop tensiometry in the presence of polymers (1 
mg/mL in water and 100 mM NaCl(aq)). Error bars represent the standard deviation of at 
least three independent measurements. 
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The kinetics of droplet coalescence upon addition of salt were monitored by 
photographing vials of droplets before and at several time points following addition of 1 
M NaCl(aq) to bring the concentration of salt to 0.1 M (Figure 5.6). Droplets stabilized by 
polySBMA coalesced significantly within 1 h, as shown by the large oil droplet at the 
bottom of the vial. On the other hand, droplets stabilized by allyl-SB-20, allyl-SB-50 and 
alkyne-SB-X did not coalesce appreciably until at least 3 h after salt addition. The lower 
interfacial values of allyl-SB-20, allyl-SB-50, alkyne-SB-50 (γeq ≈ 30 mN/m) relative to 
polySBMA (γeq = 39 mN/m) may explain the longer times required for coalescence of 
droplets stabilized by these polymers following salt addition. Photographs of droplets 
formed from allyl-SB-100 and butenyl-13 12 h after salt addition demonstrate their stability 
in 0.1 M NaCl(aq). 
 
Figure 5.6 Kinetics of salt-triggered droplet disruption. Photographs of droplets formed 
from an aqueous solution of polymer (1 mL, 1 mg/mL) and TCB (0.2 mL) at various time 
points after formation and after addition of 1 M NaCl(aq) (0.1 mL). 
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5.4 Fabrication of capsules by post-polymerization thiol-ene and thiol-yne chemistry 
The use of the alkene and alkyne groups on the sulfobetaine polymers to create 
capsules was demonstrated by forming benzene-in-water droplets and subsequently 
performing thiol-ene and thiol-yne chemistry at the interface to cross-link the polymers 
around the droplet. As shown in Figure 5.7a, cross-linking involved forming benzene-in-
water droplets by shaking an aqueous solution of polymer (1 mg/mL, 1 mL) with 0.2 mL 
of a benzene solution of 2,2-dimethoxy-2-phenylacetophenone (DMPA) photo-initiator 
and 2,2’-(ethylenedioxy)diethanethiol (2SH, 54). The droplet solutions were irradiated at 
365 nm for 2 h to initiate the thiol-ene and thiol-yne cross-linking reactions, and then 
dropcast onto glass slides and imaged by bright field optical microscopy. Optical 
micrographs of capsules formed by cross-linking droplets stabilized by allyl-SB-50 and 
alkyne-SB-50 reveal capsules that range from ~30-150 µm in diameter (Figure 5.7b-c). In 
contrast, treating polySBMA droplets (without alkene or alkyne groups) with DMPA and 
2SH produced no capsules, as evidenced by the lack of structures present in the optical 
micrograph after dropcasting and drying droplets on a glass slide following irradiation at 
365 nm (Figure 5.7d).  
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Figure 5.7 Capsule formation by cross-linking functional SB polymers following 
assembly on droplets. (a) Schematic showing photo-initiated crosslinking of capsules 
formed from functional sulfobetaine copolymers by irradiation of benzene-in-water 
droplets at 365 nm for 2 h. The aqueous phase contains polymer (1 mg/mL, 1 mL) and 
the benzene phase (0.2 mL) contains 2,2’-(ethylenedioxy)diethanethiol (2SH, 54) and 
2,2-dimethoxy-2-phenyl acetophenone (DMPA) photoinitiator. Following irradiation, 
droplets were dropcast onto slides to dry prior to imaging. Optical micrographs of 
capsules prepared from (b) allyl-SB-50 (52b) using [thiol]:[alkene]:[DMPA] = 4:1:0.2, 
(c) alkyne-SB-50 (53a) using [thiol]:[alkyne]:[DMPA] = 0.5:1:0.2, (d) polySBMA (12, 
no alkene or alkyne groups) in the presence of 2SH and DMPA.  
 
 
Stoichiometry did not play a discernible role in capsule formation with allyl-SB-50 
and alkyne-SB-50. Optimal molar ratios of [thiol]:[alkene or alkyne]:[DMPA] for cross-
linking droplets stabilized by allyl-SB-50 and alkyne-SB-50 were found to be 4:1:0.2 and 
0.5:1:0.2, respectively, yet capsules were observed at [thiol]:[alkene or alkyne] ratios 
ranging from 0.5-4 (Figure 5.8). In the absence of dithiol ([thiol]:[alkene or alkyne] = 0, 
Figure 5.8), irradiation of droplets stabilized by allyl-SB-50 and alkyne-SB-50 in the 
presence of DMPA did not result in capsule formation. In this case, a few circular structures 
were present in the images acquired following dropcasting and drying these droplets, 
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however these structures did not contain wrinkles or folds as did those produced by cross-
linking droplets in the presence of 2SH.  
 
Figure 5.8 Effect of [thiol]:[alkene or alkyne] ratio on capsules formed from allyl-SB-50 
(52b) and alkyne-SB-50 (53a). Optical micrographs of capsules formed by cross-linking 
functional sulfobetaine polymers on droplets formed from an aqueous solution of 
polymer (1 mg/mL, 1 mL) and benzene (0.2 mL) containing 2SH and DMPA in the 
indicated molar ratios. The ratio of [alkene or alkyne]:[DMPA] was held constant at 5. 
 
Crosslinking droplets stabilized by butenyl-13 required higher amounts of 2SH and 
DMPA ([thiol]:[alkene]:[DMPA] = 9:1:0.8) than for allyl-SB-50. As shown in Figure 5.9, 
the optimal conditions for cross-linking allyl-SB-50 ([thiol]:[alkene]:[DMPA] = 4:1:0.2) 
produced no capsules following irradiation of droplets stabilized by butenyl-13. Increasing 
the [thiol]:[alkene] ratio from 4 to 9 at [alkene]:[DMPA]  = 5 and the [DMPA]:[alkene] 
ratio from 0.2 to 0.8 at [thiol]:[alkene] = 4 resulted in capsule formation. Capsules were 
only formed from droplets stabililized by butenyl-13 when both the amount of photoinitator 
and dithiol were increased relative to alkene such that [thiol]:[alkene]:[DMPA] = 9:1:0.8.  
 
  182 
 
Figure 5.9 Capsules formed from butenyl-13 (47d). (a) Schematic of capsule formation 
and (b) optical micrographs of capsules prepared by cross-linking droplets formed from 
an aqueous solution of 47d (1 mg/mL, 1 mL) and benzene (0.2 mL) containing 2SH and 
DMPA at the indicated [thiol]:[alkene]:[DMPA] ratios. 
 
As additional evidence for capsule formation, the stability of cross-linked and 
uncross-linked droplets formed from allyl-SB-50, alkyne-SB-50, and butenyl-13 was 
evaluated in 0.1 M NaCl(aq). In these experiments, two vials of TCB-in-water droplets were 
formed from each of three polymers (allyl-SB-50, alkyne-SB-50, and butenyl-13) by 
mixing polymer solution (1 mL, 1 mg/mL) with 0.2 mL of a TCB solution containing 2SH 
and DMPA. One set of droplets was irradiated at 365 nm for 2 h to initiate cross-linking 
while the other was not exposed to UV light. Figure 5.10 compares cross-linked and 
uncross-linked droplets following addition of salt (0.1 mL, 1 M NaCl(aq)). Under conditions 
where uncross-linked droplets stabilized by allyl-SB-50 and alkyne-SB-50 coalesce, the 
cross-linked droplets remain stable. Both uncross-linked and cross-linked droplets formed 
from butenyl-13 are stable in 0.1 M NaCl(aq), consistent with results in Figures 5.4 and 5.6.  
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Figure 5.10 Uncross-linked and cross-linked TCB-in-water droplets stabilized by allyl-
SB-50, alkyne-SB-50, and butenyl-13, where the TCB contains 2SH (54) and DMPA, 
after addition of 1 M NaCl(aq) (0.1 mL). For allyl-SB-50 and alkyne-SB-50 droplets, 
0.0033 mmol 2SH and 0.0004 mmol DMPA was added to the TCB phase. For butenyl-
13, 0.0022 mmol 2SH and 0.0004 mmol DMPA was added to the TCB phase.  
 
5.6 Conclusions and outlook 
Sulfobetaine polymers with alkene and alkyne groups attached either to the 
methacrylate backbone or to the zwitterion were synthesized by RAFT polymerization, 
displayed stimuli-responsive properties at the oil-water interface, and facilitated capsule 
formation by thiol-ene and thiol-yne reactions on oil-in-water droplets. Copolymerization 
of SBMA with n-butenyl methacrylate or novel sulfobetaine methacrylates with allyl or 
TMS-protected alkynes attached to the methylene adjacent to the sulfonate led to 
sulfobetaine polymers with various loadings of functional groups.   
Investigation of polySBMA at the oil-water interface showed the salt- and 
temperature-dependent solution properties to translate to the oil-water interface such that 
coalescence of droplets stabilized by polySBMA was triggered by the addition of salt or 
elevation of temperature. Introduction of alkene and alkyne groups into the sulfobetaine 
polymers, either by attachment to the methacrylate backbone as in butenyl-X or directly to 
the zwitterion as in allyl-SB-X and alkyne-SB-X imparted slight hydrophobic character to 
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the functional groups and therefore impeded the salt response to various extents. 
Nevertheless, functional versions of polySBMA, wherein alkenes and alkynes were 
attached to the zwitterion, also stabilized oil-in-water droplets that exhibited salt-triggered 
coalescence. In contrast, polySBMA copolymers with alkene-containing comonomer units 
showed no such salt-responsive behavior on droplets. Pendent drop tensiometry 
experiments showed butenyl-X copolymers to be more interfacially active than allyl-SB-
X and alkyne-SB-X at similar functional group loadings (i.e., 50 mol %), offering a 
plausible explanation for the lack of salt-responsive behavior by butenyl-X on droplets. 
However, results showing interfacial tension water and salt to not be significantly different 
suggest that a difference in dynamics of the sulfobetaine polymers at the oil-water 
interface, rather than the interfacial tension level, may be responsible for the observed 
droplet destabilization upon addition of salt. Experiments that measure the rearrangement 
of polymers at the oil-water interface can be designed to test this hypothesis. Withdrawing 
an oil drop from an aqueous solution of polymer using a syringe pump will shrink the drop 
and push surfactant from the interface. Monitoring the interfacial tension as a function of 
time will allow determination of the time required for the interfacial tension to return to 
the equilibrium value, and thus provide insight into polymer dynamics at the oil-water 
interface on droplets.  
The alkene and alkyne groups on the sulfobetaine polymers enabled facile cross-
linking by photo-initiated thiol-ene and thiol-yne chemistry at the oil-water interface to 
generate robust capsules. Reaction of the allyl-SB-X and alkyne-SB-X polymers at the oil-
water interface with dithiols produced capsules over a range of thiol:alkene or alkyne molar 
ratios. Capsule formation from butenyl-X copolymers, however, required higher amounts 
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of thiol and photoinitiator relative to alkene, revealing another impact of functional group 
placement on the properties of sulfobetaine polymers on droplets.  
This work demonstrated the importance of functional group placement on the 
interfacial properties of sulfobetaine polymers, wherein direct attachment of alkenes and 
alkynes to the zwitterion rather than to the methacrylate backbone partially mitigated the 
hydrophobicity imparted by the alkenes. Since, in many applications, the hydrophilic-
lipophilic balance of polymeric materials dictates their self-assembly behavior in solution, 
this finding has implications far beyond oil-in-water droplets. For example, as suggested 
in Chapter 3 of this thesis, incorporation of such functional zwitterions on the periphery of 
polymer-DNA complexes opens opportunities for conjugation of peptides. Other 
possibilities include the use of embedded functionality to attach hydrophobic drugs to 
zwitterionic polymers such that loading can be maximized with minimal reduction in water 
solubility and tailoring emulsions to a variety of new applications by adding functionality 
in a way that does not appreciably alter their stability. 
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CHAPTER 6 
ADHESIVE OIL-IN-WATER DROPLETS STABILIZED BY SULFONIUM-
BASED POLYMER ZWITTERIONS 
6.1 Introduction 
Inter-droplet adhesion results from highly attractive interactions between 
surfactants adsorbed onto emulsion droplets, similarly as lipids assemble into bilayers.1–4 
Typically, adhesive emulsions are formed under conditions where the continuous phase is 
a good solvent for the surfactant and the droplets are dispersed (non-adhesive), and then 
the solvent quality reduced to promote adhesion. As two or more adhesive droplets come 
together, they deform to generate contact areas (adhesive patches) consisting of two 
interfaces separated by a thin film similar to the “Newton black films” found in foams.5–7 
Since the volume in the droplets is conserved, creation of adhesive patches increases the 
surface area and requires surfactant to diffuse quickly to stabilize new sections of the 
interface.3 Despite the close contact between individual droplets, which is conducive to 
coalescence, the droplets remain intact.1 The stability of adhesive emulsions is limited in 
cases where bad solvent is present above a certain volume fraction, under which conditions 
adhesive patch formation occurs faster than surfactant can diffuse to stabilize the interface.3 
For example, Bibette and coworkers report that adhesive patch formation between water-
in-chloroform droplets upon addition of silicone oil above a certain volume fraction occurs 
within 1 s, whereas the characteristic diffusion time for the phospholipid surfactants is ~10 
s (calculated from the surface concentration, surfactant concentration, and the diffusion 
coefficient in pure chloroform).3  
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Droplet adhesion is driven by multiple factors operating in concert to bring 
deformed droplets into close proximity without inducing significant coalescence. Malkin 
and coworkers state that adhesive emulsions form when an energy minimum for droplet 
separation exists for a distance smaller than the center-to-center distance between two 
droplets.4 Highly attractive interactions between droplets lead to the formation of 
appreciable contact angles between droplets (Figure 6.1a), as was first observed by Princen 
and coworkers upon adding high concentrations of salt (~ 0.4 M NaCl) to oil-in-water 
emulsions stabilized by sodium dodecyl sulfate (SDS) to reduce the solvent quality of water 
for SDS by screening ionic interactions.5,6 Increasing temperature, which increased solvent 
quality of water for SDS, led to redispersion of the droplets. Poulin, Bibette, and coworkers 
formed phospholipid bilayers by the addition of a poor solvent, silicone oil, to ether- or 
chloroform-in-water emulsions stabilized by lipids, which resulted in adhesion.2,3,8 The 
thin film between adhesive interfaces has lower surface tension than the undeformed bulk 
interfaces, and thus creation of the film is highly favorable and works to drive droplet 
adhesion.5,9 Additionally, the size exclusion of surfactant micelles and polymers from the 
thin films forces them into the compartments of continuous phase remaining outside of the 
films, called Plateau borders (Figure 6.1b).4,10 The osmotic gradient set up between the thin 
films and plateau borders drives the continuous phase from the films between droplets into 
the plateau borders. These depletion interactions serve to thin out the film between droplets, 
bringing the droplets into closer contact.  
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Figure 6.1 Adhesive emulsions: formation and properties. (a) Generation of non-zero 
contact angles (θ) between droplets stabilized by surfactants with highly attractive 
interactions as they approach each other. The adhesion force between droplets, ΔFads, can 
be calculated from the interfacial tension of the bulk phases, γ, and the contact angle 
between droplets as ΔFads = 2γ(1-cosθ). The contact angle between droplets can be 
measured directly or by an equation using the radii of each of the undeformed droplets, 
R1 and R2 and the radius of the adhesive patch (Rp) according to 2θ = sin-1(Rp/R1) + 
sin1(Rp/R2). (b) Networks of adhesive droplets that trap continuous phase in plateau 
borders and interstices between kinetically trapped droplets. As shown in the lower inset, 
attractive interactions between surfactants promote droplet adhesion, forming contact 
areas separated by a thin film of continuous phase.   
 
The energy of adhesion between droplets, ΔFads, is calculated from the interfacial 
tension of the bulk phases, γ, and the contact angle between droplets, θ, by the Young-
Dupré equation, ΔFads = 2γ(1-cosθ).4,6,10 As shown in Figure 6.1a, the contact angle 
between droplets can be measured directly or indirectly, using the radii of each of the 
undeformed droplets, R1 and R2, and the radius of the adhesive patch, Rp, according to 2θ 
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= sin-1(Rp/R1) + sin1(Rp/R2). Bibette and coworkers determined the energy of adhesion as 
a function of the continuous phase composition for oil-in-water droplets stabilized by 
phospholipids.2 As the volume fraction of silicone oil in the continuous phase increased, 
the energy of adhesion increased due to higher attractive forces between phospholipids 
induced by addition of poor solvent.  
Collections of adhesive droplets form macroscale networks that exhibit solid-like 
behavior while being primarily composed of liquids.1,4,11,12 These unique materials capture 
chemical, mechanical, and electrical properties of cell membranes13–17 and have therefore 
been employed as tissue mimics.18–21 Bayley and coworkers printed cell-mimicking 
adhesive water-in-oil droplets inside a larger oil droplet dispersed in water.21 These droplet 
networks incorporated cell membrane proteins that transmitted electrical signals and were 
patterned to spatially separate droplets with and without membrane proteins.  In a similar 
system, patterning droplets containing electrolyte at different ionic strengths resulted in 
water transfer across droplet bilayers to equilibrate the osmotic pressure.22 The ensuing 
gradient in droplet volume across the bilayer caused folding of the network similarly as in 
a bilayer film upon swelling one layer.22 Apart from biomimicry, adhesive emulsions have 
been used for sensing23 and for patterning surfaces.24 External stimuli, such as light and 
electric fields have been used to modulate droplet adhesion and stability.8,25 Furthermore, 
aggregation of adhesive droplets can yield highly concentrated emulsions, and thus they 
are often discussed in the context of high internal phase emulsions.4,6,10 
Despite the potential of polymeric surfactants to bring enhanced functionality to 
adhesive emulsions, these are usually stabilized by small molecules, such as lipids and 
SDS. Examples of adhesive emulsions using polymer surfactants are far less common.26 
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As discussed in Chapter 5, polymers can be designed with a high density of functional 
groups to facilitate stimuli-triggered droplet disruption and cross-linking at oil-water 
interfaces to generate capsules.27 Amongst polymer surfactants, amphiphilic block 
copolymers having a hydrophilic block connected to a hydrophobic block are most 
common.28 Fewer examples exist of homopolymer surfactants, such as polymers of 
surfactant monomers,29,30 poly(vinyl phenyl boronic acids),31 and double brush copolymers 
with hydrophilic and hydrophobic brushes connected to a polynorbornene backbone.32  
This chapter describes the preparation of adhesive droplets from a novel sulfonium-
based zwitterionic homopolymer. Polymers having sulfonate anions and sulfonium cations 
pendent to a polystyrene backbone are compared to those with ammonium cations for their 
ability to promote interactions between droplets when used as surfactants. Effects of salt 
concentration, temperature, polymer concentration, and polymer molecular weight on 
inter-droplet interactions are investigated. The sulfonium-based zwitterionic polymers are 
inherently reactive, offering the opportunity to use chemical triggers to modulate droplet 
adhesion. Nucleophiles were therefore added to adhesive droplets to chemically modify 
the polymer at the interface and induce changes in inter-droplet interactions. Finally, 
conditions that promote adhesive oil-in-water droplet interactions yield encapsulation of 
higher oil volume fractions and onset of gelation at lower volume fractions compared to 
conditions where droplets are dispersed. 
6.2 Sulfonium-based polymer zwitterions: synthesis and properties 
A novel zwitterionic polymer having a polystyrene backbone, a sulfonium cation, 
and a sulfonate anion was synthesized by C. Santa, as shown in Scheme 6.1. The reaction 
of vinyl benzyl chloride (55) and sodium methane thiolate yielded 4-vinylbenzyl methyl 
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sulfide (56). Ring-opening of 56 with 1,3-propane sultone (31) afforded the zwitterionic 
monomer, sulfothetin styrene (STS, 57). Reversible addition-fragmentation chain transfer 
(RAFT) polymerization of 57 using the trithiocarbonate chain transfer agent 4-cyano-4-
[(dodecylsulfanylthiocarbonyl)sulfanyl] pentanoic acid (58) in 2,2,2-trifluoroethanol 
(TFE) yielded poly(sulfothetin styrene) (polySTS, 59). Variation of the molar ratio of 
57:58 resulted in polymers 59a-c with molecular weights ranging from ~10-30 kDa and 
low molecular weight distributions (<1.3), as determined relative to PMMA standards by 
GPC eluting in TFE (Table 6.1).  
 
Scheme 6.1 Synthesis of poly(sulfothetin styrene) (polySTS, 59) 
 
Sulfobetaine polymers, containing an ammonium cation and a sulfonate anion, 
were synthesized for comparison with polySTS. A styrenic polysulfobetaine, poly(3-(N,N-
dimethylvinylbenzylammonio)propanesulfonate)  (polySBS, 60)33 was synthesized as 
previously reported using a dithiobenzoate (DTB) chain transfer agent, 4-cyano-4-
(phenylcarbonothiolylthio)pentanoic acid (46). Therefore, the DTB chain transfer agent 
was also used to prepare polySTS (59-DTB) with a similar molecular weight as 60-DTB 
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(~25 kDa, Table 6.1). Additionally, methacrylate-based polySBMA (12, 27 kDa) was 
synthesized using DTB as the chain transfer agent for inclusion in the study. The similar 
molecular weights and end groups of 12, 59-DTB and 60-DTB (Figure 6.2a) provide an 
optimal system for studying the impact of polymer structure, specifically ammonium 
versus sulfonium cations, on properties in solution and at the oil-water interface on 
droplets.  
 
Table 6.1 Molecular weight characterization of polySBMA, polySTS, and polySBS by 
TFE GPC relative to PMMA standards 
Sample Mn 
(g/mol) 
Mw/Mn 
 
12 27300 1.12 
59a 8800 1.20 
59b 18300 1.22 
59c 28900 1.28 
59-DTB 25200 1.25 
60-DTB 24500 1.05 
 
Characterization of the solution and interfacial properties of 12, 59, and 60, all with 
DTB end groups (Figure 6.2a), revealed marked differences between the three polymer 
structures stemming not only from the polymer backbone but also from the cationic moiety. 
Using temperature-controlled UV-visible spectroscopy, the percent transmittance at 550 
nm was measured through polymer solutions (0.5-1 mg/mL) as a function of temperature 
while cooling at 1 °C/min (Figure 6.2b-c). Reduced percent transmittance measured 
through polySBS and polySTS solutions at 0.5 mg/mL, as shown Figure 6.2b (red and blue 
traces), indicate the insolubility of these polymers in water below ~60 and 80  °C, 
respectively. Cooling a solution of polySBMA in water (0.5 mg/mL) from 50 °C in 5 °C 
increments and measuring the percent transmittance after equilibration at each temperature 
for 5 minutes (black trace, Figure 6.2a) demonstrated the solubility of this methacrylate-
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based sulfobetaine polymer in water from 20-50 °C. The cloud points of polySTS and SBS 
in water, taken as the onset temperature in the plot of the first derivative of percent 
transmittance with respect to temperature, were determined to be 87 and 61 °C, 
respectively. The transitions from approximately 100 to 0 % transmittance occurred over a 
20-30°C temperature range, with the temperatures at ~50 % transmittance for polySTS and 
polySBS being ~70 and ~40 °C, respectively. The increased solubility of 59-DTB, and 60-
DTB with temperature observed in the transmittance measurements shown in Figure 6.2b 
are consistent with the well-documented upper critical solution temperature (UCST) 
behavior of sulfobetaine polymers in water.34–38 The absence of a cloud point temperature 
for polySBMA in water at 1 mg/mL between 20-50 °C is reasonable given the low 
molecular weight of the sample used for these experiments (27 kDa) since the cloud point 
temperature of polySBMA is known to increase with molecular weight.34,37,38 For example, 
Roth and coworkers reported polySBMA samples of ~13 and ~28 kDa to have cloud point 
temperatures of 13 and 36 °C, respectively in water at 10 mg/mL.37 In 50 mM NaNO3(aq) at 
1 mg/mL, however, both methacrylate- and styrene-based sulfobetaine polymers permitted 
100 % light transmittance at 550 nm light over the entire temperature range investigated 
(0-50°C, Figure 6.2c). The increased solubility at room temperature for polySBS in 
aqueous solution containing NaNO3 (blue trace, Figure 6.2c) compared to that in pure water 
(blue trace, Figure 6.2b) is consistent with the anti-polyelectrolyte effect behavior observed 
for sulfobetaine polymers.35,43,44 A solution of polySTS, having a sulfonium cation, 
exhibited a cloud point temperature of 66°C in 50 mM NaNO3(aq) and allowed only 50 % 
transmitted light at 60°C (red trace, Figure 6.2c). The considerably increased percent 
transmittance measured at 60°C through polySTS in 50 mM NaNO3(aq) at 1 mg/mL (50 %, 
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Figure 6.2c) compared to the negligible transmittance measured through polySTS in water 
at 0.5 mg/mL (Figure 6.2b) indicates that polySTS exhibits anti-polyelectrolyte behavior 
similarly as sulfobetaine polymers. The large difference in solubility between polySBS and 
polySTS is striking given the identical polymer backbones and is attributed differences in 
either cation type (ammonium vs. sulfonium) or in the number of methyl groups on the 
cation (two in polySBS and one in polySTS).  
 
Figure 6.2 (a) Structures of polySBMA (12), polySBS (60-DTB), and polySTS (59-
DTB).  Percent transmittance at 550 nm measured through solutions of 12, 59-DTB, and 
60-DTB in (b) water (0.5 mg/mL) and (c) 50 mM NaNO3(aq) (1 mg/mL) while cooling at 
1 °C/min. Transmittance measurements on polySBMA in pure water were acquired by 
lowering the temperature from 50 to 25 °C in increments of 5 °C following equilibration 
at each temperature for 5 min.  (c) Equilibrium interfacial tensions (TCB-0.5 M 
NaNO3(aq) interface) of solutions of polySTS (59-DTB) and polySBS (60-DTB), Mn ~ 25 
kDa measured by pendent drop tensiometry, polymer concentration = 0.5 mg/mL. 
 
Pendent drop tensiometry was used to evaluate the interfacial activity of the 
zwitterionic polymers. In these experiments, a drop of TCB was dispensed into an aqueous 
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solution containing polymer (0.5 mg/mL) and 0.5 M NaNO3, and the shape of the drop 
imaged as a function of time. A MATLAB routine was used to iteratively produce solutions 
to the Laplace capillary equation so as to minimize the error between the calculated and 
imaged droplet shapes, and the optimal solution used to determine the interfacial tension. 
Measurements were collected over 10 min, and the mean equilibrium interfacial tension, 
γeq, taken as average and standard deviation of the last time point of 2-3 measurements on 
different days.  These measurements were performed in aqueous solutions of polySBS and 
polySTS containing 0.5 M NaNO3 to dissolve the polymers, since pendent drop 
tensiometry requires transparent solutions in order to image the shape of the drop. PolySTS 
reduced γeq from ~45 mN/m without polymer to ~ 18 mN/m, whereas polySBS provided a 
smaller reduction of interfacial tension γeq ~30 mN/m (Figure 6.2d). Compared to similar 
experiments shown in Chapter 5 that demonstrate polySBMA to only slightly lower the 
TCB-water interfacial tension from 43 to 39 mN/m, the styrenic zwitterionic polymers 
exhibit increased affinity for the oil-water interface. Additionally, the markedly higher 
affinity of polySTS for the oil-water interface compared to polySBS is interesting, given 
these measurements were preformed in the presence of salt such that both polymers were 
soluble at room temperature. The distinct solution and interfacial properties provided by 
the zwitterionic polystyrenes containing ammonium and sulfonium cations with otherwise 
identical structures encouraged the evaluation of the effect of cation structure on 
interdroplet interactions. 
PolySTS features several interesting properties that are potentially very useful in 
the context of functional emulsion droplets. First, the combination of the hydrophobic 
polystyrene backbone and hydrophilic zwitterion render this material highly interfacially 
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active, as evidenced by the interfacial tension measurements in Figure 6.2d. Due to its 
almost negligible solubility in water at room temperature that improves dramatically upon 
the addition of salt or elevation of temperature, polySTS has highly pronounced stimuli-
responsive behavior. Finally, the benzylic methylene adjacent to the sulfonium cation is 
susceptible to nucleophilic attack and subsequent debenzylation, allowing opportunities for 
post-polymerization modification. As illustrated in Figure 6.3, this chapter uses these 
properties to modulate interactions between droplets with environmental triggers, such as 
temperature and salt concentration, as well as chemical triggers, such as nucleophilic attack 
by thiol-based nucleophiles. Due to the susceptibility of polySTS to nucleophilic attack, 
sodium nitrate, rather than NaCl or NaBr, is used to improve the solubility of polySTS in 
water.  
 
 
Figure 6.3 (a) Features of polySTS and (b) adhesive oil-in-water droplets stabilized by 
polySTS, wherein inter-droplet interactions are modulated by salt concentration and/or 
temperature 
6.3 Preparation of adhesive droplets 
PolySTS (59) and water were combined at a polymer concentration of 1 mg/mL, 
and since no dissolution occurred at room temperature, the mixture was heated to 70 °C 
and stirred at 500 rpm for 30 min. Despite being below the cloud point temperature 
measured for 59-DTB in water at 0.5 mg/mL, this heating profile was selected to disperse 
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to the polymer sufficiently in solution without causing undesired side reactions at the 
benzylic position. To form droplets, 1,2,4-trichlorobenzene (TCB, 0.1-0.2 mL) was added 
to the polySTS solution (1 mL) and the mixture shaken as it cooled to room temperature. 
Rather than the emulsion forming a liquid-like layer at the bottom of the vial, as observed 
for all of the zwitterionic polymer-stabilized droplets discussed in Chapter 5, such as those 
stabilized by polySBMA (12) (Figure 6.4a), droplets stabilized by polySTS clumped 
together or floated to the top of the solution in small clusters (Figure 6.4b). Given the higher 
density of TCB relative to water, the observation of floating TCB-in water droplets is 
interesting and may be due to the presence of air trapped within the adhesive droplet 
networks. Princen and coworkers observed that clusters of adhesive droplets trap 
appreciable amounts of continuous phase,6 and therefore it is plausible that air might also 
become trapped within the droplet networks during the emulsification process. Optical 
micrographs of the TCB-in-water droplets show non-adhesive droplets to spread out into a 
monolayer on the glass slide (Figure 6.4a), whereas adhesive droplets stabilized by 
polySTS cluster into dense networks, leaving areas of the field of view uncovered by 
droplets (Figure 6.4b).  Adhesion of droplets stabilized by polySTS is attributed to its low 
solubility in water at room temperature, demonstrated in transmittance measurements in 
Figure 6.2b. In contrast, polySBMA (~27 kDa) is soluble in water at 1 mg/mL and therefore 
it is reasonable that droplets stabilized by polySBMA are non-adhesive. These observations 
are consistent with those noted for adhesive droplets stabilized by SDS in the presence of 
high concentrations of salt, which reduces the solubility of SDS in aqueous solution, that 
become non-adhesive upon increasing temperature to improve solubility of SDS.6  
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Figure 6.4 Optical micrographs, photographs, and features of (a) non-adhesive TCB-in-
water droplets stabilized by polySBMA (12) and (b) adhesive TCB-in-water droplets 
stabilized by polySTS (59b). Polymer is dissolved 1 mg/mL in water and mixed with 0.2 
mL TCB. 
 
 
While, in many cases, measurements of contact angles and interfacial tensions are 
used to quantify the force of adhesion, these droplets aggregate together into macroscopic 
networks such that it was difficult to clearly visualize the interface between pairs of 
droplets. Additionally, it was non-trivial to ensure a 90° angle with the droplet interface 
for a proper contact angle measurement. Elegant microfluidics experiments where either 
droplet pairs are trapped together in a device or where pipettes are used to bring two 
droplets into contact provide good ways to do this.3,8,13,39–42 Here, we reason that adhesive 
droplets will pile on top of one another and exhibit solid-like properties and non-adhesive 
droplets will flow like a liquid, either spreading out on a glass slide into a monolayer or 
flow and take the shape of their container in a vial. Therefore, optical microscopy images 
are used to characterize emulsions as adhesive or non-adhesive under a variety of 
conditions.  
6.4 Effect of zwitterion structure on interdroplet interactions 
To determine the effect of zwitterion structure, specifically the cation, on the 
interactions between droplets, polySTS-stabilized TCB-in-water droplets were compared 
to those formed from polySBS (60). Figure 6.5 shows TCB-in-water droplets formed from 
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polySBS (1 mL, 1-10 mg/mL in water) and TCB (0.1 mL) by heating the oil and water 
solutions prior to mixing, and shaking the oil-water mixtures as they cooled to room 
temperature. When aqueous solutions with 1-2 mg/mL of polySBS were used to form 
droplets, the resulting droplet solutions spread relatively uniformly on glass slides (Figure 
6.5a-b). As the concentration of polySBS was increased to 5 mg/mL, the droplets grouped 
together and left voids in the field of view (Figure 6.5c). This effect was most pronounced 
at the highest polySBS concentration (10 mg/mL), as shown in Figure 6.5d. Given that 
polySBS was measured to have a cloud point temperature of 61 °C in pure water, the 
observation of droplet adhesion is not surprising. It is noteworthy, however, that while 
adhesion was not observed between droplets stabilized by polySBS below a polymer 
concentration of 10 mg/mL, adhesion was observed with polySTS-stabilized droplets at a 
polymer concentration of 1 mg/mL (Figure 6.4b). This result is consistent with the lower 
water solubility of polySTS compared to polySBS, as determined from transmittance 
measurements (Figure 6.2).  
 
Figure 6.5 Optical micrographs of TCB-in-water droplets formed by mixing solutions of 
TCB (0.1 mL) and polySBS (60-DTB) at 1 mg/mL (a), 2 mg/mL (b), 5 mg/mL (c), and 
10 mg/mL (d) in pure water. 
6.5 Construction of phase diagrams 
Sulfobetaine polymers exhibit complex solution behavior in water, wherein their 
solubility is dependent upon salt concentration, temperature, polymer concentration, 
polymer molecular weight, and the specific structure of the polymer or copolymer.34–38,43,44 
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In the previous section we observed the effect of polymer surfactant structure on droplet 
adhesion, and observed polymers with low solubility in water to promote adhesion between 
droplets. Here we investigate the effect of salt concentration, polymer concentration, and 
polymer molecular weight – all of which impact solubility of sulfobetaine polymers – on 
droplet adhesion. Optical microscopy was used to determine whether droplets were 
adhesive, wherein droplets aggregated into macroscopic networks that were impenetrable 
to light, or non-adhesive, wherein droplets spread out uniformly on a glass slide, under a 
variety of conditions.  
Salt concentration significantly impacted adhesion between TCB-in-water droplets 
stabilized by polySTS. Figure 6.6 shows optical and confocal micrographs as well as 
photographs of droplets formed by heating TCB and aqueous solutions of polySTS (1 mL, 
0.5 mg/mL in water with 0-500 mM NaNO3(aq)).  Photographs and confocal micrographs 
complemented the optical micrographs for characterization of adhesive droplets. For 
example, Figure 6.6a shows polySTS-stabilized TCB-in-water droplets in the absence of 
NaNO3. The photographs of the vials show that the sedimented emulsion droplets interact 
strongly, as evidenced by the non-uniform interface between the emulsion and the bulk 
aqueous phase. Aggregation of liquid-liquid droplets into networks, as shown in the optical 
micrograph in Figure 6.6a, results in solid-like behavior, such as the rugged interface 
formed between the white emulsion layer and the bulk water. Confocal micrographs, 
acquired of TCB-in-water droplets encapsulating coumarin dye in the oil phase, show 
closely packed non-circular droplet cross-sections, indicative of non-zero contact angles 
between deformed droplets. As the concentration of NaNO3 was increased from 0-500 mM, 
the droplets became less adhesive, as evidenced by photographs of droplets in Figures 6.6c 
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and d, showing the interface between the emulsion and the bulk aqueous phase to level 
significantly, indicating the increasing liquid-like behavior of the droplets. The optical 
micrograph of polySTS droplets in 500 mM NaNO3(aq) shows droplets spread uniformly 
on the glass slides (Figure 6.6e). Confocal microscopy provided further evidence of 
decreasing droplet interactions with increasing salt concentration, as images of TCB-in-
water droplets stablilized by polySTS in the presence of 100 and 500 mM NaNO3(aq) 
(Figures 6.6d and e) show droplets that are less deformed and more spherical in shape 
compared to the confocal micrographs in Figures 6.6a-c.  
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Figure 6.6 Effects of salt on droplets stabilized by polySTS. Optical (left) and confocal 
(right) micrographs of TCB-in-water droplets, where the aqueous phase contains (a) 0 
mM, (b) 20 mM, (c) 50 mM, (d) 100 mM, and (e) 500 mM NaNO3 and polySTS (59b, 
0.5 mg/mL). Droplets for confocal microscopy contain coumarin in the oil phase. In all 
droplet solutions, 0.2 mL TCB was added to 1 mL aqueous solution. The insets are 
photographs of the droplets in vials. 
 
 A phase diagram was constructed to determine the effect of polySTS molecular 
weight, which is known to increase the cloud point temperature of sulfobetaine polymers, 
34,37,38 on the salt-dependent properties of TCB-in-water droplets. These experiments 
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involved the formation of TCB-in-water droplets were formed with polySTS solutions (0.5 
mg/mL in water having 0-500 mM NaNO3) using three different polymers, 59a-c with 
number-average molecular weights (Mn) of 8.8, 18.3, and 28.9 kDa, respectively (Figure 
6.7). The optical micrographs outlined in blue indicate that droplets spread uniformly on 
the glass slide (non-adhesive) and those outlined in red indicate adhesive droplets that 
aggregate into large networks that appear black since light could not be transmitted 
efficiently. In some of the images, higher exposure times or light intensities were employed 
in an attempt to visualize the droplet networks, which resulted in a white background and 
gray droplets.  Optical micrographs that are not outlined in red or blue indicate that droplets 
clustered together, leaving uncovered areas in the field of view, but still allowed light 
through the areas where droplets were gathered. These conditions represent a transition 
between adhesive and non-adhesive regions of the phase diagram.  The polySTS sample 
with the lowest molecular weight, 59a (8.8 kDa), stabilized droplets that formed dense, 
light-impenetrable networks in 20 mM NaNO3(aq) and transitioned to non-adhesive droplets 
at 100 mM NaNO3, whereas the higher molecular weight samples afforded droplets that 
were adhesive until 500 mM NaNO3(aq). The range of polySTS molecular weights utilized 
in this study did not give rise to significant changes in the salt-dependent droplet adhesion 
behavior. While higher molecular weight polymers may have a larger impact on droplet-
droplet interactions, RAFT polymerization provided well-defined polymers in a relatively 
straight-forward manner, but limited the range of molecular weights to < 30 kDa.  
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Figure 6.7 Optical microscopy phase diagram of TCB-in-water droplets stabilized by 
polySTS (59a-c, 0.5 mg/mL) at various salt concentrations and molecular weights. Red 
and blue backgrounds indicate adhesive and non-adhesive droplets, respectively. White 
backgrounds indicate droplets cluster together, but do not form networks that are 
impenetrable to light. 
 
 A phase diagram was generated similarly as that shown in Figure 6.7 to examine 
the effect of polymer concentration on droplet adhesion, employing the polySTS sample 
with an intermediate molecular weight (59b, 18.3 kDa) (Figure 6.8).  Droplets were formed 
by heating solutions of polySTS (64b, 0.25-1 mg/mL in water with 0-500 mM NaNO3) and 
TCB to 70 °C, mixing the solutions (1 mL polySTS solution with 0.2 mL TCB), and 
cooling to room temperature while shaking the vials to promote droplet formation.  Optical 
micrographs outlined in blue and red indicate non-adhesive, and adhesive droplets, 
respectively. The images acquired at 100 mM NaNO3 show droplets grouped together such 
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that uncovered areas remain in the field of view, but that interact less strongly than those 
outlined in red that form dense, light-impenetrable networks. The polymer concentration 
did not impact the salt-dependent droplet adhesion properties when varied from 0.25-1 
mg/mL. However, as shown in Figure 6.4, the properties of polySBS droplets changed 
appreciably from 5-10 mg/mL and therefore higher concentrations of polySTS may 
promote attractive droplet interactions above 100 mM NaNO3(aq). 
 
Figure 6.8 Optical microscopy phase diagram of TCB-in-water droplets stabilized by 
polySTS (59b) at various concentrations of salt and polymer. Red and blue backgrounds 
indicate adhesive and non-adhesive droplets, respectively. White backgrounds indicate 
droplets cluster together, but do not form networks that are impenentrable to light. 
  212 
6.6 Chemically-triggered changes in droplet adhesion 
Attempts to polymerize STS (57) in aqueous solvents containing various salts 
revealed the susceptibility of the benzylic position to attack by nucleophiles, which led to 
subsequent debenzylation. C. Santa identified two thiol nucleophiles capable of reaction 
with STS at room temperature, 2-mercaptopyridine (61) and cysteine (62), with pKa values 
at ~6 and 9, respectively. We hypothesized that reaction of polySTS with these compounds 
would afford post polymerization modification and a further way to tune inter-droplet 
interactions.  
In the following experiments, adhesive droplets stabilized by polySTS in 50 mM 
NaNO3(aq) were formed and then nucleophiles added at pH 8.5 and 11.5. The salt 
concentration was selected since it is the highest salt concentration at which droplets are 
adhesive, as higher salt concentrations result in non-adhesive droplets (Figure 6.3), and 
therefore modulation of droplet adhesion was anticipated to be most feasible under these 
conditions. Droplets were prepared on a larger scale such that the pH of the bulk aqueous 
solution could be measured easily. Briefly, polySTS (5 mL, 1 mg/mL in water with 50 mM 
NaNO3) was mixed with TCB (2 mL) at 70 °C and vortexed sporadically while cooling to 
room temperature. The pH of the bulk aqueous phase was ~ 8.5, and diluting the solution 
by addition of 50 mM NaNO3(aq) (5 mL) had a negligible effect on the pH. A second droplet 
solution was prepared similarly and diluted to a final volume of 10 mL with 50 mM 
NaNO3(aq) and NaOH(aq) such that the final pH = 11.5. Additional droplet solutions were 
prepared similarly by adding 2-mercaptopyridine or cysteine at pH 8.5 and/or 11.5, and the 
effect of these additives on the droplet adhesion evaluated.   
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The reaction of polySTS with 61 yields mercaptopyridine-substituted polystyrene 
(63) and methyl thioether propanesulfonic acid 64, as shown in Figure 6.9a. Adjusting the 
adhesive polySTS emulsion to pH 8.5 did not prevent the attractive interactions between 
droplets, as evidenced by the solid-like (non-flat) sedimented emulsion layer in the vial 
shown in Figure 6.9b as well as the clustering of droplets in the optical micrograph. 
Emulsions to which 61 was added underwent phase separation, wherein a majority of the 
TCB phase coalesced into a yellow layer at the bottom of the vial (Figure 6.9c). The pale 
yellow layer on top of the yellow TCB layer in the vial photograph is composed of 
precipitated polymer and remaining adhesive droplets, as evidenced by the dense droplet 
aggregate and irregular fiber-like structures in the optical micrograph. This experiment 
demonstrated the use of a chemical trigger to reduce the attractive interactions between 
droplets, which resulted in coalescence.  
 
Figure 6.9Addition of 2-mercaptopyridine (61) to polySTS (59c) droplets at pH 8.5. (a) 
Reaction of polySTS with 61 to afford mercaptopyridine-substituted polySTS (63) and 
methyl thioether propanesulfonic acid (64). Photographs and optical micrographs of 
TCB-in-water droplets in 50 mM NaNO3(aq) (a) without 61, and (b) 10 equivalents of 61 
relative to STS units 
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Similar experiments were conducted with the addition of cysteine (62) to polySTS-
stabilized droplets at pH 8.5 and 11.5, below and above the pKa of the thiol in the cysteine 
side chain (~9). The reaction of polySTS with cysteine to afford cysteine-substituted 
polystyrene (65) and methyl thioether propanesulfonic acid (64) is shown in Figure 6.10. 
Reactions conducted on droplets at pH 8.5 had little effect on the droplet interactions, as 
shown in Figure 6.10c, likely due to the lower reactivity of the thiol below its pKa. Addition 
of cysteine to droplets at pH 11.5, however, impacted droplet interactions in a much more 
pronounced manner. The optical micrograph in Figure 6.10e showed droplets spread out 
over the entire field of view, rather than clustering into dense networks as in Figure 6.10c. 
Control experiments performed by adjusting droplet solutions to pH 8.5 and pH 11.5 did 
not alter droplet adhesion, as shown by the macroscale groups of droplets observed by 
optical microscopy (Figures 6.10b and d, respectively). 
  215 
 
Figure 6.10 Addition of cysteine (62) to polySTS (59c) droplets at pH 8.5 and pH 11.5. 
(a) Reaction of polySTS with 62 to afford cysteine-substituted polySTS (65) and methyl 
thioether propanesulfonic acid (64). Photographs and optical micrographs of TCB-in-
water droplets in 50 mM NaNO3(aq) in the presence and absence of cysteine at pH 8.5 and 
11.5 (a) no cysteine, pH 8.5; (b) 10 equivalents of cysteine relative to STS units, pH 8.5; 
(c) no cysteine, pH 11.5; (d) 10 equivalents of cysteine relative to STS units, pH 11.5. 
6.7 Emulsions encapsulating higher oil fractions 
Adhesive droplets are often associated with highly concentrated emulsions with 
high internal phase volume fractions. Emulsions encapsulating internal phase volume 
fractions higher than 0.74, corresponding to the volume fraction of close-packed 
monodisperse spheres, are termed high internal phase emulsions (HIPEs). Such emulsions 
are composed of deformed droplets and that gel upon close packing, and the unusual 
combination of hydrophilic surfactants with hydrophobic liquids, or vice versa within a 
single material yields interesting and useful properties. The experiments discussed earlier 
in this chapter employed low internal phase volume fractions (~ 10 volume %). Therefore, 
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the effect of inter-droplet interactions on the ability to stabilize droplets with higher 
amounts of oil (> 50 volume %) was investigated by preparing droplets under conditions 
where they are adhesive (50 mM NaNO3(aq)) and non-adhesive (50 mM NaNO3(aq)).  
 
Figure 6.11 Formation and gelation of droplets encapsulating 1-4 mL oil in 1 mL aqueous 
polySTS solution. Droplets were formed by combining polySTS (1 mL, 5 mg/mL in 
water containing 50 or 500 mM NaNO3) with TCB (1-4 mL) at 70°C and vortexing the 
mixtures as they cooled to room temperature. Photographs of droplets as prepared in (a) 
50 mM and (b) 500 mM NaNO3(aq). Photographs of droplets in (c) 50 mM and (d) 500 
mM NaNO3(aq) 12 h after inversion of vials. 
 
PolySTS droplets were formed by mixing 1 mL of polySTS in aqueous solution (5 
mg/mL in water containing 50 mM or 500 mM  NaNO3) with 1-4 mL TCB at 70 °C and 
vortexing the mixture several times as it cooled to room temperature. Figure 6.11a shows 
photographs of polySTS-stabilized emulsions encapsulating 1-4 mL TCB in 50 mM 
NaNO3(aq), where polySTS emulsions are adhesive. The polySTS solutions encapsulating 
3 and 4 mL TCB qualify as high internal phase emulsions, as the TCB volume fractions 
are 0.75 and 0.8, respectively. Confocal microscopy of droplets with coumarin dye in the 
oil phase confirms the encapsulation of oil rather than emulsion inversion at high volume 
fractions of oil (Figures 6.12a and c). Droplets formed in 50 mM NaNO3(aq), where droplets 
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are non-adhesive, were capable of encapsulating only 2 mL of TCB (Figure 6.11b). The 
confocal micrograph in Figure 6.12b shows the presence of spherical TCB droplets in 500 
mM NaNO3(aq). Mixtures of polySTS with 3 and 4 mL of TCB separated into TCB, 
emulsion, and bulk aqueous phases. This observation was confirmed by confocal 
microscopy, wherein a coalesced TCB phase was observed alongside a TCB-in-water 
emulsion (Figure 6.11d). Vortexing the mixtures to form droplets, rather than merely 
shaking the vials, provided higher shear forces that permitted the encapsulation of higher 
amounts of TCB in 1 mL polySTS solution. For example, hand-shaking vials of polySTS 
solution (1 mg/mL in water containing 50 mM NaNO3) and TCB allowed encapsulation of 
only 1.4 mL TCB, whereas vortexing produced emulsions encapsulating at least 1.8 mL 
TCB.  
 
Figure 6.12 Confocal microscopy and photographs of TCB-in-water droplets 
encapsulating coumarin in the TCB phase. Droplets were formed by combining polySTS 
(1 mL, 5 mg/mL in water containing 50 or 500 mM NaNO3) with TCB (1 or 3 mL) at 
70°C and vortexing the mixtures as they cooled to room temperature. (a) 50 mM NaNO3, 
1 mL TCB, (b) 500 mM NaNO3, 1 mL TCB, (c) 50 mM NaNO3, 3 mL TCB, (d) 500 mM 
NaNO3, 3 mL TCB. 
 
Several of the emulsions encapsulating TCB volume fractions greater than 0.66 
gelled. After emulsion formation, the vials were inverted and gelation was evaluated 12 h 
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later by the existence or lack thereof of gelled droplets at the top of the vial (Figure 6.11c 
and d). Droplets formed under adhesive conditions gel when encapsulating ≥ 2 mL TCB, 
whereas no gelation was observed for non-adhesive droplets (in 500 mM NaNO3(aq)). 
Comparing polySTS solutions encapsulating 2 mL of TCB in 50 mM NaNO3(aq) (conditions 
promoting droplet adhesion) and 500 mM NaNO3(aq) (nonadhesive conditions) 
demonstrates the impact of droplet adhesion on the bulk properties of the emulsion, since 
the droplets gel under adhesive conditions and flow to the bottom of the vial under non-
adhesive conditions.  
6.8 Stability of adhesive emulsions under centrifugal force 
PolySTS-stabilized droplets formed at constant volume fractions in the presence of 
50-500 mM NaNO3(aq) were subjected to centrifugation to further investigate the effects of 
inter-droplet interactions on emulsion stability. In collaboration with C. Santa, droplets 
were formed by combining polySTS solution (1 mL, 1 mg/mL in water containing 50, 100, 
or 500 mM NaNO3) with TCB (1 mL) at 70 °C and vortexing several times as the mixtures 
cooled to room temperature. The droplet solutions were then transferred to 15 mL conical 
tubes, centrifuged at 3000 rpm for 10 min, and photographed (Figure 6.13). Droplet 
solutions in high salt concentrations (>100 mM NaNO3(aq) where droplets are not adhesive) 
partially coalesced during centrifugation, as observed by the clear TCB layer at the bottom 
of the tubes with droplets in 250 and 500 mM NaNO3(aq). Taken together with experiments 
in Figure 6.11 showing adhesive droplets to gel under conditions where non-adhesive 
droplets exhibit liquid-like properties, it is evident that the interdroplet adhesion provided 
by these novel zwitterionic surfactants imparts mechanical integrity and additional stability 
to these emulsions. 
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Figure 6.13 Photographs of TCB-in-water droplets stabilized by 59b after centrifugation 
at 3000 rpm for 10 min. Droplets were formed by mixing TCB (1 mL) with polySTS (1 
mL, 1 mg/mL in water with 50, 75, 100, 250, or 500 mM NaNO3) at 70 °C, and vortexing 
the mixtures as they cooled to room temperature. 
6.9 Conclusions and outlook 
A novel sulfur-based zwitterionic polymer, polySTS, enabled highly attractive 
interactions between oil-in-water droplets that were modulated by environmental and 
chemical triggers.  Optical and confocal microscopy were used to generate phase diagrams 
of conditions (salt concentration as well as polymer molecular weight, concentration, and 
structure) that yielded adhesive and non-adhesive droplets. Within the range of conditions 
investigated, the salt concentration and polymer structure (polySTS vs. polySBS) were 
found to exert the most influence on the inter-droplet interactions. Droplet adhesion was 
harnessed to encapsulate high volume fractions of oil, to form gels, and to control emulsion 
stability.  
Manipulation of droplets on the micron scale will yield more quantitative 
information about the interdroplet interactions, enabling calculation of the adhesion 
energies and visualization of the droplet network formation process. Additionally, 
calculation of adhesion energy requires an interfacial tension measurement under 
conditions where the droplets are adhesive. In the case of polySTS droplets, the polymer 
solution is not transparent under these conditions due to the insolubility of polySTS, 
precluding measurement of interfacial tension by pendent drop tensiometry. Micropipette 
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aspiration, however, can be used to measure the interfacial tension of droplets in situ from 
the radius of the drop, pipette, and pressure required to aspirate a droplet.39,45,46 Two 
micropipettes attached to micropositioners could be used to bring two droplets into contact 
to visualize droplet interactions in real time and obtain contact angle measurements. 
Microfluidic devices that trap pairs of droplets and generate droplets with small size 
distributions have been employed to investigate adhesive droplets in a number of 
cases.3,8,40,41 A device designed to generate droplets and introduce a chemical trigger 
downstream would provide a way demonstrate the effect of various stimuli in a controlled 
manner. Furthermore, a microfluidic device such as that shown in Figure 6.14 would allow 
generation of droplets under conditions where they are non-adhesive, and then downstream 
modulation of adhesive interactions by reducing temperature or salt concentration. This 
device would allow visualization of the way in which adhesive droplets assemble into the 
extensive networks observed by optical microscopy which span several millimeters in 
diameter. As adhesive droplets have been used to model tissues,21 monitoring the 
construction of adhesive droplet networks may provide insight into the assembly of cells 
into tissues.  
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Figure 6.14 Microfluidic device designed to monitor the assembly of adhesive droplets 
into networks. Formation of polySTS droplets at elevated temperatures or high salt 
concentrations occurs where the oil stream meets the aqueous stream. Downstream 
reduction of polySTS solubility with a salt or temperature gradient will enable 
visualization of adhesion between droplets and the subsequent aggregation process 
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CHAPTER 7 
CONCLUDING REMARKS 
This thesis explored new functional hydrophilic polymers as non-viral transfection 
reagents and at oil-water interfaces on droplets. The impacts of zwitterionic moieties, 
oligopeptide sequences, and reactive groups included in the polymers on solution assembly 
and transfection performance were investigated. Several overall conclusions and future 
directions emerged from this work. First, the way in which functional groups are attached 
to polymers was found to greatly impact their properties. Secondly, zwitterionic polymers 
display unique solution and interfacial properties extending well beyond their well-known 
water solubility and biocompatibility. Experiments presented in this thesis showcase the 
stimuli-responsive properties, wide range of behaviors on oil-in-water droplets, and 
modulation of polymer-DNA interactions within polyplexes provided by zwitterionic 
polymers. Going forward, creating advancing emulsion systems and delivery vehicles for 
drugs and genes by presenting various functional features, such as zwitterions and 
oligopeptides, on hydrophilic polymers in a way that optimally avails them to the 
surrounding environment will maximizing their potential.  
The arrangement of functional moieties on both comb polymers designed for gene 
delivery and zwitterionic polymer emulsion surfactants was found to largely impact the 
properties of these materials. Chapter 2 showed that reorienting the Simian Virus nuclear 
localization sequence (SV40 NLS, PKKKRKV) with respect to the polymer backbone such 
that valine (V) was closest to the backbone significantly improved transfection 
performance.  Interestingly, in this configuration the peptide sequence, reading from N 
terminus to C terminus VKRKKKP, is reversed with respect to the wild type orientation 
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(PKKKRKV) and several reports have shown the VKRKKKP sequence to be unable to 
facilitate specific nuclear uptake. Given that comb polymers with the VKRKKKP sequence 
provide superior transfection performance compared to analogous comb polymers with the 
wild type sequence, reconfiguring the comb polymer structures to enable maximum 
function of the SV40 NLS may further enhance gene expression levels by improving 
polyplex uptake into the cell nucleus. It is plausible that electrostatic interactions between 
DNA and the cationic SV40 NLS within the polyplex may hinder accessibility of the NLS 
to nuclear import receptors. Placing the SV40 NLS on the periphery of a polyplex micelle 
may improve accessibility of the sequence to nuclear import receptors by spatially 
separation from DNA. Similarly, experiments described in Chapter 5 showed the 
placement of alkenes on zwitterionic sulfobetaine polymers to dictate interfacial properties. 
Polymers having alkenes attached to the methacrylate backbone, i.e., by copolymeriztion 
of sulfobetaine methacrylate with n-butenyl methacrylate, were found to be highly 
interfacially active and inhibit the salt-triggered droplet coalescence exhibited by 
sulfobetaine methacrylate homopolymers on oil-in-water droplets. In contrast, embedding 
an alkene group within the zwitterion (i.e., by connecting an allyl group to a methylene 
separating the ammonium and sulfonate groups of sulfobetaine) allowed inclusion of high 
loadings of alkenes into the polymer to enable post-polymerization modification and cross-
linking while retaining salt-responsive properties on droplets. 
Another common theme carried throughout this thesis was the use of zwitterionic 
moieties. Recognition of the biocompatibility of zwitterions has led to their permeation of 
the biomaterials arena, culminating in the successful implementation of zwitterionic 
polymers in vivo, for example in hip joints and as cancer drug carriers. The experiments in 
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Chapters 3-6 attest to the many hats zwitterions wear in polymeric materials beyond 
biocompatibility. Chapters 3 and 4 demonstrate that inclusion of zwitterions within cationic 
comb polymers decreased polymer-DNA binding strength, allowing for modulation of 
DNA binding strength by the zwitterion content. In Chapter 5, the assembly of dipoles on 
sulfobetaine polymers rendered them sufficiently amphiphilic to assemble at the oil-water 
interface on droplets. The anti-polyelectrolyte and upper critical solution temperature 
properties of sulfobetaine polymers translated to the oil-water interface, affording salt- and 
temperature-triggered droplet coalescence, respectively. One of the most interesting 
findings was adhesion between oil-in-water droplets stabilized by new sulfur-based 
zwitterionic polystyrenes under conditions where the aqueous continuous phase is a poor 
solvent for the polymer. These new zwitterions also exhibited salt- and temperature-
responsive properties, which were exploited to tune interdroplet interactions. Furthermore, 
the benzylic methylene connecting the zwitterion to the polystyrene backbone proved 
reactive to nucleophiles, which provided another way to modulate droplet adhesion. 
Looking ahead, there are many exciting and promising directions toward the next 
generation of therapeutic delivery vehicles and emulsion surfactants. Emulsions are 
currently used in many commodity materials, including foods and cosmetics, as well as in 
oil recovery and as templates for the preparation of a variety of materials. Advancing 
emulsion surfactants through innovative functional features within polymers will expand 
the utility and scope of emulsion-based technologies. The finding that hydrophobicity can 
be masked by placing a hydrophobic group within a zwitterion has implications in the 
context of therapeutic delivery vehicles and surfaces, wherein masking the hydrophobicity 
will improve solubility and prevent adsorption of exogenous proteins. Additionally, the 
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concept of a primarily zwitterionic polymer that capably binds DNA, as observed with 
comb polymers having oligoarginine and sulfobetaine pendent groups, may benefit efforts 
aimed at overcoming the toxicity of cationic polymers to render them more suitable for 
biomedical applications. Finally, while RAFT and ATRP are extremely versatile 
polymerization methods that allow the preparation of elegantly designed materials with 
complex architectures a variety of functional groups, these techniques produce polymers 
that are non-degradable. Advancing polymerization methods leading to degradable 
polymers to render them as accessible and tunable as RAFT and ATRP will substantially 
improve the library of polymer biomaterials through a shift to degradable structures that 
are more appropriate for in vivo implementation. 
As discussed throughout this thesis, gene therapy has tremendous therapeutic 
potential, yet thus far significant hurdles have prevented its translation to clinical practice. 
While the challenges associated with safe and effective gene delivery are complex, 
polymers are becoming increasingly adept and closer to overcoming these issues. The 
versatility and tunability of functional hydrophilic polymers render them extremely well 
suited to overcome various obstacles encountered in the blood stream, intracellular 
trafficking, and protein synthesis. Design of novel polymeric materials through 
consideration of the structure-property relationships elucidated in this work and many 
others will increase the number of polymeric gene carriers that succeed in clinical trials. 
Continuous feedback from cell culture experiments and molecular simulations, as 
demonstrated in this thesis, facilitates rational design of new polymers through a deeper 
understanding of polymer interactions with nucleic acids and cells. Finally, more extensive 
collaboration between biologists and materials scientists developing gene therapy 
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technologies is essential to coordinate the possibilities of polymer synthesis and polyplex 
construction with the specific obstacles encountered in route to successful gene therapy.  
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CHAPTER 8 
EXPERIMENTAL SECTION 
8.1 Materials 
1,5-cyclooctadiene (99 %), hydrobromic acid (33 weight % in acetic acid), sodium cyanide 
(97 %), hydrogen peroxide solution (30 weight % in water, contains inhibitor), phosphoric 
acid (puriss. P.a., crystallized, ≥ 99.0 %), 3-bromopyridine (99%), ethyl vinyl ether (99%), 
2nd generation Grubbs catalyst ((1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene) 
dichloro(phenylmethylene)(tricyclohexylphosphine) ruthenium), triisopropylsilane (TIPS, 
99%), N,N-dimethylethylenediamine (29, ≥ 98.0%), and 1,3-propanesultone (31, 98 %), 
1,4-dioxane (anhydrous, 99.8%), methanol (anhydrous, 99.8 %), N,N-dimethylformamide 
(DMF, anhydrous, 99.8%), dimethyl sulfoxide (DMSO, anhydrous, ≥ 99.9%), acetonitrile 
(anhydrous, 99.8 %), heparin (ammonium salt from porcine intestinal mucosa), 1,2,4-
trichlorobenzene (TCB), methacryloyl chloride (97 %, containing 200 ppm 
monomethyletherhydroquinone), 3-buten-1-ol (96 %) , triethylamine (TEA) (≥ 99 %), [2-
(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammonium hydroxide (SBMA, 44, 97 
%), 4,4’-azobis(4-cyanovaleric acid) (98 %, ACVA), 4-cyano-4-
(phenylcarbonothioylthio)pentanoic acid (DTB, 46, >97 %), 2,2-dimethoxy-2-
phenylacetophenone (DMPA) (99 %), 2,2’(ethylenedioxy)diethanethiol (54, 95 %), 4-
vinylbenzyl chloride (55, 90% contains 500 ppm of t-butylcatechol as inhibitor), sodium 
thiomethoxide (95%), 4-Cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl] pentanoic acid 
(58, 97%), L-cysteine (62, 97 %), and Coumarin 153 (dye content 99 %) were purchased 
from Aldrich. Fmoc-Val-OH (≥ 98%), Fmoc-Lys(Boc)-OH (≥ 98%), Fmoc-Arg(Pbf)-OH 
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(≥ 98%), Fmoc-Pro-OH (≥ 98%), 1-hydroxybenzotriazole (HOBt, ≥98%) hydrate, 
O-(benzotriazol-1-yl)-N,N,N’,N’-tetra-methyluronium hexafluorophosphate (HBTU, 
≥ 98%), piperidine (≥ 99%), diisopropylethylamine (DIPEA, ≥ 99%), trifluoroacetic acid 
(TFA, ≥ 99%) and 2-chlorotrityl chloride resin (1.0-1.6 mmol/g, 100-200 mesh, 20) were 
purchased from Advanced ChemTech. 2,2,2-Trifluoroethanol (TFE, ≥ 99%), sodium 
hydrogen carbonate (ACS, 99.7-100.3 %), sodium nitrate (98+%), butylated 
hydroxytoluene (BHT, 99 %), and mercaptopyridine (61, 98%) were purchased from Alfa 
Aesar. 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC, > 98.0 %) 
was purchased from TCI America. Poly(ethylene glycol)-cyclooctene (Mn 4400 g/mol) 
(34) was a gift from Intezyne. Deuterated solvents were purchased from Cambridge Isotope 
Laboratories. Glacial acetic acid (ACS certified), sodium hydroxide (certified ACS, 
pellets), N,N-dimethyl formamide (Spectranalyzed®), methylene chloride (Optima®), 
hexanes (Certified ACS), ethyl ether (stabilized by butylated hydroxytoluene (BHT), 
certified ACS), hydrochloric acid (certified ACS plus), sodium hydroxide (certified ACS 
pellets), dialysis tubing (Spectra/Por®, regenerated cellulose membranes with a molecular 
weight cut-off of 6000-8000 g/mol), and polystyrene sterile culture test tubes (12 x 75 mm 
with a polyethylene cap) were purchased from Fisher Scientific. Dulbecco’s Modified 
Eagles Medium (DMEM), Lipofectamine™ 2000, and the Quant-iT™ PicoGreen® (200 
X) double stranded DNA reagent were purchased from Life Technologies. JetPEI™ (PEI) 
was purchased from Polyplus Transfection. Fetal bovine serum (FBS) was purchased from 
Atlanta Biologicals.  SKOV3 cells were purchased from American Type Culture Collection 
(ATCC). Plasmid DNA (mRFP-IRES-Puro, 4.5 kbp) was a gift from Dr. Lawrence 
Schwartz, and was replicated in bacteria by Dr. Sangram Parelkar and Emily Brackett in 
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the Emrick group. Label IT® Fluorescein plasmid DNA was purchased from Mirus Bio. 
CH2Cl2 was distilled over CaH2 and 1,5-cyclooctadiene was distilled. All other materials 
were used as received.  
8.2 Instrumentation 
1H and 13C NMR spectra were recorded on a Bruker Spectrospin DPX300, Avance400 or 
500 spectrometer.  Mass spectrometry was performed either on a JEOL MStation JMS700 
high-resolution two-sector mass spectrometer equipped with fast atom bombardment 
(FAB) and low resolution electrospray ionization (ESI) or a Bruker micrOTOF II mass 
spectrometer.  Size exclusion chromatography (SEC) of Boc- and Pbf- protected polymers 
for gene therapy (Chapters 2-4) was performed in DMF with 0.01 M LiCl at 50 °C. The 
system was operated at a flow rate of 1 mL/min with a Sonntek HPLC pump (K-501), one 
50 mm x 7.5 mm PL gel mixed guard column, one 300 mm x 7.5 mm PL gel 5 µm mixed 
C column, one 300 mm x 7.5 mm PL gel 5 µm mixed D column, a Knauer refractive index 
detector (K-2301), and an Alltech solvent recycler 3000. SEC of deprotected cationic 
polymers for gene therapy (Chapters 2-4) and zwitterionic polymers (Chapters 5 and 6) 
was performed in TFE with 0.02 M sodium trifluoroacetate at 40 °C using an Agilent 1200 
system equipped with an isocratic pump operated at 1 mL/min, a degasser, an autosampler, 
one 50 mm x 8 mm PSS PFG guard column (Polymer Standards Service), three 300 mm x 
7.5 mm PSS PFG analytical linear M columns with 7 µm particle size (Polymer Standards 
Service), and an Agilent 1200 refractive index detector. Both systems were calibrated with 
PMMA standards. Atomic force microscopy was performed on a Digital Instruments 
Dimension 3100 atomic force microscope in tapping mode. Optical microcscopy was 
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performed on an inverted optical microscope (Zeiss Axiovert 200) equipped with a 
QImaging camera (Retiga-2000R Fast 1394 Mono Cooled).  
8.3 Methods 
• Synthesis of of (Z)-cyclooct-4-ene-1-carboxylic acid (23) 
 
23 was prepared from 1,5-cyclooctadiene similarly as reported in literature procedures.1–3  
Synthesis of (Z)-cyclooct-4-ene-1-bromide. 1,5-cyclooctadiene (70 mL, 57.54 g, 
532 mmol) was added to a dry 500 mL two-necked round bottom flask equipped with a stir 
bar, septum, and a condenser topped with an inlet adapter connected to N2(g). HBr (33 
weight % in acetic acid) was added, and the mixture stirred rapidly at room temperature 
under N2(g) for at least 12 h with the flask covered with aluminum foil. The reaction mixture 
was diluted with water (100 mL) and washed three times with diethyl ether.  The organic 
layers were combined and washed three times with a saturated solution of NaHCO3(aq). 
(Note that addition of of NaHCO3 solution to the organic layer is done to remove remaining 
acetic acid and is very exothermic. This is best done by adding part of the organic layer of 
the extraction (~300 mL) to a 1 L beaker and slowly pouring in the NaHCO3(aq) solution 
(~300 mL) while stirring rapidly. Once the mixture stops bubbling, it can be poured into 
the separatory funnel.) The organic layers were combined, dried over MgSO4, and 
concentrated by rotary evaporation. (Z)-cyclooct-4-ene-1-bromide was isolated by 
distillation under vacuum at 80-105 °C as a clear liquid (54.4 g, 93 %). The product is light 
sensitive and will turn brown over time upon exposure to oxygen and light, therefore care 
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should be exercised during the reaction and workup. Additionally, (Z)-cyclooct-4-ene-1-
bromide should be used within 1-2 days after isolation. 1H NMR (CDCl3, 300 MHz): δ = 
5.47-5.67 (br m, 2H), 4.13-4.40 (br m, 1H), 1.12-2.48 (br m, 10 H). 
Synthesis of (Z)-cyclooct-4-ene-1-carbonitrile. (Z)-cyclooct-4-ene-1-bromide (54.4 
g, 290 mmol), NaCN (36 g, 734 mmol), and DMSO (100 mL) were added to a dry two-
necked 500 mL round bottom flask equipped with a stir bar, a septum, and condenser 
topped with an inlet adapter connected to N2(g). (Note that NaCN, when exposed to acid or 
water at pH < 7, forms HCN and therefore care should be taken when handling this reagent. 
It is best to weight NaCN on a mass balance inside a fume hood. Additionally, aqueous 
solutions of base (e.g. NaOH) to neutralize any acid and either iron II chloride tetrahydrate 
or iron II sulfate (to complex remaining cyanide ions) should be kept close to the reaction 
set-up in the fume hood.) The reaction was heated to 110 °C for at least 12 h under N2(g). 
Water (200 mL) was added to the reaction flask as it cooled to room temperature, and the 
reaction mixture became a thick, brown liquid. The reaction mixture was washed three 
times with diethyl ether. Note that an emulsion forms during this extraction, and therefore 
the layers were left at least 10-30 minutes during each wash to separate as much as possible 
before removal from the funnel. The organic layers were combined, dried over MgSO4, 
and concentrated by rotary evaporation. (Z)-cyclooct-4-ene-1-carbonitrile was isolated by 
column chromatography using ~800 mL silica gel, eluting first with hexanes (2L) to 
remove 1,5-cyclooctadiene byproduct, then with 10 % ethyl acetate/hexanes (2L) followed 
by 20 % ethyl acetate/hexanes (2L). Fractions containing the product were concentrated by 
rotary evaporation and dried under vacuum to afford an orange viscous liquid (13.6 g, 35 
%). Note that performing this reaction on a larger scale (i.e. 60 g (Z)-cyclooct-4-ene-1-
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bromide) results in lower yields. 1H NMR (CDCl3, 300 MHz): δ = 5.38-5.74 (br m, 2H), 
2.59-2.87 (br m, 1H), 1.01-2.59 (br m, 10 H). 
Synthesis of (Z)-cyclooct-4-ene-1-carboxylic acid. (Z)-cyclooct-4-ene-1-
carbonitrile (17 g, 126 mmol) and hydrogen peroxide (30 % aqueous solution, 45 mL, 15 
g, 441 mmol) were stirred rapidly in a three-necked 500 mL round bottom flask equipped 
with a stir bar, two septa, and a condenser topped with an inlet adapter connected to N2(g). 
Sodium hydroxide (30 % aqueous solution, 200 mL, 59 g, 1462 mmol) was added slowly 
to the reaction flask, and the mixture stirred at room temperature under N2(g) for 2 h. The 
reaction flask was heated to 40 °C for 19 h. Sodium hydroxide (60 g) was added to the 
reaction mixture. After the solution stopped bubbling, the temperature was increased to 
110 °C for two days. Upon cooling to room temperature, the reaction flask was stored at 
4°C and the precipitate isolated by gravimetric filtration. The precipitate was redissolved 
in water (300 mL) and the solution adjusted to pH 2 with phosphoric acid (80 % aqueous 
solution). (Z)-cyclooct-4-ene-1-carboxylic acid was isolated by extraction into diethyl 
ether followed by distillation under vacuum at ~170-180 °C as a clear viscous liquid (9.3 
g, 48 %). 1H NMR (CDCl3, 300 MHz): δ = 12.04 (s, 1H), 5.19-6.09 (m, 2H), 0.99-2.90 (m, 
11 H). 
• Synthesis of (Z)-cyclooct-4-ene-1-VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P 
(rNLS-COE, 24).   
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24 was prepared in collaboration with Dr. Delphine Chan-Seng similarly as previously 
reported for (Z)-cyclooct-4-ene-1-PK(Boc)K(Boc)K(Boc)R(Pbf)K(Boc)P (NLS-COE, 
25)4 using solid phase peptide synthesis by loading the resin with Fmoc-Pro-OH instead of 
Fmoc-Val-OH and by inverting the order of the sequence of amino acids added to the resin.  
2-Chlorotrityl chloride resin (6.0 g, 1.2 mmol/g, 7.2 mmol of functional groups) was 
weighed into an oven-dried vessel and swollen in dry CH2Cl2 (60 mL) for 10 min.  The 
solution was filtered, and a solution of Fmoc-Pro-OH (6.5 g, 19.2 mmol), DIPEA (6.7 mL, 
38.4 mmol), and dry CH2Cl2 (70 mL) was added to the peptide vessel.  The solution was 
agitated under N2 for 45 min, then filtered and washed with DMF three times.  An 80/15/5 
anhydrous CH2Cl2/methanol/DIPEA solution (60 mL) was agitated under N2(g) for 10 min 
(twice), and the resin was washed with DMF three times.  The Fmoc protecting groups 
were removed by agitation under N2(g) with a 25% piperidine solution in DMF (60 mL) for 
3 min, followed by filtration and agitation with a fresh piperidine solution for 20 min.  The 
resin was then washed 6 times with DMF, 3 times with CH2Cl2, 3 times with isopropanol, 
6 times with hexanes, and once with CH2Cl2.  The resin was dried under vacuum.  The 
loading density of amino acid was determined gravimetrically (typically 1.2-1.4 mmol/g 
of resin). The remaining amino acids were successively coupled to the proline-
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functionalized resin (21), using HBTU and HOBt as coupling agents, in the following 
order: Fmoc-Lys(Boc)-OH, Fmoc-Lys(Boc)-OH, Fmoc-Lys(Boc)-OH, Fmoc-Arg(Pbf)-
OH, Fmoc-Lys(Boc)-OH and Fmoc-Val-OH.  For each coupling reaction the amino acid 
(28.5 mmol), HBTU (10.8 g, 28.5 mmol) and HOBt (4.4 g, 28.5 mmol) were dissolved in 
anhydrous DMF (80 mL) in an oven-dried 500 mL round bottom flask.  DIPEA (10 mL, 
57 mmol) was added to the amino acid solution, which was then added to the peptide vessel 
and agitated under N2(g) for 1 h.  The resin was filtered, and washed 3 times with DMF.  
The Fmoc protecting groups were removed as described previously using a 25% piperidine 
solution in DMF.  The resin was washed 6 times with DMF.  Following the addition of 
Fmoc-Val-OH and Fmoc-deprotection to yield  22, a solution of (Z)-cyclooct-4-ene-1-
carboxylic acid (23, 4.4 g, 28 mmol), HOBt (4.37 g, 28.5 mmol) and HBTU (10.8 g, 28.5 
mmol) in anhydrous DMF (80 mL) was prepared. DIPEA (10 mL, 57 mmol) was added to 
the solution, immediately poured into the peptide vessel and agitated under N2(g) for 1 h.  
The solution was filtered, and the resin was washed 6 times with DMF and 6 times with 
CH2Cl2.  The oligopeptide-functionalized cyclooctene was cleaved from the resin by 
adding a 4/1 CH2Cl2/TFE solution to the peptide vessel for 45 min (twice).  The resin was 
filtered, washed three times with CH2Cl2, and the filtrates were collected in a clean round 
bottom flask.  The solution was concentrated by rotary evaporation and precipitated in 2/1 
diethyl ether/hexanes.  After standing at 4 ºC for several hours, the product was isolated by 
filtration and then dried under vacuum.  6.8 g of a white powder was obtained (57 % yield 
based upon the estimated loading density). 1H NMR (DMSO-d6, 300 MHz): δ =12.45 (br, 
1H), 7.49-8.60 (br m, 6H), 5.96-7.41 (br m, 7H), 5.62 (br m, 2H), 4.43 (br m, 1H), 4.21 (br 
m, 4H), 4.05 (br m, 1H), 3.88 (br m, 1H), 3.67 (br m, 1H), 3.51 (br m, 1H), 2.70-3.14 (br 
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m, 14 H), 2.47 (s, 3H), 2.42 (s, 3H), 1.04-2.32 (br m, 89 H), 0.73-0.91 (br m, 6H). 13C 
NMR (DMSO-d6, 100 MHz): δ = 177.09, 173.26, 173.23, 171.46, 171.28, 171.21, 169.90, 
169.87, 157.45, 156.05, 155.53, 137.29, 134.20, 131.43, 129.95, 129.89, 129.81, 124.29, 
116.25, 86.28, 77.35, 59.72, 59.39, 59.05, 58.55, 58.46, 57.73, 52.55, 52.48, 54.43, 52.37, 
52.33, 52.21, 52.00, 51.96, 50.26, 46.45, 43.57, 42.50, 32.73, 31.95, 31.81, 31.55, 30.76, 
30.15, 29.42, 29.35, 29.24, 28.60, 28.27, 27.44, 27.24, 25.39, 25.30, 25.20, 24.57, 24.10, 
22,70, 22.60, 22.18, 19.29, 18.97, 18.24, 17.61, 12.29. Low-resolution ESI (m/z): [M+H]+ 
calculated from C82H138N14O20S, 1672.0; found, 1671.9. High-resolution FAB (m/z): 
[M+H]+ calculated from C82H138N14O20S, 1672.00; found, 1672.01. 
• Synthesis of (Z)-cyclooct-4-ene-1-PK(Boc)K(Boc)K(Boc)R(Pbf)K(Boc)P 
(NLS-COE, 25).   
 
NLS-COE was prepared by Dr. Delphine Chan-Seng as previously reported.4  
• Synthesis of 3-bromopyridine-substitued Grubbs catalyst, generation III 
(G3-BrPyr, 26)  
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G3-BrPyr was synthesized similarly as previously reported in a literature procedure.5 2nd 
generation Grubbs catalyst (0.25 g, 0.3 mmol) was added to a 20 mL scintillation vial under 
N2(g) atmosphere in a glove box. The vial was capped with a septum, and the vial removed 
from the glove box. 3-bromopyridine (0.5 mL, 0.84 g, 5.3 mmol) was added and the 
solution stirred 30 min at room temperature. Within 30 s after addition of 3-bromopyridine, 
the reaction mixture becomes green. G3-BrPyr was precipitated into cold pentane (~100 
mL), isolated by filtration, and dried under vacuum for 2 h. Catalyst 26 is a green powder 
(0.233 g, 88 %). 
• Synthesis of NLS (27) 
 
NLS was synthesized in collaboration with Dr. Delphine Chan-Seng similarly as 
previously reported.4 25 (0.2 g, 0.12 mmol) was added to a 20 mL vial and dissolved in 
TFE (0.4 mL). The monomer solution was degassed using three freeze-pump-thaw cycles. 
A solution of 26 in CH2Cl2 (50 mg/mL) was prepared, degassed using three freeze-pump-
thaw cycles, and stored in an ice bath to prevent evaporation of CH2Cl2.  Catalyst 26 
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solution (0.04 mL, 0.002 mg, 0.0023 mmol) was transferred to the monomer solution, and 
the mixture was stirred for 1 h at room temperature under N2(g). Ethyl vinyl ether (0.1 mL, 
1 mmol) was added to terminate the polymerization, and the mixture stirred for 15 min 
under N2(g).  The mixture was diluted with TFE (~1 mL) and precipitated into diethyl ether 
(~40 mL), isolated by centrifugation (4000 rpm, 5 min), and dried under vacuum at room 
temperature. Note that allowing the precipitate to dry for ~2 h under N2(g) prior to pulling 
vacuum minimizes loss of product due to rapid evaporation of ether under vacuum. 
Poly((Z)-cyclooct-4-ene-1-PK(Boc)K(Boc)K(Boc)R(Pbf)K(Boc)P) and unreacted 
monomer 25 was obtained as a yellow/brown solid. 1H NMR (DMSO-d6, 300 MHz): 
Conversion 80 % (27b). SEC (0.01 M LiCl in DMF, PMMA standards): Mn 81800, Mw/Mn 
1.28 (27b). The mixture of poly((Z)-cyclooct-4-ene-1-
PK(Boc)K(Boc)K(Boc)R(Pbf)K(Boc)P) and 25 (0.1 g) was dissolved in a TFA/water/TIPS 
(95/2.5/2.5) solution (5 mL) and stirred 3 h at room temperature.  The mixture was 
precipitated into diethyl ether (~40 mL), isolated by centrifugation (4000 rpm, 5 min), and 
and dissolved in water (~10 mL). The product was dialyzed (MWCO = 6-8 kDa) against 
deionized water (once), 30% acetic acid(aq) (once) and deionized water (3x) to remove 
residual macromonomer.  The purified polymer was lyophilized to afford a white solid (27) 
in 64 % yield (27b). 1H NMR (D2O, 300 MHz): 5.46 (br, 2H), 4.14-4.51 (br m, 6H), 4.01 
(br m, 1H), 3.66 (br, 2H), 3.19 (br m, 2H), 2.97 (br m, 8H), 2.73 (br, 1H), 1.06-2.48 (br m, 
58 H), 0.90 (br m, 6H). SEC (0.02 M sodium trifluoroacetate in TFE, PMMA standards): 
Mn 58300 Mw/Mn 1.24 (27b). 
• Synthesis of rNLS (28)  
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rNLS was synthesized in collaboration with Dr. Delphine Chan-Seng. 24 (0.2 g, 0.12 
mmol) was added to a 20 mL vial and dissolved in TFE (0.4 mL). The monomer solution 
was degassed using three freeze-pump-thaw cycles. A solution of 26 in CH2Cl2 (50 
mg/mL) was prepared, degassed using three freeze-pump-thaw cycles, and stored in an ice 
bath to prevent evaporation of CH2Cl2.  Catalyst 26 solution (0.08 mL, 0.004 mg, 0.0047 
mmol) was transferred to the monomer solution, and the mixture was stirred for 1 h at room 
temperature under N2(g). Ethyl vinyl ether (0.1 mL, 1 mmol) was added to terminate the 
polymerization, and the mixture stirred for 30 min under N2(g).  The mixture was 
precipitated into diethyl ether (~40 mL), isolated by centrifugation (4000 rpm, 5 min), and 
dried under vacuum at room temperature. Note that allowing the precipitate to dry for ~2 
h under N2(g) prior to pulling vacuum minimizes loss of product due to rapid evaporation 
of ether under vacuum. A mixture of Poly((Z)-cyclooct-4-ene-1- 
VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P) and unreacted monomer 24 was obtained as a 
yellow/brown solid (92 % recovered mass). 1H NMR (DMSO-d6, 300 MHz): Conversion 
89 % (28a). SEC (0.01 M LiCl in DMF, PMMA standards): Mn 50400, Mw/Mn 1.17 (28a). 
Poly((Z)-cyclooct-4-ene-1- VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P) (0.1 g) was dissolved 
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in a TFA/water/TIPS (95/2.5/2.5) solution (5 mL) and stirred 3 h at room temperature.  The 
mixture was precipitated into diethyl ether (~40 mL), isolated by centrifugation (4000 rpm, 
5 min), and and dissolved in water (~10 mL). The product was dialyzed (MWCO = 6-8 
kDa) against deionized water (once), 30% acetic acid(aq) (once) and deionized water (3x) 
to remove residual macromonomer.  The purified polymer was lyophilized to afford a white 
solid (28) in 73 % yield (28a). 1H NMR (D2O, 300 MHz): 5.43 (br, 2H), 4.42-4.63 (m, 
1H), 4.14-4.42 (br m, 5H), 4.05 (br, 1H), 3.78 (br m, 1H), 3.64 (br m, 1H), 3.19 (br m, 2H), 
2.99 (br m, 8H), 1.08-2.51 (br m, 59 H), 0.93 (br m, 6H). 13C NMR (D2O, 75 MHz): δ = 
181.29, 179.30, 178.71, 173.55, 173.40, 173.29, 172.24, 171.53, 170.84, 156.69, 130.53, 
62.16, 59.48, 53.62, 53.51, 53.26, 53.12, 51.37, 50.97, 47.71, 47.19, 46.64, 46.03, 40.52, 
39.06, 32.09, 30.50, 29.81, 29.32, 28.35, 26.43, 26.34, 26.25, 25.14, 24.63, 24.44, 23.36, 
22.11, 21.97, 21.85, 21.73, 18.58, 18.31, 10.52. SEC (0.02 M sodium trifluoroacetate in 
TFE, PMMA standards): Mn 41500 Mw/Mn 1.18 (28a). 
• Synthesis of (Z)-cyclooct-4-ene-1-N,N-dimethylaminoethyl ester (30) 
 
30 was synthesized in collaboration with Dr. Delphine Chan-Seng. 23 (2.00 g, 12.9 mmol) 
was dissolved in CH2Cl2 (60 mL). EDC (2.74 g, 14.3 mmol) and N,N-
dimethylaminoethylamine (24, 1.56 mL, 1.26 g, 14.3 mmol) were added and the mixture 
stirred for 24 h at room temperature under N2(g). The mixture was washed with brine, 5% 
NaHCO3(aq) (2x), and again brine. The combined organic layers were dried over MgSO4, 
filtered and concentrated by rotary evaporation, then dried under vacuum to yield a yellow 
oil (2.6 g, 89 %).  
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• Synthesis of (Z)-cyclooct-4-ene-1-propylsulfonate-N,N-dimethylammonio 
ethyl ester (32).  
 
32 was synthesized in collaboration with Dr. Delphine Chan-Seng. 30 (2.55 g, 11.4 mmol) 
was dissolved in CH3CN (10 mL) in a vial equipped with a stir bar and a gas inlet adapter. 
1,3-Propanesultone (31, 1.67 g, 13.7 mmol) was added and the mixture heated to 50 °C 
and stirred under N2. After 10 min, a white precipitate was observed.   The mixture was 
stirred approximately 18 h at 50 °C, and 32 isolated by centrifugation (4000 rpm, 5 min) 
as a white powder (1.91 g, 48 %). 1H NMR (500 MHz, D2O, δ): 5.51-5.98 (m, 2H), 3.65 
(t, J = 8 MHz, 2H), 3.43-3.56 (m, 4H), 3.17 (s, 6H), 2.99 (t, J = 8 MHz, 2H), 2.34-2.46 (m, 
2H), 2.21-2.29 (m, 2H), 2.05-2.21 (m, 2H), 1.48-1.81 (m, 4H), 1.26-1.48 (m, 1H); 13C 
NMR (125 MHz, D2O, δ): 182.15, 131.13, 129.83, 62.84, 61.81, 50.96, 47.14, 44.65, 32.99, 
31.83, 29.62, 27.29, 25.17, 23.48, 18.17. FAB-mass spectrometry: calculated [M+H]+ = 
347.2005, found 347.2003. 
• Synthesis of (Z)-cyclooct-4-ene-1-phosphorylcholine (33)  
 
33 was synthesized by Chia-Chih Chang as previously reported.6 
• Synthesis of SB-X (35)  
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(Z)-cyclooct-4-ene-1- VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P (24, 0.2 g, 0.12 mmol), SB-
COE (32, 0.28 mL, 0.1 g/mL in TFE, 0.028 g, 0.08 mmol), and TFE (0.12 mL) were added 
to a 20 mL scintillation vial equipped with a stir bar and a septum, and the solution degassed 
using 3 freeze-pump-thaw cycles. A solution of 26 was prepared in CH2Cl2 (50 mg/mL), 
degassed using 3 freeze-pump, thaw cycles, and kept in an ice bath to prevent solvent 
evaporation. Catalyst 26 (0.002 g, 0.0023 mmol, 0.04 mL) was added to monomer, and the 
solution stirred 2 h at room temperature under N2. Ethyl vinyl ether (0.1 mL, 0.075 g, 1 
mmol) was added, the mixture stirred 15 min, then opened to air. The mixture was diluted 
with approximately 1 mL TFE, and then precipitated into 40 mL diethyl ether. The 
precipitate was isolated by centrifugation (4000 rpm, 5 min) and dried under vacuum.  A 
mixture of poly((Z)-cyclooct-4-ene-1-VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P-co-SB-
COE) and unreacted monomers, 24 and 32, was obtained as a yellow/brown solid. 1H NMR 
(DMSO-d6, 300 MHz): Conversion 77 % (35d). SEC (0.01 M LiCl in DMF, PMMA 
standards): Mn 74700, Mw/Mn 1.32 (35d). The mixture of poly((Z)-cyclooct-4-ene-1-
VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P-co-SB-COE), 24, and 32 (0.1 g) was dissolved in 
a TFA/water/TIPS (95/2.5/2.5) solution (5 mL) and stirred 3 h at room temperature.  The 
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mixture was precipitated into diethyl ether (~40 mL), isolated by centrifugation (4000 rpm, 
5 min), and and dissolved in water (~5 mL). The product was dialyzed (MWCO = 6-8 kDa) 
against deionized water (once), 30% acetic acid(aq) (once) and deionized water (3x) to 
remove residual macromonomer.  The purified polymer was lyophilized to afford a white 
solid (SB-X, 35) in 63 % yield (35d). The theoretical yield was calculated as (mass mixture 
of poly((Z)-cyclooct-4-ene-1-VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P-co-SB-COE), 24, 
and 32 (g)) x (conversion (%)/100) x (average molecular weight per repeat unit of Boc- 
and Pbf-protected copolymer (g/mol)/average molecular weight per repeat unit of 35 
(g/mol)), assuming equal conversion of 24 and 32. 1H NMR (D2O, 300 MHz): 5.43 (br, 2H 
from rNLS and 2H from SB), 4.42-4.64 (br m, 1H from rNLS), 4.14-4.42 (br m, 5H from 
rNLS), 4.05 (br, 1H from rNLS), 3.34-3.89 (br m, 2H from rNLS and 6H from SB), 3.09-
3.29 (br m, 2H from rNLS and 6H from SB), 2.86-3.09 (br m, 8H from rNLS and 2H from 
SB), 1.12-2.49 (br m, 59 H from rNLS and 13 H from SB), 0.93 (br m, 6H from rNLS). 
13C NMR (D2O, 75 MHz): δ = 181.38, 179.32, 173.52, 173,40, 173.26, 171.52, 156.69, 
130.70, 85.95, 62.82, 62.15, 61.64, 59.56, 53.66, 53.51, 53.33, 53.25, 53.20, 53.11, 51.38, 
51.00, 47.70, 47.22, 40.53, 32.91, 31.97, 30.57, 29.86, 29.35, 28.44, 28.38, 26.52, 26.40, 
24.63, 24.42, 23.33, 22.14, 21.95, 21.82, 21.71, 18.56, 18.32, 18.24. SEC (0.02 M sodium 
trifluoroacetate in TFE, PMMA standards): Mn 65400, Mw/Mn 1.42 (35d). 
• Synthesis of PC-X (36)  
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(Z)-cyclooct-4-ene-1- VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P (24, 0.2 g, 0.12 mmol), PC-
COE (33, 0.23 mL, 0.1 g/mL in TFE, 0.023 g, 0.08 mmol), and TFE (0.17 mL) were added 
to a 20 mL scintillation vial equipped with a stir bar and a septum, and the solution degassed 
using 3 freeze-pump-thaw cycles. A solution 26 was prepared in CH2Cl2 (50 mg/mL), 
degassed using 3 freeze-pump, thaw cycles, and kept in an ice bath to prevent solvent 
evaporation. Catalyst 26 (0.002 g, 0.0023 mmol, 0.04 mL) was added to monomer, and the 
solution stirred 2 h at room temperature under N2. Ethyl vinyl ether (0.1 mL, 0.075 g, 1 
mmol) was added, the mixture stirred 15 min, then opened to air. The mixture was diluted 
with approximately 1 mL TFE, and then precipitated into 40 mL diethyl ether. The 
precipitate was isolated by centrifugation (4000 rpm, 5 min) and dried under vacuum.  A 
mixture of poly((Z)-cyclooct-4-ene-1-VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P-co-PC-
COE) and unreacted monomers, 24 and 33, was obtained as a yellow/brown solid. 1H NMR 
(DMSO-d6, 300 MHz): Conversion 75 % (36d). SEC (0.01 M LiCl in DMF, PMMA 
standards): Mn 58500, Mw/Mn 1.30 (36d). The mixture of poly((Z)-cyclooct-4-ene-1-
VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P-co-PC-COE), 24, and 33 (0.1 g) was dissolved in 
a TFA/water/TIPS (95/2.5/2.5) solution (5 mL) and stirred 3 h at room temperature.  The 
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mixture was precipitated into diethyl ether (~40 mL), isolated by centrifugation (4000 rpm, 
5 min), and and dissolved in water (~5 mL). The product was dialyzed (MWCO = 6-8 kDa) 
against deionized water (once), 30% acetic acid(aq) (once) and deionized water (3x) to 
remove residual macromonomer.  The purified polymer was lyophilized to afford a white 
solid (PC-X, 36) in 55 % yield (36d). The theoretical yield was calculated as (mass mixture 
of poly((Z)-cyclooct-4-ene-1-VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P-co-PC-COE), 24, 
and 33 (g)) x (conversion (%)/100) x (average molecular weight per repeat unit of Boc- 
and Pbf-protected copolymer (g/mol)/average molecular weight per repeat unit of 36 
(g/mol)), assuming equal conversion of 24 and 33. 1H NMR (D2O, 300 MHz): 5.17-5.59 
(br m, 2H from rNLS and 2H from PC), 4.37-4.63 (br m, 1H from rNLS), 4.08-4.38 (br m, 
5H from rNLS and 3H from PC), 4.00 (br, 1H from rNLS), 3.75 (br m, 1H from rNLS), 
3.48-3.68 (br m, 1H from rNLS and 2H from PC), 3.07-3.29 (br m, 2H from rNLS and 9H 
from PC), 2.95 (br m, 8H from rNLS), 1.07-2.50 (br m, 59 H from rNLS and 10H from 
PC), 0.88 (br m, 6H from rNLS). 13C NMR (D2O, 75 MHz): δ = 181.29, 179.37, 173.49, 
173.36, 173.23, 171.47, 170.79, 156.63, 130.39, 66.08, 65.94, 62.20, 59.14, 53.94, 53.62, 
53.47, 53.23, 53.10, 51.34, 47.68, 40.49, 39.10, 30.52, 29.83, 29.31, 28.30, 26.45, 26.40, 
26.28, 24.59, 24.42, 23.27, 22.13, 21.92, 21.80, 21.67, 18.53, 18.30. SEC (0.02 M sodium 
trifluoroacetate in TFE, PMMA standards): Mn 83700, Mw/Mn 1.57 (36d). 
• Synthesis of PEG-X (37)  
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(Z)-cyclooct-4-ene-1- VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P (24, 0.2 g, 0.12 mmol), and 
PEG-COE (34, Mn 4400 g/mol, 0.01 g, 0.0024 mmol) were dissolved in TFE (0.4 mL) in 
a 20 mL scintillation vial equipped with a stir bar and a septum, and degassed using 3 
freeze-pump-thaw cycles. A solution 26 was prepared in CH2Cl2 (50 mg/mL), degassed 
using 3 freeze-pump, thaw cycles, and kept in an ice bath to prevent solvent evaporation. 
Catalyst 26 (0.002 g, 0.0023 mmol, 0.04 mL) was added to monomer, and the solution 
stirred 2 h at room temperature under N2. Ethyl vinyl ether (0.1 mL, 0.075 g, 1 mmol) was 
added, the mixture stirred 30 min, then opened to air. The mixture was diluted with 
approximately 2-3 mL TFE, and then precipitated into 125 mL diethyl ether. The 
precipitate was isolated by centrifugation (4000 rpm, 5 min) and dried under vacuum.  A 
mixture of poly((Z)-cyclooct-4-ene-1-VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P-co-PEG-
COE) and unreacted monomers, 24 and 34, was obtained as a yellow/brown solid. 1H NMR 
(DMSO-d6, 300 MHz): Conversion > 95 % (37b). SEC (0.01 M LiCl in DMF, PMMA 
standards): Mn 80100, Mw/Mn 1.25 (37b). The mixture of poly((Z)-cyclooct-4-ene-1-
VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P-co-PEG-COE), 24, and 34 (0.1 g) was dissolved 
in a TFA/water/TIPS (95/2.5/2.5) solution (5 mL) and stirred 3 h at room temperature.  The 
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mixture was precipitated into diethyl ether (~80 mL), isolated by centrifugation (4000 rpm, 
5 min), and and dissolved in water (~10 mL). The product was dialyzed (MWCO = 6-8 
kDa) against deionized water (once), 30% acetic acid(aq) (once) and deionized water (3x) 
to remove residual macromonomer.  The purified polymer was lyophilized to afford a white 
solid (PEG-X, 37) in 69 % yield (37b). The theoretical yield was calculated as (mass 
mixture of poly((Z)-cyclooct-4-ene-1-VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P-co-PEG-
COE), 24, and 34 (g)) x (conversion (%)/100) x (average molecular weight per repeat unit 
of Boc- and Pbf-protected copolymer (g/mol)/average molecular weight per repeat unit of 
37 (g/mol)), assuming equal conversion of 24 and 34. 1H NMR (D2O, 300 MHz): 5.24-
5.57 (br, 2H from rNLS and 2H from PEG), 4.40-4.65 (br m, 1H from rNLS), 4.12-4.40 
(br m, 5H from rNLS), 4.03 (br, 1H from rNLS), 3.51-3.87 (br m, 2H from rNLS, 389H 
from PEG), 3.17 (br m, 2H from rNLS), 2.98 (br m, 8H from rNLS), 1.07-2.52 (br m, 59H 
from rNLS and 10H from PEG), 0.91 (br m, 6H from rNLS).  SEC (0.02 M sodium 
trifluoroacetate in TFE, PMMA standards): Mn 55500, Mw/Mn 1.33 (37b). 
• Synthesis of K4-COE (38) 
 
(Z)-cyclooct-4-ene-1-tetralysine(boc) (K4-COE, 38) was synthesized in collaboration with 
Dr. Delphine Chan-Seng by solid phase peptide synthesis similarly as previously reported.4 
2-Chlorotrityl chloride resin (3.0 g, 1.2 mmol/g, 3.6 mmol of functional groups) was 
weighed into an oven-dried vessel and swollen in dry CH2Cl2 (30 mL) for 30 min.  The 
solution was filtered, and a solution of Fmoc-Lys(boc)-OH (4.5 g, 9.6 mmol), DIPEA (3.4 
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mL, 19.2 mmol), and dry CH2Cl2 (35 mL) was added to the peptide vessel.  The solution 
was agitated under N2 for 45 min, then filtered and washed with DMF three times.  A 
CH2Cl2/methanol (anhydrous)/DIPEA mixture (80/15/5 v/v/v, 30 mL) was added to the 
resin, agitated under N2(g) for 10 min, and filtered (twice). The resin was washed with DMF 
three times.  The Fmoc protecting groups were removed by agitation under N2(g) with a 
25% piperidine solution in DMF (30 mL) for 3 min, followed by filtration and agitation 
with a fresh piperidine solution (30 mL) for 20 min.  The resin was then washed 6 times 
with DMF, 3 times with CH2Cl2, 3 times with isopropanol, 6 times with hexanes, and once 
with CH2Cl2.  The resin was dried under vacuum.  The loading density of amino acid was 
determined gravimetrically (1.4 mmol amno acid/g of resin). The remaining three lysine 
residues were successively coupled to the lysine-functionalized resin, using HBTU and 
HOBt hydrate as coupling agents. For each coupling reaction, Fmoc-Lys(boc)-OH (7.68 g, 
16.4 mmol), HOBt hydrate (2.51 g, 16.4 mmol), and HBTU (6.22 g, 16.4 mmol) were 
dissolved in anhydrous DMF (40 mL) in an oven-dried 500 mL round bottom flask.  
DIPEA (5.7 mL, 32.8 mmol) was added to the Fmoc-Lys(boc)-OH solution, which was 
then added to the peptide vessel and agitated under N2(g) for 1.5 h.  The resin was filtered, 
and washed 3 times with DMF.  The Fmoc protecting groups were removed as described 
previously using a 25% piperidine solution in DMF.  Following the addition of the fourth 
lysine residue and Fmoc deprotection, the resin was washed 6 times with DMF and 6x with 
CH2Cl2. A solution of (Z)-cyclooct-4-ene-1-carboxylic acid (23, 2.53 g, 16.4 mmol), HOBt 
hydrate (2.51 g, 16.4 mmol) and HBTU (6.22 g, 16.4 mmol) in anhydrous DMF (40 mL) 
was prepared. DIPEA (5.7 mL, 32.8 mmol) was added to the solution of 23, which was 
immediately poured into the peptide vessel and agitated under N2(g) for 1 h.  The solution 
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was filtered, and the resin was washed 6 times with DMF and 6 times with CH2Cl2.  The 
oligolysine-functionalized cyclooctene was cleaved from the resin by adding a mixture of 
CH2Cl2 and TFE (4/1 v/v, 30 mL) to the peptide vessel and agitating with N2(g) for 30 min 
(3x).  The resin was filtered, washed three times with CH2Cl2, and the filtrates were 
collected in a clean round bottom flask.  The solution was concentrated by rotary 
evaporation and precipitated in 2/1 diethyl ether/hexanes (450 mL).  After standing at 4 ºC 
for 1 h, the K4-COE (38) was isolated as a white powder by filtration and then dried under 
vacuum. 1.97 g (45 % yield based upon the estimated loading density). 1H NMR (DMSO-
d6, 300 MHz): δ =12.52 (br, 1H), 7.66-8.14 (br m, 4H), 6.25-6.93 (br m, 4H), 5.64 (br m, 
2H), 4.01-4.40 (br m, 4H), 2.87 (br m, 8H), 2.32 (br m, 2H), 1.96-2.22 (br m, 3H), 1.09-
1.94 (br m, 66H). 
• Synthesis of K4SB-X (39) 
 
K4-COE (38, 0.20 g, 0.19 mmol) and SB-COE (32, 0.053 g, 0.15 mmol) were dissolved in 
TFE (0.4 mL) in a scintillation vial equipped with a stir bar and a septum, and degassed 
using 3 freeze-pump-thaw cycles. Separately, a solution of catalyst 26 was prepared in 
CH2Cl2 (50 mg/mL) and degassed. The catalyst solution (0.003 g, 0.004 mmol, 0.06 mL) 
was added to the monomer, and the mixture was stirred for 2 h at room temperature under 
N2. Ethyl vinyl ether (0.10 mL, 0.075 g, 1.0 mmol) was added, and the mixture was stirred 
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30 min and opened to air. The mixture was diluted with TFE (1 mL), and precipitated into 
diethyl ether (40 mL). The precipitate was isolated by centrifugation (4000 rpm, 5 min), 
and dried under vacuum. A mixture of poly((Z)-cyclooct-4-ene-1-[K(Boc)]4-co-SB-COE) 
and unreacted monomers, 38 and 32, was obtained as a yellow/brown solid. 1H NMR 
(500 MHz, DMSO-d6, δ): >95 % conversion (39a-d). The mixture of poly((Z)-cyclooct-4-
ene-1-[K(Boc)]4-co-SB-COE), 38, and 32, (0.1 g) was dissolved in methanol (5 mL) and 4 
M HCl in dioxane (2 mL). The mixture was stirred for 3 h at room temperature, then 
precipitated into diethyl ether (40 mL). Centrifugation (4000 rpm, 5 min), dialysis in water 
(6-8 kDa molecular weight cut-off membrane), and lyophilization afforded K4SB-X (39), 
where X denotes mol % SB, as a white powder in 66 % yield (39d). 1H NMR (500 MHz, 
D2O, δ): 5.38 (br, 2H from K4 and 2H from SB), 4.17-4.47 (br m, 4H from K4), 3.72 (s, 
8H from residual dioxane), 3.66 (br m, 2H from SB), 3.38-3.59 (br m, 4H from SB), 3.17 
(br, 6H from SB), 2.88-3.08 (br m, 8H from K4 and 2H from SB), 2.16-2.47 (br, 1H from 
K4 and 3H from SB), 1.05-2.10 (br m, 34 H from K4 and 10H from SB); 13C NMR 
(125 MHz, D2O, δ): 179.09, 176.54, 174.01, 173.75, 157.63, 130.59, 130.11, 129.86, 80.10, 
62.77, 61.59, 53.52, 53.39, 51.07, 47.26, 45.87, 39.86, 39.12, 32.93, 32.09, 30.67, 30.57, 
30.20, 29.70, 28.58, 28.12, 26.80, 26.36, 24.74, 22.51, 22.23, 22.07, 21.94, 18.27. 
• Synthesis of R4-COE (40) 
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(Z)-cyclooct-4-ene-1-tetraarginine(Pbf) (R4-COE, 40) was synthesized by solid phase 
peptide synthesis, similarly as reported for K4-COE (38).4 2-Chlorotrityl chloride resin 
(2.0 g, 1.2 mmol/g, 2.4 mmol of functional groups) was weighed into an oven-dried vessel 
and swollen in dry CH2Cl2 (40 mL) for 10-20 min.  The solution was filtered, and a solution 
of Fmoc-Arg(Pbf)-OH (4.2 g, 6.4 mmol), DIPEA (2.3 mL, 12.8 mmol), and dry CH2Cl2 
(40 mL) was added to the peptide vessel.  The solution was agitated under N2 for 3 h, then 
filtered and washed with DMF three times.  An 80/15/5 anhydrous 
CH2Cl2/methanol/DIPEA solution (50 mL) was agitated under N2(g) for 10 min (twice), and 
the resin was washed with DMF three times.  The Fmoc protecting groups were removed 
by agitation under N2(g) with a 25% piperidine solution in DMF (60 mL) for 3 min, followed 
by filtration and agitation with a fresh piperidine solution for 20 min.  The resin was then 
washed 6 times with DMF, 3 times with CH2Cl2, 3 times with isopropanol, 6 times with 
hexanes, and once with CH2Cl2.  The resin was dried under vacuum.  The loading density 
of amino acid was determined gravimetrically (1 mmol amino acid/g resin). The remaining 
three arginine residues were successively coupled to the arginine-functionalized resin, 
using HBTU and HOBt as coupling agents. For each of the subsequent coupling reactions, 
Fmoc-Arg(Pbf)-OH (5.37 g, 8.28 mmol), HOBt hydrate (1.27 g, 8.28 mmol), and HBTU 
(3.14 g, 8.28 mmol) were dissolved in anhydrous DMF (50 mL) in an oven-dried 250 mL 
round bottom flask.  DIPEA (2.9 mL, 16.6 mmol) was added to the amino acid solution, 
which was then added to the peptide vessel and agitated under N2(g) for 2 h.  The resin was 
filtered, and washed 3 times with DMF.  The Fmoc protecting groups were removed as 
described previously using a 25% piperidine solution in DMF.  Following Fmoc 
deprotection of the fourth arginine residue, the resin was washed 6 times with DMF and 
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filtered. (Z)-cyclooct-4-ene-1-carboxylic acid (23, 1.28 g, 8.28 mmol), HOBt hydrate 
(1.27 g, 8.28 mmol) and HBTU (3.14 g, 8.28 mmol) in anhydrous DMF (50 mL) was 
prepared. DIPEA (2.9 mL, 16.6 mmol) was added to the solution, immediately poured into 
the peptide vessel and agitated under N2(g) for 3.5 h.  The solution was filtered, and the 
resin was washed 3 times with DMF and 3 times with CH2Cl2.  The tetraarginine-
functionalized cyclooctene was cleaved from the resin by adding a 4/1 CH2Cl2/TFE 
solution (30 mL) to the peptide vessel for 45 min (3x).  The resin was filtered, washed three 
times with CH2Cl2, and the filtrates were collected in a clean round bottom flask.  The 
solution was concentrated by rotary evaporation and precipitated into 2/1 diethyl 
ether/hexanes (450 mL).  The precipitate was isolated by filtration and  dried under vacuum 
to yield an off-white powder (2.61 g, 71 % yield based upon the estimated loading density). 
1H NMR (DMSO-d6, 500 MHz): δ = 12.60 (s, 1H), 7.73-8.21 (br m, 4H), 6.12-7.26 (br m, 
12H), 5.53-5.70 (br m, 2H), 4.24 (m, 2H), 4.12 (m, 2H), 3.02 (m, 8H), 2.95 (s, 8H), 2.47 
(s, 12H), 2.42 (s, 12H), 2.28 (m, 2H), 1.93-2.17 (m, 15H), 1.21-1.77 (br m, 46H). 13C NMR 
(DMSO-d6, 500 MHz): δ = 177.16, 173.30, 171.80, 171.35, 171.20, 157.45, 156.06, 
137.28, 134.19, 131.44, 129.98, 129.90, 129.86, 129.82, 124.32, 116.27, 86.30, 52.06, 
43.59, 42.47, 32.31, 31.97, 29.87, 29.57, 28.90, 28.30, 27.46, 27.35, 25.41, 25.19, 23.98, 
18.96, 17.61, 12.28  ESI-MS (m/z): [M+H]+ calculated from C85H126N16O18S4, 1787.84; 
found, 1787.85. 
• Synthesis of R4 (41) 
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R4-COE (40, 0.20 g, 0.11 mmol) and was dissolved in TFE (0.4 mL) in a scintillation vial 
equipped with a stir bar and a septum, and degassed using 3 freeze-pump-thaw cycles. 
Separately, a solution of catalyst 26 was prepared in CH2Cl2 (50 mg/mL) and degassed. 
The catalyst solution (0.002 g, 0.0022 mmol, 0.04 mL) was added to the monomer, and the 
mixture was stirred for 2 h at room temperature under N2. Ethyl vinyl ether (0.10 mL, 0.075 
g, 1.0 mmol) was added, and the mixture was stirred 15 min and opened to air. The mixture 
was diluted with TFE (~1 mL), and precipitated into diethyl ether (40 mL). The precipitate 
was isolated by centrifugation (4000 rpm, 5 min), and dried under vacuum. A mixture of 
poly((Z)-cyclooct-4-ene-1-[R(Pbf)]4-co-SB-COE) and unreacted monomer, 40, was 
obtained as a yellow/brown solid. 1H NMR (500 MHz, DMSO-d6, δ): 45 % conversion. 
SEC (DMF with 0.01 M LiCl, PMMA standards): Mn 35900 g/mol, Mw/Mn 1.80. The 
mixture of poly((Z)-cyclooct-4-ene-1-[R(Pbf)]4-co-SB-COE) and 40 (0.1 g) was dissolved 
in a trifluoroacetic acid/triisopropylsilane/water mixture (90/5/5 v/v/v) and stirred 3 h at 
room temperature to remove the Pbf groups. Following precipitation of the mixture into 
diethyl ether (40 mL) and centrifugation (4000 rpm, 5 min), the product was isolated by 
dialysis in a 6-8 kDa molecular weight cut-off membrane in water (1x), 30 % acetic acid 
(1x), and water (3x). Subsequent lyophilization afforded R4 (41) as a white powder in 65 
% yield. 1H NMR (500 MHz, D2O, δ): 5.31 (br, 2H), 4.26 (br, 3H), 4.05 (br, 1H), 3.12 (br, 
8H), 1.02-2.82 (br m, 39H). SEC (TFE with 0.02 M NaTFAc, PMMA standards): Mn 
35000 g/mol, Mw/Mn 1.26. 
• Synthesis of R4SB-X (42) 
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R4-COE (40, 0.20 g, 0.11 mmol) and SB-COE (32, 0.025 g, 0.07 mmol) were dissolved in 
TFE (0.4 mL) in a scintillation vial equipped with a stir bar and a septum, and degassed 
using 3 freeze-pump-thaw cycles. Separately, a solution of catalyst 26 was prepared in 
CH2Cl2 (50 mg/mL) and degassed. The catalyst solution (0.002 g, 0.0022 mmol, 0.04 mL) 
was added to the monomer, and the mixture was stirred for 2.5 h at room temperature under 
N2. Ethyl vinyl ether (0.10 mL, 0.075 g, 1.0 mmol) was added, and the mixture was stirred 
15 min and opened to air. The mixture was diluted with TFE (~1 mL), and precipitated into 
diethyl ether (40 mL). The precipitate was isolated by centrifugation (4000 rpm, 5 min), 
and dried under vacuum. A mixture of poly((Z)-cyclooct-4-ene-1-[R(Pbf)]4-co-SB-COE) 
and unreacted monomers, 40 and 32, was obtained as a yellow/brown solid. 1H NMR 
(500 MHz, DMSO-d6, δ): 58 % conversion (42d). SEC (DMF with 0.01 M LiCl, PMMA 
standards): Mn 41900 g/mol, Mw/Mn 1.52 (42d). The mixture of poly((Z)-cyclooct-4-ene-
1-[R(Pbf)]4-co-SB-COE), 40, and 32, (0.1 g) was dissolved in a trifluoroacetic 
acid/triisopropylsilane/water mixture (90/5/5 v/v/v) and stirred 3 h at room temperature to 
remove the Pbf groups. Following precipitation of the mixture into diethyl ether (40 mL) 
and centrifugation (4000 rpm, 5 min), the product was isolated by dialysis in a 6-8 kDa 
molecular weight cut-off membrane in water (1x), 30 % acetic acid (1x), and water (3x). 
Subsequent lyophilization afforded R4SB-X (42), where X denotes mol % SB, as white 
powders (5-20 mg). 1H NMR (500 MHz, D2O, δ): 5.33 (br, 2H from R4 and 2H from SB), 
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4.26 (br, 3H from R4), 4.06 (br, 1H from R4), 3.62 (br m, 2H from SB), 3.49 (br m, 2H 
from SB), 3.41 (br m, 2H from SB), 3.12 (br, 8H from R4 and 6H from SB), 2.92 (m, 2H 
from SB), 1.07-2.47 (br m, 39 H from R4 and 13H from SB);13C NMR (125 MHz, D2O, 
δ): 181.36, 179.39, 178.08, 173.61, 156.61, 130.69, 60.60, 61.37, 54.83, 53.41, 51.13, 
47.19, 45.88, 40.57, 32.90, 32.26, 31.92, 30.01, 28.63, 28.33, 28.18, 26.68, 24.69, 24.47, 
24.35, 23.19, 18.21. SEC (TFE with 0.02 M NaTFAc, PMMA standards): Mn 44300 g/mol, 
Mw/Mn 1.31 (42d).  
• Synthesis of R4rNLS-X (43) 
 
R4-COE (40, 0.098 g, 0.055 mmol) and rNLS-COE (24, 0.092 g, 0.055 mmol) were 
dissolved in TFE (0.4 mL) in a scintillation vial equipped with a stir bar and a septum, and 
degassed using 3 freeze-pump-thaw cycles. Separately, a solution of catalyst 26 was 
prepared in CH2Cl2 (50 mg/mL) and degassed. The catalyst solution (0.002 g, 0.0022 
mmol, 0.04 mL) was added to the monomer, and the mixture was stirred for 2 h at room 
temperature under N2. Ethyl vinyl ether (0.10 mL, 0.075 g, 1.0 mmol) was added, and the 
mixture was stirred 1 h and opened to air. The mixture was diluted with TFE (~1 mL), and 
precipitated into diethyl ether (40 mL). The precipitate was isolated by centrifugation (4000 
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rpm, 5 min), and dried under vacuum. A mixture of poly((Z)-cyclooct-4-ene-1-[R(Pbf)]4-
co-(Z)-cyclooct-4-ene-1-VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P) and unreacted 
monomers, 40 and 24, was obtained as a yellow/brown solid. 1H NMR (500 MHz, DMSO-
d6, δ): 63 % conversion (43b). SEC (DMF with 0.01 M LiCl, PMMA standards): Mn 44500 
g/mol, Mw/Mn 1.54 (43b). The mixture of poly((Z)-cyclooct-4-ene-1-[R(Pbf)]4-co-(Z)-
cyclooct-4-ene-1-VK(Boc)R(Pbf)K(Boc)K(Boc)K(Boc)P), 40, and 24, (0.1 g) was 
dissolved in a trifluoroacetic acid/triisopropylsilane/water mixture (90/5/5 v/v/v) and 
stirred 3 h at room temperature to remove the Boc and Pbf groups. Following precipitation 
of the mixture into diethyl ether (40 mL) and centrifugation (4000 rpm, 5 min), the product 
was isolated by dialysis in a 6-8 kDa molecular weight cut-off membrane in water (1x), 30 
% acetic acid (1x), and water (3x). Subsequent lyophilization afforded R4SB-X (43), where 
X denotes mol % rNLS, as white powders (60-80 % yield). 1H NMR (500 MHz, D2O, δ): 
5.34 (br, 2H from R4 and 2H from rNLS), 4.37-4.58 (m, 1H from rNLS), 4.10-4.37 (br m, 
3H from R4 and 5H from rNLS), 4.06 (br, 1H from R4), 3.99 (br, 1H from rNLS), 3.73 (br 
m, 1H from rNLS), 3.57 (br m, 1H from rNLS), 3.13 (br, 8H from R4 and 2H from rNLS), 
2.94 (br m, 8H from rNLS), 1.04-2.48 (br m, 39H from R4 and 59H from rNLS), 0.87 (br 
m, 6H from rNLS); 13C NMR (125 MHz, D2O, δ): 180.02, 179.26, 178.69, 178.14, 173.83, 
173.56, 173.47, 173.29, 172.53, 170.80, 156.57, 130.84, 62.12, 59.45, 54.81, 53.66, 53.58, 
53.48, 53.35, 53.30, 53.15, 51.32, 50.92, 47.64, 47.09, 46.63, 46.02, 40.61, 40.47, 39.05, 
39.00, 32.36, 30.43, 29.85, 29.71, 29.27, 28.64, 28.23, 26.37, 26.28, 26.19, 24, 56, 24, 42, 
22.39, 22.06, 21.92, 21.79, 21.67, 18.51, 18.26, 10.49. SEC (TFE with 0.02 M NaTFAc, 
PMMA standards): Mn 47700 g/mol, Mw/Mn 1.32 (43b). 
• Synthesis of n-butenyl methacrylate (45) 
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45 was synthesized similarly as previously reported.7 3-buten-1-ol (6.8 g, 94 mmol) was 
dissolved in anhydrous CH2Cl2 (70 mL) in a dry 250 mL round bottom flask under N2(g). 
TEA (17 mL, 122 mmol) was added and the mixture cooled to 0 °C in an ice bath. 
Methacryoylchloride (11.8 g, 113 mmol) was added slowly, upon which TEA 
hydrochloride salt appeared. The reaction mixture was allowed to warm to room 
temperature, stirred under N2(g) overnight, and filtered through celite to remove the TEA 
hydrochloride salt. The filtrate was purified by column chromatography (silica gel, eluting 
in 10 % ethyl acetate hexanes), concentrated under reduced pressure, and dried under 
vacuum to yield 45 as a clear oil (11.6 g, 88 %). 1H NMR (500 MHz, CDCl3, δ): 6.09 (s, 
1H), 5.80 (m, 1H), 5.54 (m, 1H), 5.09 (m, 2H), 4.19 (t, 2H, J = 7.5 MHz), 2.42 (q, 2H, J = 
7.5 MHz), 1.93 (s, 3H).  
• Synthesis of butenyl-X (47) 
 
SBMA (44, 2 g, 7.16 mmol), n-butenyl methacrylate (0.18 g, 1.23 mmol), 46 (46, 0.02 g, 
0.07 mmol), and ACVA (0.002 g, 0.007 mmol) were added to a 10 mL 2 neck round-
bottom flask, equipped with a stir bar, septum and a gas inlet, then dissolved in TFE at 0.5 
g/mL. The monomer solution was degassed using three freeze-pump-thaw cycles, 
immersed in an oil bath at 70 °C, and stirred under N2(g) for 12 h. The flask was opened to 
air and immersed in liquid N2 to quench the polymerization. The polymer solution was 
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diluted with brine (~2-3 mL), then precipitated into acetone (500 mL) to remove residual 
butenyl methacrylate. The acetone was decanted and the precipitate redissolved in brine. 
The polymer was dialyzed against a 3.5 kDa MWCO membrane in water, and lyophilized 
to afford a light pink powder in 54 % yield. Yields are calculated as (mass of polymer after 
lyophilization/mass of monomer employed in the polymerization) x 100 %. 1H NMR (500 
MHz, 0.2 M NaCl D2O, δ): 8.19-7.55 (br m, 5H from DTB), 6.08-5.87 (s, 1H from butenyl 
methacrylate), 5.41-5.11 (s, 2H from butenyl methacrylate), 4.70-4.29 (s, 2H from SBMA), 
4.26-4.05 (s, 2H from butenyl methacrylate), 3.87 (s, 2H from SBMA), 3.66 (s, 2H from 
SBMA), 3.30 (s, 6H from SBMA), 3.04 (s, 2H from SBMA), 2.66-0.57 (br m, 7H from 
SBMA and 7H from butenyl methacrylate); 13C NMR (125 MHz, 0.2 M NaCl D2O, δ): 
179.4, 178.1, 177.4, 135.1, 117.7, 65.3, 63.4, 62.3, 59.2, 53.3, 51.5, 47.5, 45.1, 32.0, 19.6, 
19.0, 18.5. SEC (TFE with 0.02 M NaTFAc, PMMA standards): Mn 26600 g/mol, Mw/Mn 
1.15(47d). 
• Synthesis of allylSBMA (51) 
 
51 was synthesized by C. Chang as previously reported.8 
• Synthesis of allyl-SB-X (52) 
 
52 was synthesized by C. Chang as previously reported.8 
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• Synthesis of alkyne-SB-X (53) 
 
53 was synthesized by C. Chang as previously reported.8 
• Synthesis of STS (57) 
 
STS (57) was synthesized by C. Santa. Sodium thiomethoxide (3.4 g, 49 mmol) was 
dissolved in dry THF (40 mL). The solution was immersed in an ice bath and 4-vinylbenzyl 
chloride (55, 6.3 g, 37 mmol) was added dropwise. The reaction was allowed to warm to 
room temperature and stirred for 20 h. The mixture was concentrated under vacuum to 
afford 56 as a yellow oil (96% yield). 1H NMR (500 MHZ, CDCl3, δ): 7.4 (d, J = 8.11 Hz, 
2H), 7.29 (d, J = 8.23 Hz, 2H) 6.74 (dd, J = 10.89, 17.58 Hz, 1H) 5.77 (d, J = 17.61 Hz, 
1H), 5.27 (d, J = 10.88 Hz, 1H), 3.70 (s, 2H), 2.02 (s, 3H); 13C NMR (500 MHZ, CDCl3, 
δ): 137.9, 136.5, 136.3, 129.1, 126.3, 113.7, 38.1, 14.9. Subsequently, 4-vinylbenzyl 
methyl sulfide  (56, 4.5 g, 27 mmol) was dissolved in anhydrous acetonitrile (25 mL). BHT 
(0.25 g, 1.13 mmol) was added to this solution, followed by 1,3-propanesultone (31, 16.6 
g, 136 mmol). The mixture was stirred at room temperature until a homogeneous solution 
was formed, and then it was immersed in an oil bath preheated to 50 °C and stirred for 67 
h. Upon cooling to room temperature 57 precipitates as a white solid, which was isolated 
by centrifugation and washing with THF and ether, then dried under vacuum (5.2 g, 67% 
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yield). 1H NMR (500 MHz, D2O, δ): 7.60 (d, J = 7.9 Hz, 2H, ArH), 7.49 (d, J = 7.9 Hz, 
2H, ArH), 6.83 (dd, J = 17.6, 10.9 Hz, 1H Ar-CH=), 5.96 (d, J = 17.6 Hz, 1H, CH2=), 5.45 
(d, J = 10.9 Hz, 1H, CH2=), 4.70 (d, J = 13.2 Hz, 1H, Ar-CH2-S+), 4.63 (d, J = 13.2 Hz, 
1H, Ha or Hb of Ar-CH2-S+), 3.47 (ddd, J = 13.1, 9.2, 6.6 Hz, 1H, CH2-S+), 3.37 (ddd, J = 
13.0, 9.2, 6.2 Hz, 1H, CH2-S+), 3.12 (t, J = 7.4 Hz, 2H, -CH2-SO3-), 2.84 (s, 3H, CH3-S+), 
2.20 (m, 2H, -CH2-); 13C NMR (125 MHz, D2O, δ): 139.23, 135.85, 131.20, 127.32, 
125.82, 116.15, 48.76, 45.47, 39.49, 21.50, 19.49.  ESI-MS (m/z): [M+H]+ calculated from 
C13H18O3S2, 287.08; found, 287.09.	
• Synthesis of polySTS (59) 
 
PolySTS (59) was synthesized by C. Santa. STS (57, 0.5 g, 1.7 mmol), 4-cyano-4-
[(dodecylsulfanylthiocarbonyl)sulfanyl] pentanoic acid (58, 17.7 mg, 0.044 mmol), and 
ACVA (2.5 mg, 0.0088 mmol) were added to a 20 mL glass vial equipped with a rubber 
septum and a magnetic stirring bar. The solids were dissolved in TFE (1 mL) and purged 
with N2(g) for at least 30 min. The degassed solution was immersed in an oil bath preheated 
to 70 °C and after 15 h, the reaction was quenched by immersing the vial in liquid nitrogen. 
1H NMR (500 MHz, D2O with 0.5 M NaClO4, δ): Conversion = 95 % (59a). The 
polymerization solution was diluted in 0.5 M NaNO3(aq) (15 mL) and dialyzed in a 3.5 kDA 
MWCO membrane against 0.5 M NaNO3(aq) to remove unreacted monomer and TFE, and 
then against water to remove the salt. PolySTS (59) was recovered as a yellow solid by 
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lyophilization (430 mg, 86 %, 59a). 1H NMR (500 MHz, TFE-d3, δ): 7.24 (ArH), 6.62 
(ArH) 4.57 (Ar-CH2-S+), 3.49 (CH2-S+), 3.05 (CH3-SO3-), 2.73 (CH3-S+), 2.29 (CH2), 0.8-
2.00 (CH2 and CH backbone), 1.32 and 0.9ppm (CH3 and CH2 end group signals). SEC 
(TFE with 0.02 M NaTFAc, PMMA standards): Mn 8800 g/mol, Mw/Mn 1.20 (59a). 
• Synthesis of polySBS (60) 
 
PolySBS (60) was synthesized by C. Santa following a previously reported procedure.9 
• Preparation of N/P 200 polymer stock solutions 
The N/P ratio is defined as the ratio of protonatable nitrogens on the polymer: DNA 
phosphates, and is calculated as shown below:   
N/P = (mpolymer/mDNA)*(MDNA /Mp)*(NRU/PRU) = 200 
mp = mass of polymer (g) 
mDNA = mass of DNA (g) 
Mp = molecular weight per repeat unit on polymer  
MDNA = average molecular weight per repeat unit on DNA = 330 g/mol 
NRU = protonatable amines per repeat unit polymer  
PRU  = phosphates per repeat unit DNA = 1 
mp/mDNA (g polymer/g DNA) = N/P*(Mp/MDNA)*(PRU/NRU) 
In experiments, polymer solution at a given N/P ratio is mixed with DNA solution 
at 0.02 g/L (1/1 volume/volume).  
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[polymer] (g/L) = (mp/mDNA)*[DNA]  
        = (mp/mDNA)*0.02  
V (mL) = 0.001mp/[polymer] 
Polymer (mp) was added to an Eppendorf tube (1.5 mL) and dissolved in water (1 mL, 
DNase-free water filtered through polyether sulfone (PES) filters with a 0.45 µm pore size). 
Add (V-1) mL to a 15 mL centrifuge tube. The polymer solution in the eppendorf tube was 
mixed with the water in the 15 mL centrifuge tube to obtain the desired solution volume 
and polymer concentration of V and [polymer], respectively.  This solution was filtered 
through a PES filter with a pore size of 0.45 µm into a second 15 mL centrifuge tube, and 
aliquotted into 1.5 mL eppendorf tubes (~1 mL per aliquot). The stocks were stored at 4 
°C when in use, at -20 °C for long term storage. 
Example N/P calculation for polymer 28 (5 mg):  
N/P = (mpolymer/mDNA)*(MDNA /Mp)*(NRU/PRU) = 200 
mp = mass of polymer = 0.005 g 
mDNA = mass of DNA (g) 
Mp = molecular weight per repeat unit on polymer = 1341.59 g/mol 
MDNA = average molecular weight per repeat unit on DNA = 330 g/mol 
While there are 5 basic residues per repeat unit of 28, we assume there are 4 
protonatable amines per repeat unit due to the carboxylate group on the end of each 
graft. 
NRU = protonatable amines per repeat unit polymer = 4 
PRU  = phosphates per repeat unit DNA = 1 
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mp/mDNA = N/P*(Mp/MDNA)*(PRU/NRU) = 200*(1341.59/330)*(1/4) = 203.27 g 
polymer/g DNA 
[polymer] = (mp/mDNA)*[DNA] = (203.27 g polymer/g DNA)* 0.02 g DNA/ L 
water = 4.07 g/L polymer  
V = mp/[polymer] = 0.005 g/4.07 g/L = 0.0012 L = 1.2 mL  
Therefore, 1.2 mL water is required for dissolving 5 mg polymer at N/P 200. 
• Polyplex formation Picogreen® assay:  
Polymer solutions (N/P 10, 1 mL) were prepared from N/P 200 stock solutions by mixing 
N/P 200 solution (0.05 mL) and DNase-free water (0.95 mL). Polymer solution (N/P 10, 
100 µL) and DNase-free water (80 µL) were added to a 1.5 mL Eppendorf tube. 
Picogreen® (10 X, 40 µL), DNA solution (20 µL, 0.2 µg/µL), and DNase-free water (140 
µL) were added to the Eppendorf tube, and the mixture added 3 wells of a 96 well plate 
(100 µL/well). As a positive control (100 % accessible DNA), Picogreen® (10 X, 40 µL), 
DNA solution (20 µL, 0.2 µg/µL), and DNase-free water (340 µL) were added to an 
Eppendorf tube, and the mixture added 3 wells of a 96 well plate (100 µL/well). This 
formulation was selected such that polyplexes were formed at N/P 5 (1/1 v/v N/P 5 polymer 
solution/ DNA solution @ 0.02 µg/µL) in the presence of 1 X Picogreen®. As a blank (no 
DNA or polymer), Picogreen® (10 X, 40 µL) and DNase-free water (360 µL) were added 
to an Eppendorf tube, and the mixture added 3 wells of a 96 well plate (100 µL/well). The 
plate was incubated at 37 °C and the fluorescence intensity (wavelengths) of the wells was 
measured at predetermined time points for 16 h on a plate reader in fluorescence mode 
(BMG Labtech FLUOstar OPTIMA plate reader), with the gain set to 1130. The relative 
percentage of DNA accessible to Picogreen ® dye was calculated as the (fluorescence from 
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each well-fluorescence of blank)/(fluorescence of the positive control-fluorescence of 
blank) x 100 %. The percentage of DNA accessible to Picogreen® as a function of time 
after polyplex incubation with Picogreen® was averaged over the three wells to correct for 
pipetting error. The average was reported as (PG fluorescence/PG fluorescence*) x 100 %, 
where PG fluorescence* is the Picogreen® fluorescence in the absence of polymer 
(positive control). The error bars represent the standard deviation of the fluorescence of the 
three wells. 
• Atomic force microscopy of polyplexes 
Mica substrates (Muscovite Mica, 25 mm x 25 mm, thickness: 0.26-0.31 mm, Electron 
Microscopy Sciences) were prepared by adhering mica to glass slides using fast dry nail 
enamel (Maybelline). Polymer solution at a given N/P ratio (400 µL) and DNA solution 
(400 µL, 0.02 µg/µL) were added to a polystyrene transfection tube, and the mixture 
equilibrated for 40 min at room temperature. Mica was freshly cleaved twice with ScotchTM 
tape. Polyplex solution (400-600 µL) was dispersed onto the freshly cleaved mica sheet 
such that liquid covered the entire surface. The substrates were allowed to stand 10-15 min 
to allow polyplex adsorption, then rinsed with DNase-free water (10 mL, filtered through 
a 0.45 µm PES filter). Excess water was removed by tilting the subsrate onto filter paper, 
and touching the edges of the mica to the filter paper to remove water between the mica 
and glass slide. The substrates were then dried with N2(g) (filtered through a 0. 45 µm PES 
filter) and imaged on a Digital Instruments Dimension 3100 atomic force microscope in 
tapping mode.  The tip velocity was 10-20 µm/s and the imaging area 1-5 µm2. Line-wise 
leveling was applied by SPIP 6.0.6 software for Windows. The size distribution of 
polyplexes was determined using color thresholding in ImageJ software to provide the area 
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(A) for each particle (nm2). Polyplex diameters (d) were then calculated from the area 
according to d (nm) = 2 (A/π). 
• Atomic force microscopy of polyplexes following incubation with DMEM (1X) 
Polymer solution at N/P 4 (400 µL) and DNA solution (400 µL, 0.02 µg/µL) were added 
to a polystyrene transfection tube, and the mixture equilibrated for 40 min at room 
temperature. DMEM (10 X, 0.1 mL) and water (0.1 mL) were added to the polyplex 
solution, which was then incubated 12 h at 37 °C. Polyplex solution (400-600 µL) was 
dispersed onto a freshly cleaved mica sheet such that liquid covered the entire surface. The 
substrates were allowed to stand 10-15 min to allow polyplex adsorption, then rinsed with 
DNase-free water (10 mL, filtered through a 0.45 µm PES filter). Excess water was 
removed by tilting the subsrate onto filter paper, and touching the edges of the mica to the 
filter paper to remove water between the mica and glass slide. The substrates were then 
dried with N2(g) (filtered through a 0. 45 µm PES filter) and imaged on a Digital Instrument 
Dimension 3100 atomic force microscope in tapping mode at 1 Hz.  The tip velocity was 
10-20 µm/s and the imaging area was 5 µm2. Line-wise leveling was applied by SPIP 6.0.6 
software for Windows.   
• Dynamic light scattering (DLS) and zeta potential measurements of polyplexes 
Polyplexes were formed by mixing polymer solution at a given N/P ratio (400 µL) with 
DNA solution (0.02 µg/µL) in a polystyrene transfection tube, and allowing the solution to 
equilibrate 40 minutes at room temperature. DNase-free water (0.1 mL) and 100 mM 
NaCl(aq) were added to the polyplex solution, which was then transferred to zeta potential 
measurement cells (DTS 1070, Malvern Instruments Ltd). Polyplex size (hydrodynamic 
diameter, Dh) and zeta potential measurements were acquired on a Malvern Zetasizer 
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NanoZS. Polyplex diameters represent the mean intensity-average size over three 
measurements on the same solution, with at least 12 runs per measurement. was measured 
by DLS, and the intensity-average size reported. Zeta potentials were calculated from the 
electrophoretic mobility using the Smoluchowski approximation and were reported as the 
mean over three measurements on the same solution, with at least 12 runs per measurement. 
• Evaluation of polyplex stability in the presence of salt and/or serum using 
dynamic light scattering (DLS) 
Polyplexes (N/P 4) were formed by mixing polymer solution (N/P 4, 400 µL) with DNA 
solution (0.02 µg/µL, 400 µL) in a polystyrene transfection tube, and allowing the solution 
to equilibrate 40 minutes at room temperature. DMEM (10X, 0.1 mL) and FBS (0.1 mL) 
were added to the polyplex solution, which was then transferred to zeta potential 
measurement cells (DTS 1070, Malvern Instruments Ltd). Polyplex size (hydrodynamic 
diameter, Dh) measurements were acquired on a Malvern Zetasizer NanoZS immediately 
after addition of salt and serum to polyplexes, and then every 12 h for 48 h. Polyplex 
diameters represent the mean intensity-average size over three measurements on the same 
solution, with at least 12 runs per measurement. was measured by DLS, and the intensity-
average size reported. Two set of control experiments were performed in which (1) FBS 
(0.1 mL) and water (0.1 mL), and (2) DMEM (10X, 0.1 mL) and water (0.1 mL) were 
added to polyplexes after formation. 
• Heparin-induced polyplex decomplexation Picogreen® assay 
Polymer solutions (N/P 10, 1 mL) were prepared from N/P 200 stock solutions by mixing 
N/P 200 solution (0.05 mL) and DNase-free water (0.95 mL). Polymer solution (N/P 10, 
100 µL) and DNase-free water (80 µL) were added to a 1.5 mL Eppendorf tube. DNA 
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solution (20 µL, 0.2 µg/µL) was added, and the mixture allowed to stand 40 minutes at 
room temperature to form polyplexes. Picogreen® (10 X, 40 µL), heparin (20 µL, 2 
units/µL), and DNase-free water (140 µL) were added to the Eppendorf tube, and the 
mixture added 3 wells of a 96 well plate (100 µL/well). This formulation was selected such 
that polyplexes were formed at N/P 5 (1/1 v/v N/P 5 polymer solution/ DNA solution @ 
0.02 µg/µL) in the presence of heparin (40 units) and 1 X Picogreen®. As a positive control 
(100 % accessible DNA), DNA solution (20 µL, 0.2 µg/µL), Picogreen® (10 X, 40 µL), 
heparin (20 µL, 2 units/µL), and DNase-free water (320 µL) were added to an Eppendorf 
tube, and the mixture added 3 wells of a 96 well plate (100 µL/well). As a blank (no DNA 
or polymer), Picogreen® (10 X, 40 µL), heparin (20 µL, 2 units/µL), and DNase-free water 
(340 µL) were added to an Eppendorf tube, and the mixture added 3 wells of a 96 well 
plate (100 µL/well). The was incubated at 37 °C and the fluorescence intensity 
(wavelengths) of the wells was measured at predetermined time points for 16 h on a plate 
reader in fluorescence mode (BMG Labtech FLUOstar OPTIMA plate reader), with the 
gain set to 1130. The relative percentage of DNA accessible to Picogreen ® dye was 
calculated as the (fluorescence from each well-fluorescence of blank)/(fluorescence of the 
positive control-fluorescence of blank) x 100 %. The relative percentage of DNA 
accessible to Picogreen® 16 h after polyplex incubation with Picogreen® and heparin was 
averaged over the three wells (to correct for pipetting error) from three experiments 
performed on different days and is reported as (PG fluorescence/PG fluorescence*) x 100 
%, where PG fluorescence* is the Picogreen® fluorescence in the absence of polymer 
(positive control). The error bars represent the standard deviation of the average of the 
three experiments. 
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• Quantitative PCR (qPCR) 
Dr. Sangram Parelkar in the Emrick group performed qPCR to determine the number of 
plasmids per cell and per nucleus 24 h after the addition of polyplexes (N/P 5.3) to SKOV3 
cells, as previously reported.10 
• Transfection experiments in SKOV3 cells 
Culture and transfection of SKOV3 cells was performed by Dr. Sangram Parelkar in the 
Emrick group, as previously reported.10 
• Ultrasound-mediated gene delivery in mice 
Evaluation of the transfection performance of polyplexes formed from 8c and 9d was 
performed by Olga Zolochevska and Jayne Ellis in Professor Marxa Figueiredo’s 
laboratory (University of Texas Medical Branch, Galveston, TX) by intramuscular 
ultrasound-mediated delivery as previously reported.10  
• Preparation of oil-in-water droplets 
Polymer (1 mL, 1 mg/mL in water) and oil (1,2,4-trichlorobenzene (TCB) or benzene, 0.2 
mL) were added to a 7 mL vial, which was hand-shaken to form TCB-in-water droplets.  
• Optical microscopy of oil-in-water droplets 
Droplets were imaged using an inverted optical microscope (Zeiss Axiovert 200) equipped 
with a QImaging camera (Retiga-2000R Fast 1394 Mono Cooled). Images were acquired 
in bright field mode with the condenser aperture diaphragm completely open. 
• Salt-triggered disruption of oil-in-water droplets 
TCB-in-water droplets were formed from polymer solutions (1 mg/mL in water) and TCB 
as described above. The droplet solution was photographed immediately after formation 
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and ~12 h after formation, at which point 1 M NaCl(aq) (0.1 mL) was added. The droplet 
solution was photographed ~12 h after addition of 1 M NaCl(aq).  
• Temperature-triggered disruption of oil-in-water droplets 
TCB-in-water droplets were formed from 12 as described above in two separate vials. The 
droplet solution was photographed immediately after formation. One vial was kept at room 
temperature, while the other was immersed in a 20 °C water bath. The water bath was 
immediately set to 30 °C, and the droplet solutions allowed 10 min to reach 30 °C and 
stabilize. The droplet solutions were removed from the water bath, photographed, and 
placed back into the water bath. This procedure was repeated for each temperature tested. 
The droplet solution stored at room temperature was photographed at the end of the 
experiment (2 h after formation). 
• Interfacial tension measurements 
Polymer solution (2-4 mL, 1 mg/mL in water) was added to a glass cuvette. TCB was 
dispensed into the solution from a glass syringe using a syringe pump. The droplet shape 
as a function of time was recorded using a Marlin F131b camera interfaced with MATLAB 
by a homebuilt program. The interfacial tension was determined every 20 s for 600 s by a 
MATLAB routine that iteratively solves the Laplace capillary equations to obtain a droplet 
shape that minimizes the error between the measured and fit droplet shapes.11 Inputs to the 
program include the density difference between the dispersed and continuous phases, the 
outer diameter of the needle used to dispense the drop (actual distance and distance in 
pixels), coordinates for the start of the drop on the image, a threshold grayscale value to 
separate the inside and outside of the drop, and two guesses for constants in the equation 
(i.e., the curvature of the drop at the origin = 1/300 to 1/160 pixels-2 and the capillary 
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constant = -1e-5 pixels-1). Equilibrium interfacial tension (γeq) was calculated by averaging 
the values from the interfacial tension determined at the 500-600 s time points and the error 
calculated by averaging the uncertainties determined at each of those time points. 
Equilibrium interfacial tension measurements of 64-DTB and 65-DTB were performed 
similarly by C. Santa. 
• Preparation of cross-linked oil-in-water droplets 
Polymer solution (1 mg/mL in water) was added to a 7 mL scintillation vial. Benzene 
solution (0.2 mL) containing dithiol 2,2’(ethylenedioxy)diethanethiol (2SH, 54) and 
photoinitiator 2,2-dimethoxy2-phenylacetophenone (DMPA) was added and the vial hand-
shaken ~10 s to form droplets. The vial was then placed on its side in a CL-100 Ultraviolet 
Crosslinker (Ultra-Violet Products) and irradiated at 365 nm (intensity = 100 mJ/cm2) for 
2 h. Solutions containing cross-linked oil-in-water droplets were drop-cast onto glass slides 
and allowed to dry uncovered in a fume hood for at least 8 h prior to imaging. Compositions 
of aqueous and benzene phases used to form the capsules in Figure 5.6 are listed below. 
Capsules from allyl-SB-50 (52b): Benzene containing 54 (0.12 mL, 5 mg/mL, 3.3 
µmol) and DMPA (0.02 mL, 5 mg/mL, 0.4 µmol) was added to an aqueous solution of 52b 
(1 mg, 1 mg/mL in water, 1.7 µmol alkene).  
Capsules from alkyne-SB-50 (53a): Benzene containing 54 (0.015 mL, 5 mg/mL, 
0.8 µmol) and DMPA (0.02 mL, 5 mg/mL, 0.4 µmol) was added to an aqueous solution of 
53a (1 mg, 1 mg/mL in water, 1.7 µmol alkyne).  
Control experiment with polySBMA (12, no alkene or alkyne groups): Benzene 
containing 54 (0.12 mL, 5 mg/mL, 3.3 µmol) and DMPA (0.02 mL, 5 mg/mL, 0.4 µmol) 
was added to an aqueous solution of 12 (1 mg, 1 mg/mL in water).  
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• Cloud point measurements 
Cloud point of 12, 64-DTB, and 65-DTB were measured by C. Santa on a Hitachi U-3010 
spectrophotometer spectrometer equipped with a t2 temperature-controlled cuvette holder 
and TC-1 temperature controller (Quantum northwest). The percent transmittance was 
measured at 550 nm while cooling the solutions at 1 °C/min. Cloud points are reported as 
the onset of the transmittance decrease. 
• Formation of adhesive droplets 
Polymer (59 or 60) and aqueous NaNO3 solution (0-0.5 M) were added to a 20 mL 
scintillation vial to yield polymer concentrations ranging from 0.25-10 mg/mL once 
dissolved. Vials containing polymer and aqueous NaNO3 were heated to 70 °C for 30 min-
1 h while stirring to disperse or dissolve the polymer in the aqueous NaNO3 solution. A 
vial of TCB was simultaneously heated to 70 °C. Using a plastic syringe, heated polymer 
solution (1 mL) was added to a 7 mL vial. Subsequently, TCB (0.2-4 mL) was dispensed 
into the vial of heated polymer solution using a glass syringe, and the vial shaken or 
vortexed to form droplets. Mixtures of polymer, NaNO3(aq), and TCB having >1 mL TCB 
per mL aqueous phase required longer vortexing times to form stable droplets. Droplets 
were photographed several times after formation to evaluate stability.  
• Confocal microscopy of adhesive droplets 
Polymer (59 or 60) and aqueous NaNO3 solution (0-0.5 M) were added to a 20 mL 
scintillation vial to yield polymer concentrations ranging from 0.5 mg/mL once dissolved. 
The vial containing polymer and aqueous NaNO3 was heated to 70 °C for 30 min-1 h while 
stirring to disperse or dissolve the polymer in the aqueous NaNO3 solution. A solution of 
Coumarin 153 (0.1 mg/mL in TCB) was prepared and heated to 70 °C. Using a plastic 
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syringe, heated polymer solution (1 mL) was added to a 7 mL vial. Subsequently, TCB (0.2 
mL) was dispensed into the vial of heated polymer solution using a glass syringe, and the 
vial shaken or vortexed to form droplets. A drop of emulsion solution was pipetted into the 
cavity of BRAND® cavity slides (76 x 26 x 1.2-1.5 mm, 1 concavity, Aldrich). A coverslip 
placed over the cavity and secured with tape to enclose the solution during imaging. 
Confocal microscopy was performed on a Leica SP2 laser scanning confocal microscope, 
using a 458/514 nm filter set and exciting with an Ar/HeNe laser (458 nm) at 49 % power. 
Fluorescence was collected between 470-500 nm. 
• Reaction of nucleophiles with polySTS on droplets 
A solution of polySTS (59) in 50 mM NaNO3(aq) (1 mg/mL) was prepared by adding 
polymer and 50 mM NaNO3(aq) to a 20 mL scintillation vial and heating to 70 °C for 30 
min while stirring. A vial of TCB was simultaneously heated to 70 °C. Heated polySTS 
solution (5 mL) and TCB (2 mL) were added to each of 6 vials, which were vortexed while 
cooling to form adhesive droplets. Solutions of mercaptopyrdine (61) and cysteine (62) 
were prepared in 50 mM NaNO3(aq) (10 mg/mL) and purged with N2(g). Mercaptopyridine, 
cysteine, or blank (i.e., 50 mM NaNO3(aq)) solutions were added to each of two vials of 
droplets in the amounts shown below.  The droplet solutions were adjusted as indicated 
below to pH 8.5 and 11.5 with NaOH(aq) and the vials photographed at several time points 
after addition of nucleophiles and base.  
 Droplet solution 1 (mercaptopyridine, pH 8.5) contains polySTS (59, 5 mL, 1 
mg/mL in 50 mM NaNO3(aq), 0.017 mmol STS), TCB (2 mL), 61 (1.9 mL, 10 mg/mL in 
50 mM NaNO3(aq), 0.17 mmol), NaOH (0.1 mL, 0.5 M in 25 mM NaNO3(aq)), and 50 mM 
NaNO3(aq) (3 mL).  
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Droplet solution 2 (mercaptopyridine, pH 11.5) contains polySTS (59, 5 mL, 1 
mg/mL in 50 mM NaNO3(aq), 0.017 mmol STS), TCB (2 mL), 61 (1.9 mL, 10 mg/mL in 
50 mM NaNO3(aq), 0.17 mmol), NaOH (0.3 mL, 0.5 M in 25 mM NaNO3(aq)), and 50 mM 
NaNO3(aq) (2.8 mL). 
Droplet solution 3 (cysteine, pH 8.5) contains polySTS (59, 5 mL, 1 mg/mL in 50 
mM NaNO3(aq), 0.017 mmol STS), TCB (2 mL), 62 (2.1 mL, 10 mg/mL in 50 mM 
NaNO3(aq), 0.17 mmol), NaOH (0.2 mL, 0.5 M in 25 mM NaNO3(aq)), and 50 mM NaNO3(aq) 
(2.7 mL). 
Droplet solution 4 (cysteine, pH 11.5) contains polySTS (59, 5 mL, 1 mg/mL in 50 
mM NaNO3(aq), 0.017 mmol STS), TCB (2 mL), 62 (2.1 mL, 10 mg/mL in 50 mM 
NaNO3(aq), 0.17 mmol), NaOH (0.4 mL, 0.5 M in 25 mM NaNO3(aq)), and 50 mM NaNO3(aq) 
(2.5 mL). 
Droplet solution 5 (blank, pH 8.5) contains polySTS (59, 5 mL, 1 mg/mL in 50 mM 
NaNO3(aq), 0.017 mmol STS), TCB (2 mL), and 50 mM NaNO3(aq) (5 mL). 
Droplet solution 6 (blank, pH 11.5) contains polySTS (59, 5 mL, 1 mg/mL in 50 
mM NaNO3(aq), 0.017 mmol STS), TCB (2 mL), NaOH (0.05 mL, 0.5 M in 25 mM 
NaNO3(aq)), and 50 mM NaNO3(aq) (4.95 mL). 
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APPENDIX 
PICOGREEN® ASSAYS FOR EVALUATION OF POLYMER-DNA BINDING 
A.1 Introduction 
DNA binding reagents, such as Hoechst 33258, ethidium bromide, and YOYO-1, 
that fluoresce brightly upon binding DNA are used for the quantification and visualization 
of DNA for research, medicine, and forensic purposes.1,2 In developing transfection 
reagents, DNA binding reagents are used to characterize the complexation of DNA by 
cationic polymers and lipids.3–9 The Picogreen double stranded DNA was found to be 
particularly useful in DNA quantification assays due to its greater sensitivity relative to 
other DNA binding reagents and ability to detect DNA over large concentration ranges.2 
As shown in Figure A.1, Picogreen binds strongly to DNA by electrostatic interaction of 
the cationic benzothiazol group with the phosphate anions on DNA, interaction of 
dimethylamines with the minor grooves of DNA, and by intercalation of the quinolinium 
group on Picogreen with DNA.2,10,11 Upon binding double-stranded DNA, Picogreen 
undergoes a substantial fluorescence enhancement. The fluorescence intensity of Picogreen 
when bound to double-stranded DNA is >1000 times greater than in the unbound state.2,10 
Additionally, the fluorescence of Picogreen in the unbound state is lower than similar DNA 
reagents, increasing its appeal for use in DNA quantification assays.2 
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Figure A.1 Structure of the Picogreen double-stranded DNA reagent, showing 
contributions of the different moieties to DNA binding and intercalation. 
 
Singer and coworkers developed a DNA quantification assay using the DNA 
binding-induced fluorescence enhancement property of the Picogreen dye.2 Picogreen was 
mixed with DNA at different concentrations, and the fluorescence at 520 nm upon 
excitation at 480 nm plotted as a function of DNA concentration. From each fluorescence 
measurement, the fluorescence of a solution of Picogreen in the absence of DNA was 
subtracted as a blank. Linear plots were obtained over a large range of DNA concentrations, 
from 25 pg/mL – 1 µg/mL. DNA quantification was possible in solutions with salt 
concentrations up to 1 M NaCl(aq). An optimal Picogreen concentration of 0.8 µM was 
identified. Higher Picogreen concentrations allowed quantification of DNA at higher 
concentrations, however with reduced sensitivity.  In addition to sodium chloride, the effect 
of a range of additives normally used in DNA isolation was investigated, and sodium 
dodecyl sulfate was among the compounds found to alter the fluorescence vs. DNA 
concentration plots. However, the authors suggest that the effects of contaminants can be 
compensated for by including the contaminent in the blank sample (without DNA). 
Heparin, an anionic biopolymer, was found to compete with DNA for binding Picogreen, 
which suggests its use in competitive binding assays. 
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This DNA quantification assay was adapted by gene therapy researchers to study 
polymer-DNA complexation.3–5 For example, Choi et al. studied the polyplexes formed 
from polyacrylamidoamine dendrimers and DNA.5 In their experiments, polyplexes were 
formed by mixing solutions of polymer and DNA at various charge ratios. After 
equilibration for 30 minutes to allow polyplex formation, Picogreen was added to 
determine the amount of uncomplexed DNA. Negligible fluorescence intensities were 
observed at charge ratios greater than 2, indicating complexation of DNA by the polymers. 
While this assay is useful to demonstrate the formation of polyplexes, it does not provide 
information about polyplex binding strength beyond the charge ratio needed to prevent 
access of Picogreen to DNA. In a modification of the Picogreen assay, Tsai and coworkers 
used heparin to restore Picogreen fluorescence after complexation of DNA by a cationic 
lipid.4  Like Singer et al., they found that addition of heparin to Picogreen in the absence 
of DNA produced a fluorescence enhancement and corrected for this by adding heparin to 
the blank solution.  
This thesis includes Picogreen assays performed in the presence and absence of 
heparin to gauge polyplex formation and heparin-induced polyplex decomplexation 
(Figure A.2). For these experiments, the Quant-iT Picogreen® double stranded DNA 
reagent from Invitrogen is used, and the fluorescence is collected at 520 nm upon excitation 
at 480 nm. In the polyplex formation assay, cationic polymer is added to a mixture of DNA 
and Picogreen, and the fluorescence intensity decreases as polymer complexes DNA and 
prevents Picogreen access (Figure A.2a). The Picogreen fluorescence in the absence of 
polymer is measured as a positive control and the fluorescence in the absence of polymer 
and DNA (Picogreen only) is subtracted from all measurements as a blank. The plot in 
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Figure A.2c of (PG fluorescence/PG fluorescence*) x 100 %, where PG fluroescnece* is 
the Picogreen fluorescence in the absence of polymer, provides a measure of the percentage 
of DNA accessible to Picogreen upon addition of poly(5-tetralysine-1-cyclooctene) to a 
mixture of plasmid DNA (mRFP-IRES-Puro, 4.5 kBp, N/P 3.8) and Picogreen as a function 
of time. As polymer competes with Picogreen and binds DNA, the Picogreen fluorescence 
decreases and plateaus at ~15 %. The heparin-induced polyplex decomplexation assay 
involves the addition of heparin and Picogreen to a solution of polyplexes formed by 
mixing solutions of polymer and DNA at a given N/P ratio for 40 minutes. An example of 
this assay is shown in Figure 2d, wherein polyplexes formed from poly(5-tetralysine-1-
cyclooctene) and plasmid DNA (mRFP-IRES-Puro, 4.5 kBp, N/P 3.8) were incubated with 
Picogreen and heparin (40 units, 0.1 units/µL), and (PG fluorescence/PG fluorescence*) x 
100 % plotted as a function of time. The heparin-induced decomplexation assay provides 
a relative, rather than an absolute, measure of DNA accessible to Picogreen since heparin 
competes with DNA for binding with the polymer and with Picogreen. Both the polyplex 
formation and decomplexation assays are performed on a plate reader in fluorescence 
mode, where each mixture is divided into three different wells of a 96 well plate to account 
for pipetting error, and the average DNA accessibility determined. To ensure there is 
enough solution to fill three wells, each mixture is prepared to fill four wells. In most cases, 
the DNA accessibility is reported as the average and standard deviation of three 
independent experiments. This appendix describes the impacts of several experimental 
parameters, including reagent concentrations and the order of reagent addition, on the 
resulting DNA accessibility values. It is intended to aid in interpretation of data obtained 
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from these experiments presented throughout this thesis to evaluate polymer-DNA binding 
and to provide guidance to other researchers performing similar experiments.  
 
Figure A.2 Fluorescence microplate DNA binding assays using the Quant-it Picogreen® 
double-stranded DNA reagent (1X). Schematics of the polyplex formation assay (a) and 
heparin-induced polyplex decomplexation assay (b). Examples of the polyplex formation 
(c) and heparin-induced polyplex decomplexation (d) assays performed with poly(5-
tetralysine-1-cyclooctene) and plasmid DNA (mRFP-IRES-Puro, 4.5 kBp) at N/P 3.8. 
The heparin concentration in (d) is 0.1 units/µL (40 units, 10 units/well). Instrument gain 
= 1130. Points indicate the average and standard deviation of 3 wells from one 
experiment. 
 
A.2 Polyplex formation procedure: effects of the order of reagent addition 
Given that Picogreen binds strongly with DNA, it is possible that addition of 
cationic polymer to Picogreen-DNA complexes might limit the amount of polymer-DNA 
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binding, compared as compared to addition of DNA to a mixture of polymer and 
Picogreen. To determine whether reagent addition order impacts the results of these 
assays, an experiment was performed to compare polyplex formation experiments in 
which (1) polymer was added to a mixture of DNA and Picogreen (Figure A.3, black 
trace) and (2) DNA was added to a mixture of polymer and Picogreen (Figure A.3, red 
trace). The plots of (PG fluorescence/PG fluorescence*) x 100 % as a function of time 
during the complexation of poly(5-tetralysine-1-cyclooctene) and plasmid DNA (mRFP-
IRES-Puro, 4.5 kBp, N/P 3.8) in the presence of Picogreen® (1X) using the two different 
procedures are nearly identical, well within the measurement error. From these 
experiments, it is evident that the order of reagent addition does not impact the results 
obtained from this assay. 
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Figure A.3 Effect of reagent addition order on the percentage of DNA accessible to 
Picogreen®.  Plot of (PG fluorescence/PG fluorescence*) x 100 % as a function of time 
for during the complexation of poly(5-tetralysine-1-cyclooctene) and plasmid DNA 
(mRFP-IRES-Puro, 4.5 kBp, N/P 3.8) in the presence of Picogreen® (1X), where 
polymer was added to DNA and Picogreen (PG) (black trace) and DNA was added to 
polymer and PG (red trace). Points indicate the mean and standard deviation of three 
wells from one experiment and instrument gain = 1130. 
 
A.3 Competition between polymer and Picogreen for DNA binding 
To determine the impact of Picogreen on polymer-DNA binding, polyplexes were 
formed from poly(5-tetralysine-1-cyclooctene) and plasmid DNA (mRFP-IRES-Puro, 4.5 
kBp, N/P 3.8) in the presence and absence of Picogreen, and then evaluated using the 
heparin-induced polyplex decomplexation assay. Figure A.4 shows (PG fluorescence/PG 
fluorescence*) x 100 % for (1) polyplexes formed in the presence of Picogreen® (1X) for 
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40 minutes followed by the addition of heparin (5 µL, 10 units) and water (10 µL) to each 
well and (2) polyplexes formed in the absence of Picogreen followed by the addition of 
heparin (5 µL, 10 units) and Picogreen (10X, 10 µL) to each well. Polyplexes formed 
without Picogreen showed lower percentages of DNA accessible to Picogreen throughout 
the duration of the assay compared to polyplexes formed in the presence of Picogreen. 
These results indicate that Picogreen competes strongly with polymer for binding DNA, 
and therefore the results from the polyplex formation assay should not be interpreted as the 
percentage of accessible DNA in polyplexes, but rather as a second competitive binding 
assay to complement the heparin-induced complexation in which heparin and DNA 
compete for polymer binding. To determine the percentage of DNA accessible in the 
polyplex in the absence of competing reagents, Picogreen can be added to the polyplexes 
in the absence of heparin as done by Choi and coworkers.5 However, as mentioned in the 
introduction, the addition of a reagent that competes for binding with polymer or DNA 
allows the comparison of the DNA binding strengths of different polymers within 
polyplexes that fully complex DNA (i.e., such as those by Choi and coworkers for 
polyplexes with charge ratios greater than 4).5 Since polyplexes that complex DNA fully 
are desired to protect of DNA during delivery, these competitive binding assays are 
advantageous for the evaluation of DNA binding strength in polyplexes with charge ratios 
similar to those used in transfection experiments.  
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Figure A.4 Effect of Picogreen® competition with polymer for binding DNA.  Plot of 
(PG fluorescence/PG fluorescence*) x 100 % as a function of time after addition of 
heparin (5 µL/well, 10 units/well) and water (10 µL/well) to polyplexes formed in the 
presence of Picogreen (black trace) and after addition of heparin (5 µL/well, 10 
units/well) and Picogreen (10 units, 10 µL/well) to polyplexes formed in the absence of 
Picogreen (red trace). Polyplexes for these experiments were formed from poly(5-
tetralysine-1-cyclooctene) (N/P 3.8) and plasmid DNA (mRFP-IRES-Puro, 4.5 kBp). 
Points indicate the mean and standard deviation of three wells from one experiment and 
instrument gain = 1130. 
 
A.4 Effect of polymer and DNA concentration on polyplex binding strength 
Polyplex formation assays are conducted in DNase-free water with 0.4 mL total 
solution volume, using polymer solution (concentration determined by N/P ratio, 100 µL), 
DNA (20 µL, 0.2 µg/µL), Picogreen® (40 µL, 10X), and DNase-free water (40 µL). In 
heparin-induced decomplexation assays, polyplexes are formed in DNase-free water (total 
solution volume = 0.2 mL), then diluted with a mixture of Picogreen® (40 µL, 10X), 
heparin (20 µL, 40 units), and DNase-free water (140 µL) water to bring the total solution 
volume to 0.4 mL. Note that in both of these assays, 100 µL of polymer solution is added 
using N/P = 2 x desired N/P ratio, for example to form polyplexes at N/P 5, N/P 10 stocks 
are used. This is done so that the final mixture of polymer, DNA, Picogreen and heparin 
contains polymer (amount/concentration selected to achieve the desired N/P ratio) is mixed 
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1/1 volume/volume with DNA at 0.02 µg/µL in the presence of 1X Picogreen and 40 units 
of heparin. To examine the effect of total solution volume during polyplex formation, and 
thus the effect of polymer and DNA concentration on DNA binding properties, polyplexes 
were formed from poly(5-tetralysine-1-cyclooctene) (N/P 3.8) and plasmid DNA (mRFP-
IRES-Puro, 4.5 kBp, N/P 3.8) in either 0.2 mL or 0.4 mL total solution volume. After 
allowing the solutions to equilibration 40 minutes, polyplex solutions formed in 0.2 mL 
water were diluted with 0.2 mL water to bring the final volume to 0.4 mL. The polyplex 
solutions (equilibrated in 0.2 mL and 0.4 mL) were dispensed into 3 wells (100 µL /well), 
and then heparin (5 µL, 10 units) and Picogreen (10X, 10 µL) were added to each well. 
While this exceeds the normal 100 µL reaction volume per well, the reagent amounts were 
held constant and the polyplex formation reaction volume set to match that of the polyplex 
formation assay (0.4 mL) or polyplex decomplexation assay (0.2 mL) to determine effects 
of the reaction volume during polyplex formation. The plots in Figure A.5 of (PG 
fluorescence/PG fluorescence*) x 100 % as a function of time show no significant 
differences in complexation properties of mixtures of polymer and DNA solution 
equilibrated in 0.2 and 0.4 mL water.  
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Figure A.5 Effect of the total solution volume during polyplex formation on polymer-
DNA binding. Plot of (PG fluorescence/PG fluorescence*) x 100 % as a function of time 
after addition of heparin (5 µL/well, 10 units/well) and Picogreen (10 units, 10 µL/well) 
to polyplexes formed in 0.2 mL water (and diluted to 0.4 mL with DNase-free water after 
equilibration) (black trace) and polyplexes formed in 0.4 mL water (red trace). 
Polyplexes for these experiments were formed from poly(5-tetralysine-1-cyclooctene) 
(N/P 3.8) and plasmid DNA (mRFP-IRES-Puro, 4.5 kBp). Points indicate the mean and 
standard deviation of three wells from one experiment and instrument gain = 1130. 
A.5 Effect of Picogreen concentration 
To determine the effect of Picogreen concentration on the results obtained from the 
heparin-induced polplex decomplexation assay, experiments were performed using 
Picogreen concentrations of 1X and 2X (Figure A.6). Polyplexes were formed from rNLS 
(N/P 5) and DNA (mRFP-IRES-Puro, 4.5 kBp), followed by the addition of heparin and 
Picogreen (1X or 2X), and (PG fluorescence/PG fluorescence*) plotted as a function of 
time. Experiments performed in 2X Picogreen produced higher fluorescence values which 
required a lower instrument gain setting (gain = 1080 for 2X Picogreen, gain = 1130 for 
1X Picogreen). However, despite the increase in absolute Picogreen fluorescence values 
obtained in experiments performed in 2X Picogreen, the relative percentage accessibility 
calculated as (PG fluorescence/PG fluorescence*) x 100 % was not significantly different 
between experiments performed in 1X and 2X Picogreen.  
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Singer et al. determined the optimal Picogreen concentration for DNA 
quantification assays to be 0.8 µM, and that higher concentrations allowed detection of 
higher amounts of DNA at the cost of lower sensitivity.2 The Quant-it Picogreen® double-
stranded DNA reagent from Invitrogen is specified for the quantification of DNA in 
amounts ranging from 50 pg – 1 µg. In our plate reader assays, each well contains 100 µL 
of a 10 µg/mL solution of DNA and therefore 1 µg, which is the upper limit of the range. 
To ensure linearity of Picogreen fluorescence vs. DNA concentration at 10 µg/mL, DNA 
quantification experiments can be performed using 1X Picogreen at DNA concentrations 
ranging at least from 0.5-20 ug/mL. 
 
 
Figure A.6 Effect of Picogreen concentration on decomplexation assays performed on 
polyplexes formed from rNLS (9a, N/P 5) and plasmid DNA (mRFP-IRES-Puro, 4.5 
kBp). Plot of (PG fluorescence/PG fluorescence*) x 100 % as a function of time after 
addition of heparin (20 µL, 40 units, 10 units/well) and Picogreen at 1X (black traces) 
and 2X (red trace). Points indicate the mean and standard deviation of three wells from 
one experiment. Instrument gain = 1130 (1X Picogreen) and 1080 (2X Picogreen). 
 
A.6 Effect of heparin concentration 
Since heparin competes with DNA for binding with the cationic polymer, it can be 
anticipated that higher heparin concentrations will afford higher percentages of DNA 
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accessible to Picogreen. To determine the effect of heparin concentration in terms of the 
number of units added to the polyplex mixture, polyplexes were formed from PLL (N/P 3) 
and plasmid DNA (mRFP-IRES-Puro, 4.5 kBp) and equilibrated 40 min at room 
temperature. Picogreen (1X) and heparin (10, 20, or 40) units were added to the polyplex 
solution prior to measurement of Picogreen fluorescence as a function of time. This assay 
included three sets of positive controls and blank solutions, one each with 10, 20, and 40 
units of heparin. From the plot in Figure A.7 of (PG fluorescence/PG fluorescence*) x 100 
%, it is clear that the amount of heparin impacts the percentage of DNA accessible to 
Picogreen, however this increases is not linear. The (PG fluorescence/PG fluorescence*) x 
100 % values increased dramatically from 10 to 20 units of heparin, however a minimal 
increase was observed upon increasing the heparin amount to 40 units indicative of 
saturation. Since heparin contributes to Picogreen fluorescence, addition of too much 
heparin will decrease the sensitivity of the assay by increasing background fluorescence. 
On the other hand, addition of 10 units of heparin resulted in a negligible percentage of 
DNA accessible to Picogreen and therefore differences between polymer binding strength 
at this heparin concentration would be difficult to discern. Therefore, optimal 
concentrations of heparin should be selected to allow comparison of polymers with 
different complexation strengths without oversaturating the fluorescence signal, which 
would result in reduced sensitivity of the Picogreen assay. A heparin amount of 40 units 
(10 units per well, 0.1 units/µL) works well and is used in all of the experiments presented 
in this thesis. However, since the percentage of DNA accessible to DNA increases with 
increasing amounts of heparin, this assay provides only a relative measure of percentage 
DNA accessible to Picogreen that can be used for the comparison of DNA binding 
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strengths of different polymers. For example, these conditions allowed the determination 
of differences in DNA binding strength of comb polymers with both cationic and 
zwitterionic pendent groups with zwitterionic contents ranging from 0-50 mol %.12 The 
percentage of DNA accessible to Picogreen increased with the zwitterion content in the 
polymer.  
 
Figure A.7 Effect of heparin amount on decomplexation assays performed on polyplexes 
formed from PLL (N/P 3) and plasmid DNA (mRFP-IRES-Puro, 4.5 kBp). Plot of (PG 
fluorescence/PG fluorescence*) x 100 % as a function of time after addition of Picogreen 
(1X) and either 10 (black trace), 20 (red trace), or 40 units (blue trace). Positive controls 
and blank solutions were prepared with 10, 20, and 40 units of heparin for use with each 
of the polyplex solutions. Points indicate the mean and standard deviation of three wells 
from one experiment. Instrument gain = 1130. 
 
A.7 Summary and conclusions 
Two competitive binding assays discussed here allow for the investigation of DNA 
binding strength of polyplexes formed at high N/P ratios where DNA is close to or 
completely condensed. The polyplex formation assay involves the competition of cationic 
polymer and Picogreen for binding DNA, where Picogreen fluorescence decreases as the 
polymer displaces Picogreen for binding on the polymer. The order of reagent addition (i.e. 
addition of polymer to a mixture of DNA and Picogreen compared to addition of DNA to 
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a mixture of DNA and polymer) in the polyplex formation assay did not impact the results. 
Heparin-induced decomplexation assays using polyplexes formed in the presence and 
absence of Picogreen show that polyplexes formed in the absence of Picogreen permit less 
Picogreen access to DNA relative to those formed in the presence of Picogreen due to the 
competition of Picogreen with polymer for binding DNA. The PG concentration and 
volume of the polyplex formation solution, and thus the polymer and DNA concentration, 
did not impact polyplex binding strength appreciably. Heparin had a large impact on DNA 
binding strength, wherein increased amounts of heparin resulted in a higher percentage of 
DNA accessible to Picogreen. Similar assays for the investigation of N/P ratio on polymer-
DNA binding strength in the presence of heparin can be developed by a series of polyplex 
decomplexation assays, using either a constant amount of heparin or constant N/P/heparin 
ratios.  
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